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ABSTRACT
The study of cellular function within the context of intact living organisms is a grand
challenge in biological research. Addressing this challenge requires imaging tools
that can visualize cells inside the body. If successful, this would greatly increase
our ability to study a battery of processes from brain development to tumorigenesis,
to monitoring cell-based therapeutics. To date, most common methods for imaging
cellular processes such as gene expression have relied on optical reporters, such
as fluorescent or luminescent proteins, which provide high molecular precision for
studies in petri dishes and transparent organisms, but have limited performance in
large animals due to the poor penetration of light in biological tissue. Conversely,
magnetic resonance imaging (MRI) and ultrasound can image tissues at depth with
high spatial and temporal resolution, but they lack molecular reporters analogous to
the green fluorescent protein (GFP). As a result, they have made limited impact on
biological research. To address this, we focus on developing biomolecular reporters
for MRI and ultrasound   based on a unique class of air-filled protein nanostructures
called gas vesicles   using them to image the location and function of cells deep
inside the body.
This thesis begins with a brief review of genetically encoded materials for
noninvasive imaging, highlighting key advances over the past two decades and
providing context for the work below. We discuss the development of increasingly
sophisticated tools starting from early e orts to engineer single molecule reporters
to recent work on multi-component genetic machinery (including gas vesicles) with
multi-modality capabilities. In Chapter 2, we present a platform for engineering the
surface of gas vesicles to modulate their acoustic, surface charge, and molecular-
targeting properties as injectable acoustic biomolecules. In Chapter 3, we present
the recombinant expression of gas vesicles as injectable contrast agents in common
lab strain bacteria to facilitate the genetic engineering of the entire gas vesicle gene
cluster and to assist this technology’s adoption by other (non-specialist) research
groups. This work characterized the ultrasound and hyperpolarized 129Xenon-MRI
contrast of gas vesicles as nanoscale contrast agents.
In a parallel e ort, we developed a hybrid gene cluster that when introduced
to microbes enables the imaging of their gene expression using ultrasound. These
bacterial acoustic reporter genes were used to image the location of probiotic cells
inside the gastrointestinal tract of mice. However, the ability for these genes to be
expressed in mammalian cells had not been demonstrated and presented a major
vi
challenge in synthetic biology. In Chapter 4, we addressed this by introducing the
first mammalian acoustic reporter genes   a genetic program whose introduction to
mammalian cells resulted in the expression of gas vesicles that can be visualized by
ultrasound. These mammalian acoustic reporter genes will enable previously im-
possible approaches to monitoring the location, viability and function of mammalian
cells in vivo.
In Chapter 5, we explore a new paradigm in MRI by taking advantage of the
acousto-magnetic property of gas vesicles. Here, we present background-free MRI
to address a longstanding challenge in untangling the signal of exogenous contrast
agents from the endogenous MRI contrast produced by biological tissues. Chapter
6 explores the optical properties of gas vesicles as genetically encodable phase
contrast agents in digital holographic imaging. Chapter 7 is a brief discussion of
the potential future directions for this work.
The data presented in this thesis lays the ground for exciting new research on
developing noninvasive biomolecular tools that will enable the discovery of novel
biological processes.
vii
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C h a p t e r 1
GENETICALLY ENCODABLE MATERIALS FOR
NONINVASIVE BIOLOGICAL IMAGING
This chapter is in large part a reformatted version of the manuscript entitled “Ge-
netically Encodable Materials for Noninvasive Biological Imaging” currently un-
der peer-review. Under the supervision of Mikhail Shapiro, I contributed to the
writing of the manuscript with valuable input from Felix Sigmund and Gil Wes-
meyer. The section on ultrasound imaging is in part from the manuscript entitled
“Biomolecular Ultrasound and Sonogenetics” published in Annual Review of Chem-
ical and Biomolecular Engineering1. Under the supervision of Mikhail Shapiro,
I contributed to the preparation of the manuscript and wrote the ’Development of
acoustic reporter genes’ section.
1.1 The Need for Noninvasive Imaging of Gene Expression
Biology is complex. One of the best ways to unravel its mysteries is to look at
biological processes and then turn these observations into models that summarize
our understanding. Therefore, it should come as no surprise that many advances
in biology arise from new abilities to observe previously inaccessible biological
processes. For example, the development of the lens enabled Robert Hooke to
access the microscopic world, allowing him to see and described the first (plant)
cell, and the Golgi staining technique allowed Ramón y Cajal to see the cellular
organization of the brain and create illustrations that inspired modern neuroscience.
Few technologies have had as significant an impact as the green fluorescent protein
(GFP) – an imaging agent that can be genetically encoded inside a cell, providing
an intimate connection to its internal life cycle and molecular signals. Due to
its success, GFP has become just one-of-among-many available reporter genes
used by scientists. There are two common uses of reporter genes are: always-on
configuration used to locate and track cells over time, and dynamic reporters used
for connecting the expression of the reporter gene to the transcriptional state of the
cell. Reporter genes can be engineered further to report on the molecular state of
cells with genetically encoded calcium indicators (i.e. GCaMP) being the most
widely used example.
Currently, most reporter genes rely on light, which due to its strong scattering
2
in biological tissue has limited utility beyond approximately one mm in depth2.
Vast demand exists to go deeper, driven by the need to study cellular function
within the context of intact organisms, the development of cell-based diagnostic and
therapeutic agents, and the engineering of complex living materials.
Unlike optical imaging, ultrasound and magnetic resonance imaging (MRI)
penetrate deep inside intact tissue, resulting in their widespread use in clinical
medicine. Over the past 20 years, substantial e ort has been devoted to developing
genetically encodable reporters for these noninvasive imaging modalities: a “GFP
for ultrasound” and a “GFP for MRI”, resulting in important conceptual and practical
advances. In this chapter, I will summarize key advances in the recent developments
of richer, more complex biological materials using the tools of protein engineering
and synthetic biology. A brief introduction to concepts in ultrasound imaging and
MRI important to this thesis will be summarized below.
1.2 Ultrasound Imaging
Ultrasound is defined by sound wave frequencies above those audible to humans (>
20,000 Hz). Generated by transducers coupled to a transmission medium such as
biological tissue, ultrasound waves travel through the medium and interact with its
components to form images. In biological tissues, as in liquids, compression waves
are dominant and are used for most modes of imaging. In tissue, sound waves travel
at ⇠1540 m/s, and are reflected and scattered wherever they experience a change in
acoustic impedance, which is a function of the local density and compressibility3
(Fig. 1-1a). The relative homogeneity of the speed of sound in soft tissues results in
sound waves remaining coherent as they traverse the tissue, enabling simple image
reconstruction without major aberrations4. By comparison, visible light is strongly
scattered in tissues, making it challenging for it to retain a ballistic path at depths
greater than a few hundred microns (Fig. 1-1b).
Ultrasound reflection at tissue interfaces is highly directional and reveals
anatomical contours. Soft tissues have similar acoustic impedance values, resulting
in relatively low contrast between them; air and bones have much lower and higher
acoustic impedances, respectively, resulting in strong reflections4. When the ultra-
sound wave encounters a target smaller than approximately 1/10th the wavelength,
it is scattered omnidirectionally5. Biological tissues include a wide range of such
scatterers in the form of fibers, cells and organelles. The echo from a single scatterer
is usually very weak. When a large number of very close scatterers are imaged,
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Figure 1-1: Properties of ultrasound waves for imaging applications. (A) Physical
properties of ultrasound waves in biological tissues. (B) Physical properties of light traveling
in biological tissue. (C) Fundamental tradeo  between ultrasound resolution and penetration
depth as a function of frequency in brain tissue (penetration depth was assessed based on a
60-decibel round-trip attenuation). At an ultrasound frequency of 15 MHz, one can expect
to image the brain 2 cm deep at a 100-µm resolution. (D) Illustration of ultrasound imaging
capabilities; conventional B-mode image of an infant brain with a submillimeter resolution
of cerebral structures; 15-MHz superresolution ultrasound image of the rat brain vasculature
with an 8-µm resolution, breaking the classical tradeo  exposed in (C) (Adapted from Errico
et al.6)
amplitude of the ultrasound wave decreases exponentially as a function of depth.
Part of the energy of the ultrasonic wave is absorbed in the tissue and dissipated
as heat. Attenuation refers to both absorption and any reduction in wave amplitude
due to reflection or scattering. Each tissue is characterized by a di erent attenuation
coe cient value, which increases non-linearly with frequency4.
Ultrasound imaging is the most prescribed diagnostic modality in clinical
practice7. Typical equipment involves an ultrasound scanner and an ultrasound
probe made of a linear array of transducer elements (i.e. 128 to 256 ultrasound
transmitting/receiving elements)8. Numerous ultrasound imaging modes have been
translated to clinical practice; several of these modes are relevant to biomolecular
ultrasound and will be briefly outlined below.
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B-mode imaging
Ultrasound scanners are primarily used to produce real-time 2-dimensional images
of underlying tissue (Fig. 1-1d). These grayscale images are referred to as B-mode
images (where B stands for brightness) and are acquired through transmission, into
a tissue, of short ultrasound pulses and recording of backscattered echoes. The
location of a scattering or reflecting source is reconstructed from the arrival time of
its signal at each array element in a process known as beamforming. The position of
a point in the reconstructed B-mode image depends on the time of flight of the echo
and the position of the transmitting probe element. The in-depth or axial resolution
of B-mode images depends on the wavelength (  = ctissue/ fUS) and the number of
cycles of vibration of the transmitted pulse. The axial resolution typically ranges
from 500 µm (medical imaging) down to 50 µm (ultrasound biomicroscopy)9. Since
both attenuation and resolution increase with frequency, there is an inherent tradeo 
between resolution and imaging depth (Fig. 1-1c). The lateral resolution of B-mode
images depends on the transmitted ultrasound beam width and is typically a few
hundred microns. The transverse resolution or image thickness is usually on the
order of a millimeter. B-mode imaging is used to image every organ of the body
with the exception of bones or air-filled organs as the lungs.
Contrast imaging
Contrast-enhanced ultrasound relies on the administration of contrast agents to label
specific aspects of anatomy or physiology. The conventional contrast agents used
for this purpose are microbubbles: synthetic, micron-sized bubbles of gas stabilized
by a lipid or protein shell10–13. When injected into the blood stream, microbub-
bles produce strong scattering as they resonate at ultrasound imaging frequencies
(1–20 MHz). Dedicated ultrasound contrast modes have been developed to benefit
from that resonant behavior, such as amplitude modulation14 or phase inversion15,
allowing the detection of microbubbles in vivo with higher specificity. Amplitude
modulation isolates nonlinear ultrasound signals by transmitting ultrasound waves at
di erent amplitudes (for example one high amplitude wave and two half-amplitude
waves) and by subtracting the high amplitude signal from the superposition of the
fractional amplitudes, all the linear backscattered signal will cancel out to reveal the
nonlinear ultrasound signals. Pulse inversion uses the transmission of ultrasound
waves at 180° phase-shift, and the subtracted backscattered ultrasound suppresses
linear signal to reveal nonlinear signals.
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Ultrafast imaging
Conventional B-mode imaging utilizes a series of focused transmissions along an
ultrasound array to form an image, such that the acquisition of a 10 cm-deep image
with a 128-element probe takes at least 128 ⇤ 10 cm ⇤ 2/1540 m/s ⇠ 17 ms, resulting
in a framerate of 59 Hz. A major recent advance, known as ultrafast ultrasound,
uses single plane wave transmissions, rather than focused line transmissions, to
form images, resulting in a two-orders-of-magnitude acceleration in framerate16.
The equivalent temporal resolution for a 10 cm image is 10 cm ⇤ 2/1540 m/s ⇠ 130
µs, or 7,700 frames per second. This advance was made possible by improvements
in computer hardware allowing flexible software beamforming. This technology
was initially developed for shear wave elastography and later applied to Doppler
imaging.
Functional ultrasound imaging
Ultrasound Doppler imaging detects the motion of red blood cells (RBCs) and,
therefore, blood flow17. RBCs scatter weak ultrasound echoes, which can be cap-
tured with modern ultrasound probes. At a given depth in tissue, the temporal shifts
observed in consecutive RBC echoes allow detection of the displacement of RBCs
and derivation of a Doppler signal proportional to RBC velocity. By combining ul-
trafast ultrasound and Doppler imaging, ultrafast Doppler imaging has increased the
sensitivity of conventional Doppler imaging by a factor 30. This leads to high reso-
lution, high signal-to-noise ratio (SNR) maps of the brain vasculature in rodents18.
The sequential acquisition of vascular maps of the brain with ultrafast Doppler has
enabled the detection of neural activity through neurovascular coupling19. Research
e orts are ongoing to turn functional ultrasound imaging of the brain into a full-
fledged neuroscience modality which complements functional-MRI with improved
spatiotemporal resolution, portability and cost.
1.3 Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is an imaging modality that interacts with the
magnetic moment of nuclear spins, typically of protons (1H) from water, due to
their abundance in biological samples. Protons can be thought of as tiny molecular
magnets with a magnetic moment (µ). When a sample is placed in a strong magnetic
field (B1), an ensemble of the protons align longitudinally, parallel to the applied
magnetic field. In a typical MRI experiment, a pulsed radiofrequency wave is
applied to tilt the aligned protons to the transverse plane, 90° from the B1 plane,
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and the resultant radiofrequency signal as the nuclear spins relax to equilibrium is
detected and used to produce MR images.
Two common modes of acquiring MRI contrast are transverse T2 (spin-spin)
relaxation and longitudinal T1 (spin-lattice) relaxation. For T2 relaxation contrast,
initially the transverse magnetic component of protons are in-phase but quickly begin
to dephase (due local field inhomogeneities and the interaction between di erent
spins) and the transverse magnetic components decay at an exponential time constant
T2. For T1 relaxation constant, the longitudinal magnetic component recovers at
an exponential time constant T1 as the excited spins align back to the B1 field and
release their energy to their environment. T1 and T2 relaxation time constants can be
a ected a number of factors including type of nuclei, rate of motion of the molecule,
chemical environment, presence of paramagnetic metal ions and temperature.
1.4 Genetically Encodable Materials: Small Proteins
The earliest genetically encoded reporter used for MRI was an enzyme working in
conjunction with a synthetic organometallic contrast agent (Fig. 1-2a). In 2000,
Louie et al. synthesized a Gd3+ chelator named EgadMe that incorporated a sugar
as part of its organic structure20. The coordination of Gd3+ by water, which leads to
T1-weighted MRI contrast, was competitively inhibited by EgadMe’s sugar moiety.
The enzyme  -galactosidase, then commonly used as an optical reporter of gene
expression visualized with sugar-containing chromogens, cleaved o  the sugar on
EgadMe and thereby increased MRI contrast. While this reporter has not been used
beyond its initial demonstration in frog embryos due to its modest contrast change
and challenging biodistribution, it inspired the development of other genetically
encodable MRI reporters.
The first protein to produce MRI contrast in the absence of external reagents
was the iron storage protein ferritin, which accumulates bioavailable paramagnetic
iron inside an 8-nm protein shell (inner diameter) and produces T2-weighted MRI
contrast. In 2005, two groups independently showed that overexpression of this
protein could result in contrast detectable in vivo21,22. To date, ferritin has been
used in more MRI reporter gene studies than any other protein. However, it leaves
much to be desired in terms of its performance, and significant e orts have been
made to engineer improved ferritins and alternative protein nanocompartments, as
described in the next section.
Besides ferritin, other iron-containing proteins used to generate MRI contrast
include methemoglobin25, transferrin, and the cytochrome P450-BM3. A variant
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Figure 1-2: Small proteins as genetically encoded contrast agents for noninvasive imag-
ing. (A) The tetrameric enzyme beta-galactosidase cleaves the galactopyranosyl ring on the
synthetic Gd3+ chelator EgadMe, leading to increased water binding and T1-weighted MRI
contrast. (B) The heme-binding domain of P450-BM3 was evolved to selectively bind the
neurotransmitter dopamine to alter water access to the paramagnetic Fe3+, yielding a molec-
ular sensor of dopamine for T1-weighted MRI. (C) Designed lysine repeat proteins (LRPs)
rapidly exchange amide protons with water, thus yielding enhanced contrast in chemi-
cal exchange saturation transfer (CEST) MRI. (D) Reporter gene for di usion-weighted
MRI based on increased water di usion across the cell membrane after overexpression of
Aquaporin 1 (AQP1) (E) Hemodynamic contrast mechanism based on local expression and
release of vasoactive peptides lead to increased blood flow detectable with fMRI or other
imaging techniques sensitive to hemodynamics. (Adapted from Desai et al.23) (F) Bacte-
rial phytochrome-derived infrared fluorescent proteins (iFPs) can serve as contrast agents
for optoacoustic imaging. When absorbing near-infrared laser pulses, the chromophores
transform photons into pressure waves detectable with ultrasound. PDB structures 3J7H ( -
galactosidase), 4DU2 (BM3h-B7) and 4CQH (iFP 2.0) were visualized using ChimeraX24.
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of the latter protein was the first MRI reagent engineered with the help of directed
evolution and served as a dynamic molecular sensor of dopamine26 (Fig. 1-2b).
While versions of this sensor have been used to map neurotransmitter release in
the brain, it has so far been employed as an injectable contrast agent rather than
one expressed locally in the tissue. Besides iron, proteins have been engineered
to produce MRI contrast by binding other paramagnetic metal ions such as Gd3+
ref.27. In addition, transporters such as the transferrin receptor and OATP1 have
been used to selectively accumulate externally administered iron and Gd3+ chelates,
respectively28,29.
Metals are not the only way to achieve MRI contrast. Other early work on
protein-based MRI contrast agents focused on proteins with large numbers of ex-
changeable protons that can be imaged with chemical exchange saturation transfer
(CEST) MRI30 (Fig. 1-2c). One of the main advantages of CEST-based reporter
genes is that they do not require metal cofactors, which may have limited in situ
availability. On the other hand, they must typically be expressed at relatively high
concentrations and imaged at high field strengths to be detected above the back-
ground of endogenous cellular proteins. More recently, reporter genes for CEST
MRI have also been developed based on enzymes that catalyze the intracellular
accumulation of synthetic CEST-active substrates31.
While these pioneering approaches demonstrated the feasibility of protein-
based MRI contrast, they have not been widely adopted by the broader biological
community. The primary reasons include the requirement for relatively high con-
centrations, the need for metal cofactors, and competition from background tissue
contrast32.
Recently another class of non-metallic MRI reporter genes was introduced
that overcomes some of these limitations. These reporters produce contrast in
di usion-weighted imaging (DWI) by altering the apparent di usivity of water in
tissue (Fig. 1-2d). Recognizing that the cell membrane is a dominant barrier to
water di usion, Mukherjee et al. showed that the overexpression of aquaporin, a
simple transmembrane channel that exclusively conducts water, could increase the
apparent di usivity of model tissues by up to 200%, resulting in a dramatic change
in DWI contrast33. An experiment in mice showed that intracranial tumors triggered
to express aquaporin could be distinguished by DWI. In a similar study published
at nearly the same time, Schilling et al. overexpressed the urea transporter UT-B,
which co-transports water with urea and also acts as a passive water channel34.
Another innovative mechanism for genetically encodable MRI contrast is based
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on vasoactive peptides whose expression leads to local vasodilation, resulting in
fMRI-like contrast23 (Fig. 1-2e). This allows a modest concentration of peptide
to produce a relatively large signal. Reliance on hemodynamic signals complicates
imaging procedures, but maybe extendable beyond MRI to other hemodynamic
modalities. In addition, vasoactive probes can be engineered as sensors with activity
conditioned on other molecules35.
Unlike in the case of MRI, in which reporter genes had to be developed from
scratch, the task of generating optoacoustic contrast with proteins was, in some ways,
more straightforward. Optoacoustic imaging is a fast, volumetric technique that can
map the distribution of photoabsorbers at deeper tissue layers than accessible by
conventional optical microscopy by converting light absorption into sound waves via
thermoelastic expansion36,37. Any photoabsorbing molecule that dissipates at least
some of the absorbed energy non-radiatively can in principle produce optoacoustic
contrast.
Genetically expressed chromoproteins can provide su cient optoacoustic con-
trast, especially if they possess a high extinction coe cient in the near-infrared
range in which absorbance from endogenous molecules such as hemoglobin is rel-
atively low (Fig. 1-2f). In addition, low quantum yield is desired to maximize
the conversion of photoexcitation into heat. These conditions can be fulfilled in
bacteriophytochromes in which biliverdin serves as a chromophore38–40.
Particularly attractive for increasing signal-to-noise are reversibly photoswitch-
able chromoproteins whose signal time course can be di erentiated from static back-
ground signals even if the latter have higher amplitude41. Multiplexing of several
reversibly switchable chromoproteins can be achieved by temporal unmixing of the
respective signal time courses. In addition, the concentration-independent switching
kinetics can be used to correct signal degradation due to spatially varying intensities
of the illumination42,43. This strategy to suppress static background was particularly
e ective using chromoproteins with absorbance spectra in the near-infrared win-
dow44. Furthermore, molecules that change their absorbance spectrum as a function
of surrounding analytes can be used as dynamic optoacoustic sensors. This mech-
anism was showcased by adapting GCaMP for optoacoustic imaging of calcium
transients in zebrafish45. The tissue depth and sensitivity with which optoacoustic
reporters and sensors can be visualized can be improved by using chromoproteins
with absorption spectra further toward near-infrared wavelengths46.
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1.5 Genetically Encodable Materials: Protein Nanocompartments
As briefly discussed above, the primary mammalian iron-storage compartment fer-
ritin has been over-expressed to generate T2-weighted MRI contrast. However,
its performance is limited by the relatively small size of its iron core (7-8 nm47)
and its weak magnetism (mostly anti-ferromagnetic48 with paramagnetic surface
spins). Several groups have attempted to improve the properties of mammalian
ferritin. A fusion of the heavy and light chain was, for instance, proposed to im-
prove performance as a one-component system49. Two prokaryotic one-component
ferritins were also subjected to a mutational screen, yielding variants with improved
iron occupancy50,51. However, the highly conserved iron transport and ferroxi-
dase functionalities in ferritins seem to limit the improvement possible via protein
engineering.
Could larger genetically controlled nanocompartments be generated that are
more modular than ferritins and provide larger storage capacity? Nanostructures
that self-assemble from proteinaceous building blocks are widespread in nature and
have long been explored as miniature reaction vessels in semi-synthetic approaches.
Douglas et al. showed in 2002 that the interior of the capsid encoded by the Cowpea
chlorotic mottle virus (CCMV) could be subjected to electrostatic engineering to
facilitate iron-mineralization in vitro52.
Recently it was shown that members of a large family of prokaryotic nanocom-
partments called encapsulins53–55 could be heterologously expressed in mammalian
cells (Fig. 1-3). There they self-assemble, auto-encapsulate ferritin-like cargo
proteins and lead to non-toxic iron biomineralization of up to an order of mag-
nitude more iron compared to ferritin56. Heterologous expression of encapsulin
variants enabled T2* contrast enhancement in mammalian cells in culture and upon
xenografting into rat brains56 (Fig. 1-3a, b). Thanks to the electron-dense iron-oxide
core, encapsulins are also readily detectable as fiducial markers in cryo-electron to-
mograms56. Di erent variants of encapsulants can also serve as multiplexable
reporter genes for conventional transmission electron microscopy (TEM) to, for
instance, label neuronal types or states in model organisms based on distinct geo-
metrical features57 (Fig. 1-3b, d). The genetically controlled iron biomineralization
thus enables multimodal molecular imaging that can be cross-registered across vast
scales ranging from MRI to electron microscopy. The two-component encapsulin-
shell:ferroxidase system furthermore enables functionalization of the inner surface
with proteins that can modify the crystallization process and redox state of iron,
such as peptides derived from magnetotactic bacteria56. Notably, overexpression of
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Figure 1-3: Proteinaceous nanocompartments as multiscale contrast agents. Schematic
summarizing work on metalloproteins for molecular imaging applications. (A) Genetic con-
structs for expression of the M. xanthus encapsulin system in mammalian systems consisting
of its shell forming monomer MxEncA and a multigene expression cassette for co-expression
of its endogenous cargo proteins (MxEncBCD) or engineered cargos such as a soluble bacte-
rial tyrosinase (BmTyr) with a C-terminal encapsulation signal. Cutaway view of the MxEnc
nanocompartment (T=3) schematically showing internal cargo proteins either yielding iron
oxides for detection in MRI or cryoET or melanin pigments that a ord (B) detection by
MRI, optoacoustics, and cryo-electron tomography. (Adapted from Sigmund et al.56.) (C)
Genetic constructs for expression of the Q. thermotolerans encapsulin system in mammalian
systems consisting of its shell forming monomer QtEnc and its iron-mineralizing cargo pro-
tein QtIMEF, or other engineered cargos such as fluorescent proteins. Cutaway view of the
larger QtEnc nanocompartment (T=4 icosahedral symmetry) showing a zoom-in onto the
pore region at the five fold symmetry center and docked QtIMEF cargo yielding e ective
iron biomineralization a ording contrast in TEM images of (D) HEK293T cells and T4/5
Drosophila neurons. (Adapted from Sigmund et al.57.) Structures of BM3h (PDB: 4DU2),
ferritin (EMD-2788), Mx Encapsulin (EMD-5917), BmTyr (PDB: 3NM8), Qt Encapsulin
(EMD-4879) and QtIMEF (PDB: 6N63) were visualized using ChimeraX24.
iron-filled encapsulins from Myxococcus xanthus allowed for magnetically actuated
cell sorting (MACS) using standard commercial columns, whereas expressing iron-
loaded ferritin did not enable this feature56. Similarly, substantial MRI contrast and
MACS separation were also enabled in E. coli expressing a fusion protein mediating
iron oxidation and accumulation into a disordered ferrogel58.
While the preceding results demonstrate that high levels of paramagnetic iron
can be e ective, even stronger MRI contrast and magnetic manipulation could be
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achieved with the formation of superparamagnetic or ferromagnetic magnetite or
maghemite crystals, such as those found in the magnetosomes of magnetotactic
bacteria59. To date, magnetosomes have only been heterologously expressed in
a close genetic relative of magnetotactic bacteria60. This remarkable feat has,
however, not yet been achieved in common prokaryotes applied in biotechnology or
eukaryotic cells.
Encapsulins can also be engineered to form nanomaterials with other mate-
rial properties, such as strong photoabsorbance. This feature can, for instance,
be achieved by selective targeting of enzymatic activity to the encapsulin lumen
by either complementing split enzymes inside the compartment or by attaching a
degradation signal that ablates all copies of the enzyme that are not encapsulated. In
this way, robust contrast can be obtained in optoacoustic images by encapsulating a
soluble bacterial tyrosinase, which converts tyrosine molecules entering through the
shell’s pores into polymeric melanin that becomes trapped in the lumen (Fig. 1-3a).
Melanin has a broad absorbance spectrum reaching into the near-infrared range and
generates strong signals in optoacoustic imaging61 (Fig. 1-3b). However, melanin,
in its natural form, for example in human skin, is sequestered in membrane-enclosed
melanosomes expressed by specialized melanophore cells because it tends to be
toxic when freely available in cells. Compartmentalizing melanin formation into
encapsulin-based “designer melanosomes” thus successfully emulates detoxification
by sequestration. Given that multiple enzymes can be arrayed inside encapsulins,
biosynthetic pathways for pigments such as violacein62, with sharper absorption
spectra than melanin, could be produced inside encapsulins to optimize multiplex-
ing via multispectral optoacoustic tomography (MSOT). Such use of biosynthetic
pigments can be superior to chromoproteins, which have a comparably lower photo-
stability, presenting challenges, especially for optoacoustic microscopy techniques
that apply relatively high energy densities to the sample.
Inspired by the capability of animals such as the cuttlefish to change their
skin color by relocalizing pigment-filled organelles inside dedicated chromatophore
cells, it was recently furthermore demonstrated that melanin-filled melanophore can
be turned into optoacoustic sensors for imaging the activation of the important class
of G-protein-coupled receptors (GPCRs)63. GPCR-ligand-induced agglomeration
of the melanin-filled cellular organelles inside the reporter cells could not only be
detected via an increase in the optoacoustic signal amplitude but also by a shift
in the optoacoustic signal frequency, providing an orthogonal means of observing
dynamically changing molecular contrast63.
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1.6 Genetically Encodable Materials: Proteins with gas
The ability of gas to produce contrast is well-established for both ultrasound and
MRI. Synthetic ultrasound contrast agents include microbubbles, which obtain their
ability to scatter sound waves from their di erential density and compressibility
relative to aqueous tissue64. Meanwhile, the di erential magnetic susceptibility of
air-filled body cavities (such as lungs and nasal passages) relative to tissue distorts
MR images. Can the unique properties of gas be harnessed in the context of
genetically encodable materials?
In 2014, Shapiro et al. described the use of a unique class of air-filled protein
nanostructures, called gas vesicles (GVs), as acoustic biomolecules for ultrasound
imaging65. GVs are made of a 2-nm thick protein shell that assembles into a hollow
nanostructure with dimensions on the order of 100 nm (Fig. 1-4a). GVs are natively
expressed as flotation devices in a number of waterborne microbes, where they are
encoded by operons of 8-14 genes, including structural proteins and assembly factors
essential for GV formation. The large acoustic impedance mismatch between the
GVs’ gaseous interior and surrounding aqueous media allows these nanoparticles to
produce ultrasound contrast in vitro and in vivo. In addition, the ability of certain
natural and engineered GV genotypes to undergo buckling mechanical deformations
under ultrasound results in nonlinear contrast, facilitating their detection against
background tissue66–69. Since GVs are genetically encodable, their mechanics can
be tuned using protein engineering techniques, and they can be functionalized with
new surface properties and targeting moieties68,70.
To turn GVs into acoustic reporter genes (ARGs) for ultrasound, the poly-
cistronic gene clusters encoding GV assembly must be adapted from their native
organisms into new species. This was first accomplished in bacteria. By combining
GV genes from two organisms, Anabaena flos-aquae and Bacillus megaterium, a
hybrid cluster was developed (Fig. 1-4b) that encodes the expression of GVs in E.
coli and Salmonella typhimurium, two commensal microbes and common chassis
for synthetic biology74. This approach enabled the imaging of bacterial gene ex-
pression inside the GI tract of mice. Bacterial ARGs open the possibility of studying
and tracking microbial interactions inside mammalian hosts with ultrasound, and
can be a powerful tool in the development of microbial diagnostics and therapeu-
tics75. Significant scope exists to optimize the expression and acoustic properties
of bacterial ARGs, and to deploy them in a greater number of species and in vivo
scenarios. In each application, it will be critical to verify that ARG expression does
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Figure 1-4: Genetically encodable air-filled protein nanostructures as multimodality
contrast agents. (A) Transmission electron micrograph of a gas vesicle, and a diagram
of the various material properties used to produce contrast in imaging modalities. Z,
acoustic impedance;   magnetic susceptibility; n, index of refraction. (B) Engineered
bacterial gene cluster, ARG1, comprising genes from Anabaena flos-aquea (orange) and
Bacillus megaterium (blue) that encode the heterologous expression of GVs in bacteria.
(C) Representative electron micrograph of heterologously expressed GVs in the cytosol
of mammalian cells. (D) Synthetic mammalian operon, mARG1, comprising 9 genes
originating from B. megaterium that result in GV expression in mammalian cells. (E-G)
GVs as genetically encodable contrast agents and reporter genes for in vivo (E) ultrasound
imaging71, (F) magnetic resonance imaging72 and (G) optical coherence tomography73.
After bacterial expression, the next major milestone was to develop ARGs
for mammalian cells. Transferring a large polycistronic program for self-assembly
from prokaryotes to eukaryotes is a major challenge in synthetic biology due to the
di erential handling of transcription and translation between these kingdoms and
the need to ensure proper folding, stoichiometry and assembly of the constituent
proteins. Farhadi et al. overcame this challenge by constructing mammalian ARG
operons based on 9 genes from B. megaterium, stringing groups of these genes
together using viral 2A self-cleavage peptides and controlling stoichiometry though
copy number71 (Fig. 1-4c, d). ARG expression could then be imaged in human cells
in vitro at volumetric densities below 0.5% and in cells expressing just a few GVs
per cell. In vivo ARG expression was imaged in a mouse tumor xenograft, revealing
localized gene expression with a spatial resolution of 100 µm (Fig. 1-4e). ARG
imaging in mammalian cells was enabled by a highly sensitive ultrasound imaging
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paradigm taking advantage of strong acoustic emissions from GVs as they collapse
in response to acoustic pressure. Further optimization is needed to turn mammalian
ARGs into a commonly used reporter gene. For example, expression in primary
cells such as neurons and immune cells will benefit from the packaging of ARGs
into viral vectors, which typically requires a smaller genetic footprint. Additional
study of the immune response to GVs and GV-expression is also needed to enable
clinical translation of this technology in the context of cell-based diagnostics and
therapeutics.
Can GVs also serve as reporter genes for MRI? This possibility was realized
by Lu et al. by demonstrating that the presence of GVs leads to dephasing of
proton nuclear spins, yielding T2/T2*-weighted MRI contrast. This phenomenon is
based on the magnetic susceptibility di erence between the air-filled interior of GVs
(slightly paramagnetic) and surrounding aqueous media (diamagnetic) (Fig. 1-4a)72.
Furthermore, the collapse of GVs with ultrasound during MRI acquisition allowed
acoustic modulation of the GVs’ MRI contrast and the acquisition of background-
subtracted images. This allowed their molecular contrast to be easily distinguished
from potentially confounding endogenous contrast sources, as demonstrated in vitro
and in several mouse organs (Fig. 1-4f). In addition to conventional proton MRI,
GVs are also able to serve as contrast agents for hyperpolarized 129Xe ref.76. In
this application, the protein shell of GVs allows xenon dissolved in the surrounding
solution to partition in and out of the GV, enabling the production of CEST contrast.
Because hyperpolarization greatly boosts the signal obtained from each nucleus, this
scheme increases the sensitivity of GV detection, reaching sub-nM levels. Since the
introduction of GVs as the first reporter gene for 129Xe-MRI, other proteins have
also been shown to bind xenon and produce CEST contrast77.
Besides ultrasound and MRI, the gaseous core of GVs provides an opportunity
for their use as genetically encodable contrast agents for optical imaging techniques
sensitive to refractive index, which di ers substantially between air and water (Fig.
1-4a). For example, it was recently shown that GVs can serve as contrast agents
for optical coherence tomography (OCT), a modality widely used in biomedical
imaging due to its ability to provide single-µm spatial resolution at tissue depths of
several mm. In this application, GVs play a role directly analogous to ultrasound
by backscattering photons, as shown in vitro and the mouse eye73 (Fig. 1-4g). In
a separate study, it was shown that the propagation of light waves through GVs
distorts their phase, allowing GVs and GV-expressing cells to be visualized using
digital holographic microscopy (DHM), a volumetric imaging technique with unique
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advantages for in vitro microscopy78.
Alongside their uses in imaging, GVs can transduce ultrasound into mechanical
force79 and inertial bubble cavitation80, allowing GVs and GV-expressing cells to
be manipulated with acoustic fields and serve as therapeutic agents for targeted cell
killing and drug release. These additional capabilities enable new possibilities in
cellular actuation, engineered living materials81 and theranostics that are beyond the
scope of this Introduction.
1.7 Genetically Encodable Materials: Outlook
The new materials and approaches described above are already providing unprece-
dented ways to visualize cellular function in vivo. However, many challenges and
opportunities remain for improved performance and broader applications. While
most of the materials used as genetically encoded contrast agents have been derived
from naturally evolved genes, it should be possible to access a wider range of physical
properties through de novo protein design, taking advantage of rapid progress in the
engineering of proteins with new structure, self-assembly, and function82. As with
natural proteins, de novo constructs for imaging could be improved with directed
evolution26 and machine learning83, and new properties could be added by em-
ploying non-canonical amino acids and bio-orthogonal chemistry84. Going beyond
proteins, new ways to generate complex structures with nucleic acids, sugars, and
other cellular polymers may enable new functionality. In parallel, natural genomes
containing the Earth’s collective evolutionary diversity will doubtless continue to
o er unexpected new materials and inspiration for biomimetic designs.
Here, we have emphasized the advantages of leveraging more complex, self-
assembling biomaterials. Continuing to engineer such materials and harness even
more complex structures such as magnetosomes will require operating at the limits
of synthetic biology, including not just improved ways of combining and delivering
genes, but gaining control over cellular phases, compartments, and specialized
organelles. Besides, modifications of the host cell’s genome may also be needed
to enable the expression of new materials or minimize the impact on host cell
viability and function. In addition, it may be possible to leverage the dynamic
behavior of synthetic biological circuits to produce time-varying signals to enhance
the sensitivity and specificity of imaging. Achieving these goals is likely to advance
not just biological imaging, but synthetic biology itself85.
Another relatively unexplored frontier in biological imaging in vivo is the
development of dynamic sensors for cellular signals ranging from extracellular
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neurotransmitters and proteases to intracellular ions such as calcium. A wide array
of dynamic biosensors is available for fluorescence microscopy86, while relatively
few examples have been put forward for ultrasound, MRI or optoacoustic imaging.
With these improvements in performance and capabilities, genetically encod-
able reporters for noninvasive imaging will play a more significant role in basic
biology, cell-based diagnostics, therapeutics, and engineered living materials. It
may one day be possible for biologists to order a GV-expressing or encapsulin-
expressing transgenic mouse to study the function of a certain cell type in vivo as
easily as is standard today with mouse lines expressing GFP, or to select from a
catalog of viral vectors expressing these reporters for convenient labeling of cells or
tissues. In engineered living materials81, these same reporters are likely to play an
increasing role as cell-based, and cell-made structures continue to scale in dimen-
sions beyond the reach of optical microscopy. Finally, genetically encoded reporters
have the opportunity to help address the need to track and monitor the performance
of genetic and cellular therapeutics during both preclinical development and deploy-
ment in patients. The possibility that some of the materials discussed in this chapter
can also serve as agents for cellular manipulation and therapy will help propel them
deeper into each of these application areas.
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C h a p t e r 2
MOLECULAR ENGINEERING OF ACOUSTIC PROTEIN
NANOSTRUCTURES
This chapter is in large part a reformatted version of the manuscript entitled “ Molec-
ular Engineering of Acoustic Protein Nanostructures” published by Lakshmanan,
A., Farhadi, A., Nety, S.P., Lee-Gosselin, A., Bourdeau, R.W., Maresca, D., and
Shapiro M.G., in ACS Nano1. Under the supervision of Mikhail Shapiro, my con-
tributions to the work was to help design and conduct the experiments in addition to
analyzing and interpreting the data, in particular experiments related to engineering
the surface properties of gas vesicles to modulate their surface charge and human
cell targeting capabilities.
2.1 Abstract
Ultrasound is among the most widely used biomedical imaging modalities, but
has limited ability to image specific molecular targets due to the lack of suitable
nanoscale contrast agents. Gas vesicles – genetically encoded protein nanostructures
isolated from buoyant photosynthetic microbes – have recently been identified as
novel nanoscale reporters for ultrasound. Their unique physical properties give gas
vesicles major advantages over conventional microbubble contrast agents, including
nanoscale dimensions and inherent physical stability. Furthermore, as a genetically
encoded material, gas vesicles present the possibility that the nanoscale mechanical,
acoustic and targeting properties of an imaging agent can be engineered at the
level of its constituent proteins. Here, we demonstrate for the first time that genetic
engineering of gas vesicles results in nanostructures with novel mechanical, acoustic,
surface and functional properties to enable new types of harmonic, multiplexed and
multimodal imaging, as well as cell-specific molecular targeting. These results
establish an unprecedented biomolecular platform for the engineering of acoustic
nanomaterials to address a critical unmet need in biology and medicine.
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2.2 Introduction
Ultrasound is among the most widely used biomedical imaging modalities due to its
superior spatiotemporal resolution, safety, cost and ease of use compared to other
techniques such as magnetic resonance and nuclear imaging. In addition to visual-
izing anatomy and physiology, ultrasound can take advantage of contrast agents to
more specifically image blood flow, discern the location of certain molecular targets,
and resolve structures beyond its normal wavelength limit via super-localization.2,3
However, existing “microbubble” contrast agents–micron-sized bubbles of gas sta-
bilized by a biocompatible shell–face limitations as molecular reporters due to their
size and inherent physical instability, restricting their use to primarily within the vas-
culature.4,5 Recently, we introduced gas vesicles (GVs) as a new class of nanoscale
imaging agents for ultrasound.6 GVs are gas-filled protein-shelled nanostructures
(Fig. 2-1a) expressed intracellularly in certain bacteria and archaea as a mechanism
to regulate cellular buoyancy in aqueous environments.7,8 GVs have widths of 45-
250 nm and lengths of 100-800 nm depending on their genetic origins.7,8 Unlike
microbubbles, which trap pre-loaded gas in an unstable configuration, GVs’ 2-nm
thick protein shells exclude water but permit gas to freely di use in and out from
the surrounding media7 (Fig. 2-1b), making them physically stable despite their
nanometer size. GVs produce robust ultrasound contrast across a range of frequen-
cies at picomolar concentrations, exhibit harmonic scattering to enable enhanced
detection versus background in vivo, and have species- dependent thresholds for
pressure-induced collapse to enable multiplexed imaging.6 Furthermore, the genetic
encodability of GVs raises the possibility of engineering the properties of these
nanoscale imaging agents at the level of their protein composition and DNA se-
quence. Here, we establish this capability for the first time by biochemically and
genetically engineering the mechanical, acoustic, surface and targeting properties
of GVs from the cyanobacterium Anabaena flos-aquae (Ana GVs).
Ana GVs are cone-tipped cylindrical structures with a diameter of approxi-
mately 140 nm and length of 200-800 nm (Fig. 2-1a, b). These structures are
encoded by a cluster of 9 di erent genes, including the two primary structural pro-
teins, GvpA and GvpC, and several putative minor components and chaperones8–10
(Fig. 2-1b). GvpA is a 7.4 kDa amphiphilic protein that assembles into the main
structural backbone of the GV shell by forming 4.6 nm-wide ribs that run perpen-
dicular to the long axis of the nanostructure11,12(Fig. 2-1c). GvpC is the second
most abundant protein, and strengthens the GV shell by binding to its exterior sur-
face.12,13 This protein comprises five highly conserved 33-amino acid repeats with
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Figure 2-1: Molecular engineering platform for acoustic protein nanostructures. (a)
Transmission Electron Microscopy (TEM) image of a single Ana GV. (b) Schematic illus-
tration of Ana GV, and the gene cluster encoding GvpA, GvpC and several other essential
proteins. (c) GvpA and GvpC are the two major structural constituents of GVs, with GvpA
ribs (gray) forming the primary GV shell and the outer sca old protein GvpC (blue) con-
ferring structural integrity. Each GvpC molecule has five 33-amino acid repeats flanked
by N- and C- terminal regions (d) Paradigm for modular genetic engineering of Ana GVs.
Native gas vesicles are treated with 6M urea to produce stripped Ana GVs without native
GvpC (blue). Genetically engineered GvpC is recombinantly expressed in Escherichia coli
(orange) and added to the stripped Ana GVs during dialysis to create engineered GVs with
a modified GvpC layer. (e) GvpC engineering can be used to modulate the properties of
acoustic GV nanostructures including their harmonic response, collapse pressure, surface
charge, targeting specificity and fluorescence.
predicted alpha-helical structure, and is believed to bind across GvpA ribs to provide
structural reinforcement12 (Fig. 2-1c). In biochemical studies, removal of GvpC
and truncations to its sequence were shown to result in a reduced threshold for Ana
GV collapse under hydrostatic pressure.13,14 In addition, previous studies in other
species have demonstrated that GvpC can tolerate fusions of bacterial and viral
polypeptides.15,16 Given these properties, we hypothesized that GvpC could serve
as a versatile platform for molecular engineering of GV-based ultrasound contrast
agents. Specifically, we predicted that changes in GV mechanical properties result-
ing from the removal, addition, or modification of GvpC would alter the acoustic
properties of Ana GVs, thereby allowing us to tune their ultrasound response and
enable harmonic and multiplexed imaging (Figure 2-1d, e). Furthermore, we hy-
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pothesized that GvpC could serve as a modular genetic hook enabling the tuning of
GV surface properties such as zeta potential, the display of ligands for reduced or
enhanced cellular targeting and uptake, and the attachment of fluorescent proteins
to enable multimodal imaging (Figure 2-1e).
2.3 Results and Discussions
Modular Genetic Engineering Platform for Acoustic Protein Nanostructures.
To enable modular molecular engineering of Ana GVs, we established a platform
in which genetically engineered GvpC variants are recombinantly expressed in Es-
cherichia coli and subsequently added to Ana GVs that have been purified from A.
flos-aquae and stripped of their native GvpC proteins (Figure 2-1d). The GVs were
isolated by hypertonic and detergent-mediated lysis, followed by purification with
centrifugally assisted floatation. Native GvpC was removed by treating the GVs
with 6 M urea, which leaves the GvpA-based shell intact.13,14 We produced genet-
ically engineered variants of Ana GvpC containing N- or C-terminal hexahistidine
sequences in E. coli and purified the resulting inclusion bodies by nickel chromatog-
raphy in 6 M urea. Dialysis of recombinant GvpC in the presence of stripped Ana
GVs into physiological bu er resulted in Ana GVs with a new, engineered GvpC
layer (Figure 2-1d). Sodium dodecyl sulphate polyacrylamide gel electrophoresis
(SDS-PAGE) analysis confirmed the complete removal of GvpC from native Ana
GVs and the re-addition of engineered proteins (Figure 2-S1).
Genetic Engineering Enables Tuning of Collapse Pressure for Acoustic
Multiplexing. The gaseous interior of GVs can be collapsed with hydrostatic and
acoustic pressure, erasing their ultrasound scattering signal and enabling multiplexed
imaging of GVs with distinct collapse pressure thresholds.6 To determine whether
genetic tuning could enable enhanced multiplexing, we engineered three Ana GV
variants with distinct mechanical properties.  GvpC comprises GVs completely
lacking the outer GvpC layer;  N&C contains a truncated form of GvpC without its
N- and C-terminal regions; GvpCWT has an engineered GvpC protein that closely
resembles the wild-type sequence (Figure 2-2a). We assessed the hydrostatic col-
lapse behavior of these nanostructures using pressurized absorbance spectroscopy,
in which the optical density of GVs (which scatter 500 nm light when intact) is
measured under increasing hydrostatic pressure. This provides a rapid assessment
of GV mechanics and allows comparisons to literature.7 Our three variants spanned
a dynamic range of 380 kPa (Figure 2-2b, Table 2-S1).  GvpC had the lowest
collapse pressure midpoint at 195.3 ± 0.3 kPa, the  N&C variant showed an inter-
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mediate value of 374.3 ± 1 kPa, and GvpCWT had the highest value of 569.9 ± 4 kPa
(Table 2-S1, N =7, ± SEM). To ensure that the decrease in collapse pressure for the
 N&C variant was not due to unsaturated binding caused by reduced a nity of this
GvpC variant for GvpA, we measured collapse midpoints as a function of re-added
GvpC concentration and confirmed that binding was near saturation (Figures 2-S2,
2-S3).
Figure 2-2: (Caption on next page.)
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Figure 2-2: GvpC engineering enables tuning of GV collapse pressurenvpC engineer-
ing enables tuning of GV collapse pressure for acoustic multiplexing. (a) Schematic
illustration of the three engineered GV variants used for acoustic multiplexing.  GvpC,
 N&C and GvpCWT variants are represented by green, orange and purple colors respec-
tively. Accompanying TEM images show the conservation of GV shape among the three
variants (scale bars are 200 nm). (b) Optical density measurements of engineered Ana GVs
as a function of hydrostatic pressure (N=7 independent preparations, error bars are SEM).
The data was fitted with a Boltzmann sigmoid function. Fit parameters and R2 values are
provided in Table 2-S1. (c) Acoustic collapse curves for the GV variants showing nor-
malized ultrasound signal intensity as a function of increasing peak positive pressure from
290 kPa to 1.23 MPa (N= 3 independent trials, error bars are SEM). The data was fitted
with a Boltzmann sigmoid function (parameters provided in Table 2-S2), the derivatives
of which with respect to pressure are plotted in (d). (e) Schematic illustration of acoustic
spectral unmixing, showing serial collapse of the GV variants based on their critical collapse
pressure and indicating the pressures used in panels f and g. (f) Ultrasound images of an
agarose phantom containing wells with  GvpC,  N&C and GvpCWT and a mixture of the
three variants (all GVs at final OD 1.0 in PBS), acquired at 6.25 MHz. I0; before collapse
I1: after collapse at 630 kPa I2: after collapse at 790 kPa I3: after collapse at 1230 kPa.
(g) Spectrally unmixed images processed from the raw ultrasound data in (f). The bottom
panel shows an overlay of the three unmixed channels C1, C2, and C3.
Next, we evaluated collapse profiles under ultrasound. GVs were imaged in
multiwell agarose phantoms at 6.25 MHz while being subjected to ultrasound pulses
with increasing peak positive pressure amplitudes ranging from 290 kPa to 1.23 MPa.
Similar to trends observed for hydrostatic collapse, the  GvpC variant collapses
under the lowest acoustic pressure, followed by  N&C and GvpCWT (Figure 2-
2c, Table 2-S2). Notably, the collapse midpoints in the acoustic regime were
substantially higher than in the hydrostatic regime. This is explained by GVs having
a gas e ux time of approximately 1.5 µs,17 which is too slow for gas molecules
contained in the GV to exit the nanostructure during the 80 ns positive half-cycle
of 6.25 MHz ultrasound, allowing the gas to compressively reinforce the GV shell.
On the other hand, under hydrostatic conditions, pressure changes occur on the time
scale of seconds, allowing gas molecules to exit the GV during pressurization and
resulting in the shell carrying the full compressive load by itself.18 We also note that
the acoustic collapse curves appear somewhat more closely spaced than hydrostatic
collapse curves, which can be explained by the applied acoustic pressure field having
a nonuniform profile over the imaged GV sample. Fitting a Boltzmann sigmoidal
function to these collapse curves reveals a unique acoustic collapse spectrum for
each engineered GV (Figure 2-2d).
To take advantage of the distinct acoustic collapse spectra of GV variants for
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multiplexed imaging, we developed a pressure spectral unmixing paradigm. This
paradigm posits that the total signal for a mixed population of GVs in any given
pixel is the sum of signals contributed by each subpopulation present in that pixel.
Images acquired after sequentially applying collapse pulses of increasing pressure
(Pi) reveal changes in pixel-wise signal intensity (I) that provide information about
the abundance of each GV type in the pixel (Figure 2-2e). This information is
extracted by multiplying the measured di erential signals:
 i = I(Pi 1)   I(Pi)
by the inverse of a matrix containing the collapse spectrum of each type of GV,
denoted by ↵i, j . The contribution of each GV type to the observed signal represented
as Cj is given by the matrix operation:
C = ↵ 1 
We used pressure spectral unmixing to obtain multiplexed images of our three
GV variants. Figure 2-2f shows ultrasound images taken at a nondestructive baseline
pressure before and after exposing the GV samples to three sequentially increasing
collapse pulses. The spectrally unmixed images (Figure 2-2g) uniquely identify
acoustic signals from each GV variant. Figure 2-S4 shows the matrix of coe cients
used to generate these images. We anticipate that this combination of engineered
GVs and pressure spectral unmixing will be useful in many scenarios requiring
ultrasound imaging of multiple molecular targets in the same sample.
Molecular Engineering Enables Modulation of Harmonic Ultrasound Sig-
nals. Nonlinear signals from ultrasound contrast agents can dramatically enhance
their ability to be distinguished from background tissues, which mainly scatter lin-
early.19,20 In our initial description of GVs as ultrasound reporters, we found that
GVs from Halobacterium salinarum (Halo GVs) produce strong nonlinear signals
in the form of harmonics filtering around the fundamental and second harmonic
frequencies showed a substantial di erence in the harmonic acoustic response of
GV variants (p < 0.01, N= 7, paired t test), for the same level of fundamental signal
(Figure 2-3b-e). The harmonic signals from  GvpC were 3.71 fold higher than
GvpCWT (Figure 2-3e). These results demonstrate that protein engineering can be
used to modulate the acoustic properties of a nanostructure.
To show that engineered Ana GV variants are capable of producing harmonic
signals in vivo, we performed intravenous injections of the  GvpC and GvpCWT


































































Figure 2-3: GV engineering enables modulation of harmonic signals in vitro. (a) Power
spectrum of signal backscattered from  GvpC (green) and GvpCWT (purple) variants in
an agarose phantom in response to 4.46 MHz pulses. (b) Fundamental and (c) second
harmonic ultrasound images of  GvpC and GvpCWT acquired with 4.46 MHz transmission
and band-pass filtered around 4.46 and 8.92 MHz respectively. Images are shown before
and after collapse using a high power burst from the transducer to collapse the GVs. Scale
bars are 1 mm. (d) Mean fundamental and (e) harmonic signals from  GvpC and GvpCWT
variants after filtering at the indicated frequencies (N = 7 independent measurements, error
bars are SEM). Data in all panels comes from GVs prepared at OD 2.5 in PBS and loaded
into 1% agarose phantoms.
(IVC) was performed in fundamental and second harmonic modes (transmission
at 4.46 MHz and reception filtered around 4.46 and 8.9 MHz center frequencies,
respectively). Figure 2-4a provides a schematic illustration of the in vivo experi-
ment. Five seconds after the start of the injection, enhanced nonlinear signals were
observed for the  GvpC variant compared to GvpCWT, while their fundamental
signals were comparable (Figure 2-4b-d). Repeated trials showed a statistically
significant di erence (p < 0.01, N = 6, paired t test) in the harmonic response of
the two variants for the same level of fundamental signal (Figure 2-4e), consistent
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with in vitro results. The ability to genetically tune the harmonic properties of GV
contrast agents will enhance their utility for in vitro and in vivo imaging.
Genetic Engineering Enables Tuning of Surface Charge, Targeting Speci-
ficity, and Multimodal Imaging. After demonstrating the ability of GvpC to serve
as a genetic platform for tuning the mechanical and acoustic properties of GVs,
we examined its capacity to enable the engineering of GV surface and targeting
properties. To do so, we used the C- terminus of GvpC as a modular site for protein
fusion (Figures 2-5a and 2-S5). As a first proof of concept, we tested the ability of
GvpC fusions to modulate GV surface charge, an important property that influences
the behavior of nanostructures in solution and in vivo.21 We fused GvpC with the
lysine-rich protein (LRP), which contains 100 positive charges at physiological pH.
Re-addition of this protein to GVs resulted in nanostructures with 28 ± 4 mV higher
Figure 2-4: GV engineering enables modulation of harmonic signals in vivo. (a)
Schematic depiction of intravenous GV injection and in vivo ultrasound imaging during pas-
sage through the inferior vena cava (IVC). (b) Fundamental and second harmonic ultrasound
images taken at 4.46 MHz transmission frequency and band-pass filtered receive around
4.46 and 8.92 MHz respectively. Engineered Ana GVs at OD 23.5 in PBS were used for
injections. The IVC ROI used for subsequent analysis is circled in green. The white arrow
points to the increased harmonic signal observed in the IVC for the  GvpC variant. Time
course of the mean (c) fundamental and (d) harmonic acoustic signal in the IVC before,
during and after steady infusion, with shaded regions representing SEM (N = 6 mice). (e)
Histogram showing the area under the curve (AUC) of average fundamental and harmonic
contrast in the IVC after  GvpC and GvpCWT GV injections (N=6, error bars are SEM).
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zeta potential compared to GvpCWT (Figure 2-5b).
Next, we tested the ability of GvpC fusions to endow GVs with functionality
for specific cellular targeting. A well-studied receptor-targeting peptide is arginyl-
glycylaspartic acid (RGD), which binds e ectively to a wide range of integrins.22
GVs engineered to express GvpCRGD on their surface were compared with wild-
type GvpC and scrambled GvpCRDG controls in terms of their ability to target the
integrin-overexpressing U87 human glioblastoma cell line in vitro. The GVs were
chemically conjugated with the Alexa Fluor-488 fluorophore for visualization using
confocal microscopy. GVs functionalized with RGD exhibited a marked increase
in cell binding compared to controls (Figure 2-5c, d). This technique presents a
generalizable approach for future studies targeting GVs to molecular markers in
vivo.
Using a similar engineering strategy, we created GvpC fusions to modulate the
interaction of GVs with macrophages, which are both imaging targets and important
actors in nanoparticle clearance from circulation. CD47, present on endogenous
cell membranes in humans, mice, and other mammals, is a well-studied putative
marker of self. Discher and colleagues recently described a minimized peptide
from the human CD47 protein, dubbed the “self” peptide, which led to reduced
uptake of cells and nanoparticles by the mononuclear phagocytic system.23 On
the other hand, polycationic peptides such as polyarginine (R8) promote particle
uptake by phagocytic cells.24 By fusing each of these molecules to GvpC, we
tested whether genetic engineering could modulate GV uptake in mouse leukaemic
monocyte macrophage cell line (RAW 264.7) murine macrophages. As visualized
by confocal microscopy, GVs genetically functionalized with GvpCmCD47 showed
reduced macrophage uptake compared to GVs with GvpCWT. On the other hand,
GVs functionalized with GvpCR8 were taken up much more e ciently (Figure 2-
5e, f). These molecular strategies can be used in future studies to enable cellular
labeling for in vivo tracking applications or to enhance the circulation lifetime of
targeted GVs.
Finally, to further simplify GV functionalization, we developed a highly mod-
ular approach through which the GV surface can be covalently conjugated to other
recombinant proteins through a facile process that does not involve urea treatment
and dialysis. To achieve this goal, we fused GvpC with SpyTag (ST), a 13-residue
peptide that forms a covalent amide bond with a partner SpyCatcher protein under
physiological conditions.25 This system allows SpyTagged GVs to be functional-
ized with SpyCatcher fusions in a rapid biocompatible reaction. We found that
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GvpCST binds to GVs with similar stoichiometry to GvpCWT and provides rein-
forcement against pressure-induced collapse (Figure 2-S6). Each modified GV
had an average of 1000 SpyTag functionalities (Figure 2-S7). To demonstrate the
utility of this modular functionalization approach, we reacted these GVs with the
recombinantly expressed fluorescent protein SpyCatcher-mNeonGreen (SC-mNG)
to enable multimodal acoustic and fluorescent imaging. The resulting fluores-
cent GVs were purified by buoyancy enrichment. SDS-PAGE analysis confirmed
SpyTag-SpyCatcher covalent bond formation (Figure 2-S8), and Figure 2-5g shows
multimodal imaging of mNG-labeled GVs with ultrasound and fluorescence. The
ultrasound images show similar echogenicity between fluorescently labeled GVs,
wild-type, and unreacted controls (Figure 2-5h). GvpCWT Ana GVs do not show
any fluorescence after reaction with SC-mNG (Figure 2-5g, h), highlighting the
specificity of the SpyTag-SpyCatcher reaction and confirming that buoyancy en-
richment eliminates unreacted fluorescent proteins (Figure 2-S8). Notably, labeled
ST-GVs remain fluorescent after acoustic pressure-induced collapse, which may be
useful for follow-up histological examinations after ultrasound imaging. These re-
sults establish the GvpCST-SpyCatcher system as a highly modular and convenient
approach to generate functionalized GVs, thereby enabling dual-mode imaging of
these nanostructures.
2.4 Conclusions
In summary, our results demonstrate the genetic engineering of a biologically de-
rived acoustic nanomaterial, which we use as an imaging agent for ultrasound. Re-
markably, a single constituent protein on the surface of GVs can serve as a genetic
platform to modulate the mechanical, acoustic, surface, and targeting properties of
these nanostructures. This molecular engineering capability will enable the design
of GV-based contrast agents with enhanced harmonic responses, biodistribution,
multiplexing, multimodal detection, and molecular targeting to help ultrasound ful-
fill its potential as a high-performance modality for molecular imaging. In addition,
as a nanomaterial with genetically tunable mechanical properties, GVs may create
opportunities for applications outside biology and medicine.
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Figure 2-5: Genetic engineering of GV surface properties, cellular targeting and
multimodal imaging. (a) Diagram of GvpC genetic fusions used to engineer novel GV
properties and functions. (b) Zeta potential measurements of engineered GVs having GvpC
fused to LRP and wild-type GvpC (N = 4, error bars are SEM) (c) Confocal fluorescence
images showing RGD-functionalized, RDG-functionalized and wild-type Alexa Fluor-488
fluorescently labeled (green) GVs after 24 hr incubation with U87 glioblastoma cells (DAPI-
stained nuclei, blue). Scale bars are 50 µm (d) Mean GV fluorescence measured for each
condition in (c) (N = 3, error bars are SEM). (e) Confocal fluorescence images of RAW
264.7 macrophages (DAPI-stained nuclei, blue) incubated for 30 min with fluorescently
labeled GVs (green) displaying GvpC fused to mCD47, R8 or wild-type GvpC. Scale bars
are 50 µm. (f) Mean GV fluorescence measured for each condition in (e) (N = 3, error bars
are SEM). (g) Top panel: Ultrasound images of engineered and SpyCatcher-mNeonGreen
(SC-mNG) reacted GVs at OD 2.5 in PBS, acquired using a 19 MHz transmission pulse
in fundamental mode. Scale bars are 1 mm. Bottom panel: Fluorescence images of the
agarose phantoms before and after acoustic collapse. (h) Mean ultrasound and fluorescence
signals from the GV samples tested in (g). (N   4, error bars are SEM).
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2.5 Methods
Gas Vesicle Preparation. Ana was cultured in Gorham’s media supplemented
with BG-11 solution (Sigma, St. Louis, MO) and 10 mM sodium bicarbonate
(NaHCO3)at 25°C, 100 rpm shaking, and 1% CO2 under a 14h light cycle and 10
h dark cycle. Once confluency was reached, the cultures were transferred to sterile
separating funnels, and the buoyant cells were allowed to float to the top and separate
from the spent media over a 48h period. Ana GVs were harvested by hypertonic lysis
of the buoyant cells with 500 mM sorbitol and 10% Solulyse (Genlantis, San Diego,
CA). Purification was done by repeated centrifugally assisted floatation followed by
resuspension in 1x phosphate bu ered saline (PBS) (Corning, Union City, CA). GV
concentration was determined by pressure-sensitive OD measurements at 500 nm
(ODPS,500). Precollapsed GVs prepared by application of hydrostatic pressure in a
capped syringe were used as the blank.
Expression and Purification of Ana GvpC Variants. The Ana GvpC gene
sequence codon-optimized for E. coli expression was synthesized by Life Technolo-
gies, Santa Clara, CA. Ana GvpC was cloned into a pET28a(+) plasmid (Novagen,
Temecula, CA) downstream of a T7 promoter with an N- or C-terminal His-tag.
All constructs were made via restriction cloning, KLD mutagenesis, or Gibson as-
sembly using enzymes from New England Biolabs, Ipswich, MA. Purified plasmids
with the genetically engineered GvpC constructs were transformed into BL21(DE3)
cells (Invitrogen, Carlsbad, CA). Starter cultures were diluted 1:250 in Terrific
Broth (Sigma, St. Louis, MO) and allowed to reach OD600 ⇠0.4-0.7 (250 rpm
shaking at 37°C). Protein expression was induced by addition of isopropyl  -D-1-
thiogalactopyranoside (to a final concentration of 1 mM), and cells were harvested
by centrifugation after expression at 30°C for 6 h.
GvpC in the form of inclusion bodies was purified by lysing the cells using
Solulyse supplemented with DNaseI (10 µg/mL) and lysozyme (400 µg/mL) at room
temperature. Inclusion bodies were recovered by centrifugation at 27,000g for 15
min in an ultracentrifuge. The inclusion body pellets were resuspended in 20 mM
Tris-HCl bu er with 500 mM sodium chloride (NaCl) and 6 M urea (pH 8.0) and
incubated with Ni-NTA resin (Qiagen, Valencia, CA) for 2 h at 4°C. After washing,
proteins were eluted using 250 mM imidazole. Bradford assay was used to measure
the concentration of the purified protein. Recombinant GvpC variants were verified
to be >95% pure by SDS- PAGE analysis.
Ana GV Stripping and Re-Addition of Engineered GvpC Variants. Native
Ana GVs were stripped of their outer GvpC layer by treatment with 6 M urea
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solution bu ered with 100 mM Tris-HCl (pH 8.5). Two rounds of centrifugally
assisted floatation followed by removal of the subnatant layer were done to ensure
complete removal of native GvpC, as confirmed by SDS-PAGE. Stripped Ana GVs
were then combined with 2x molar excess of the engineered GvpC variant in 6 M urea
bu er after accounting for a 1:25 binding ratio of GvpC:GvpA. Estimating 12,768
GvpA molecules per Ana GV and 564.2 pM of GVs per ODPS,500 (1 cm path length),
the molar concentration of GvpA per ODPS,500 of Ana GVs was determined to be
7.2 µM and used for calculating the amount of engineered GvpC to be added. The
engineered GvpC was then allowed to slowly refold onto the surface of the stripped
Ana GVs by dialysis against 1x PBS for >12 h at 4°C using a regenerated cellulose
membrane with a 6-8 kDa MW cuto  (Spectrum Laboratories, Rancho Dominguez,
CA). Dialyzed samples were subjected to at least two rounds of centrifugally assisted
floatation to remove any excess unbound GvpC.
Transmission Electron Microscopy. GV samples were diluted to ODPS,500
⇠0.2 in 10 mM HEPES bu er containing 150 mM NaCl (pH 8) and spotted on
Formvar/Carbon 200 mesh grids (Ted Pella, Redding, CA) that were rendered hy-
drophilic by glow discharging (Emitek K100X). GV samples were negatively stained
using 2% uranyl acetate. Images were acquired using the Tecnai T12 LaB6 120 kV
transmission electron microscope (TEM) equipped with a Gatan Ultrascan 2k x 2k
CCD and “Leginon” automated data collection software suite.
Pressurized Absorbance Spectroscopy. GV samples were diluted to ODPS,500
⇠0.2 and loaded onto a flow-through, 1 cm path-length quartz cuvette (Hellma
Analytics, Plainview, NY) that was connected to a N2 cylinder through a pressure
controller (Alicat Scientific, Tucson, AZ). The pressure was increased stepwise in
20 kPa increments up to 1 MPa, and the ODPS,500 at each step was measured using
a spectrophotometer (EcoVis, OceanOptics, Winter Park, FL). Fully collapsed GV
sample was used as the blank.
In Vitro Ultrasound Imaging. Imaging phantoms were prepared from 1%
agarose in PBS. Two times concentrated GV samples were mixed 1:1 with melted
1% agarose at 50°C, and 100 µL of the mixture was quickly loaded into the phan-
tom wells. Imaging was performed using a Verasonics Vantage programmable
ultrasound scanning system. The L11-4v or L22-14v 128-element linear array
transducers (Verasonics, Kirkland, WA) were used for image acquisition, with a
pitch of 0.3 mm or 0.1 mm and elevation focus of 15-20 mm or 6 mm, respectively.
The phantom was placed on a custom 3-D printed holder, and the transducer was
mounted on a computer-controlled 3-D translating stage (Velmex, Inc., Bloomfield,
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NY). During imaging, the transducer was immersed in PBS at an elevation that
positioned the focal zone of the ultrasound beam at the center of the sample well.
All images were acquired using a conventional B-mode sequence with 128 ray lines.
The acoustic multiplexing and collapse spectrum measurements were obtained
by using GV samples at a final OD of 1 and a transmit frequency of 6.25 MHz on the
L11-4v, with a four-cycle pulse and transmit focus of 20 mm, focal ratio (F-number)
of 2, and persistence of 90. The images were acquired at a transmit voltage of 1.6 V.
To collapse GVs, acoustic pressure was delivered to the specimen by lowering the
F-number to 0.1 and ramping up the voltage gradually. At each collapse step, the
transducer was translated in the y and z planes to ensure homogeneous GV collapse
over the entire well.
Nonlinear imaging experiments were performed using the L11-4v transducer
with a transmit frequency of 4.46 MHz and receive filtering using a 2 MHz band-
pass around 4.46 and 8.92 MHz for the fundamental and second harmonic signals,
respectively. GV samples at OD 2.5 were imaged at 2.5 V and F-number 3 using a
three-cycle pulse and a persistence of 90.
In Vivo Ultrasound Imaging. Intravenously injected GVs were imaged in
5-7 week old female severe combined immunodeficiency mice using the L11-4v
transducer. To be consistent with in vitro experiments, a transmit frequency of 4.46
MHz and reception frequencies of 4.46 and 8.92 MHz were used for the fundamental
and nonlinear imaging, respectively. Imaging was done at 2.5 V using a three-cycle
pulse at an F-number 3 and persistence of 20. The mice were maintained under
isofluorane anesthesia on a heated imaging platform. Images were acquired at a rate
of 16 frames/s for ⇠50 s. A 50 µL volume of GVs at OD 23.5 in PBS was infused
⇠5 s after the start of the experiment at a flow rate of 0.3 mL·min-1. Between sample
injections, a 10 s high-power burst from the transducer was used to completely
collapse any residual GVs in circulation.
Image Analysis. Matrix Laboratory (MATLAB) and ImageJ (NIH, Bethesda,
MD) were used to process in vitro and in vivo ultrasound data. Regions of interest
(ROIs) were manually defined so as to capture signals from the entire sample well
or the IVC. ROI dimensions were preserved between di erent GV samples and the
mean intensity per pixel calculated using all pixels within the ROI. Quantification of
in vitro harmonic and fundamental GV signals was performed by subtraction of the
postcollapse images from the precollapse images. In vivo IVC signals were analyzed
for all acquired frames over the 50 s imaging window, and smoothed infusion time-
course curves were generated using locally weighted scatterplot smoothing. Area
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under the curve (AUC) values were obtained from the raw data normalized to the
preinfusion baseline. Acoustic spectral unmixing was performed using MATLAB
after applying a spectral averaging filter with a kernel size of [20 20] pixels to reduce
out-of-well noise. Pseudocolor assignments and merging of spectrally unmixed
images were performed using ImageJ (color maps are shown next to the images in
Figure 2-2g).
Zeta Potential Measurements. Zeta potentials of GVs with GvpC-WT and
GvpC-LRP were measured using Brookhaven Instruments Corporation Zeta-PALS
instrument (Hotsville, NY). 40 µL of GVs (in PBS) was added to 1.5 mL of double-
distilled water at a final concentration of 35 pM and conductance of 1 mS. Electrodes
were placed in the cuvette with the samples, and average zeta potential for each run
was determined from 10 measurements.
In Vitro Characterization of Functionalized GVs. Alexa-488 succinimidyl
ester fluorescent dye (Invitrogen, Carlsbad, CA) was reacted with GVs in PBS
for 2 h at 10,000:1 molar excess of dye to GVs. Excess succimidyl ester was
quenched with 10 mM Tris. Fluorescently labeled GVs were purified using dialysis
against PBS. Cells were seeded on 22 x 22 mm coverglass and cultured for 24
h prior to the start of the experiments. Due to the buoyant nature of GVs, in
vitro characterization was carried out using modified 6-well plates that contain 3
pegs to enable inverted cell growth (facing down). For receptor (↵v 3) targeting
experiments, 16 µL of fluorescently labeled GVs (GvpCWT, GvpCWT-RGD, and
GvpCWT- RDG) at 1.2 nM were added to U87 cells (ATCC, Manassas, VA) and
incubated for 24 h. To test phagocytic uptake using GvpCWT, GvpCWT-mCD47, and
GvpCWT-R8, 8 µL of fluorescently labeled GVs at 1.2 nM was added to RAW 264.7
cells (ATCC). After the allotted GV incubation, cells were washed 3x with PBS,
fixed with 4% paraformaldehyde, and mounted with 40,6-diamidino-2-phenylindole
(DAPI)-containing mounting media. Confocal fluorescence images were acquired
using inverted Zeiss LSM 710 NLO (Thornwood, NY) using a 20x objective.
SpyTag-SpyCatcher Functionalization of Ana GVs. SpyTag-Ana GVs were
prepared using the re-addition protocol described above. SC-mNG was expressed
and purified from BL21 E. coli using nondenaturing Ni-NTA purification. ST-GVs
(OD 5-10) were incubated with SC-mNG at a 2x molar excess of SpyCatcher:SpyTag
in PBS for 1 h at room temperature. GVs were spun at 300g for 4 h twice in order to
remove excess unbound protein; the supernatant containing GVs was resuspended
in fresh PBS.
ST-GV (±SC-mNG) and WT-GV (+SC-mNG) samples were prepared in a 1%
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agarose phantom at a final OD of 2.5 and imaged with the Verasonics L22-14 V
transducer at 19 MHz, 5.0 V, and F- number 3 with a persistence of 90. The agarose
phantom was also imaged through the green channel of a BioRad Chemidoc MP
system (Hercules, CA). The fluorescence intensity of the ST-GV (±SC- mNG) and
WT-GV (+SC-mNG) samples was determined by first collapsing the samples and
then measuring fluorescence intensity (ex 506 nm, em 550 nm) in a Molecular
Devices SpectraMax M5 plate reader (Sunnyvale, CA).
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2.6 Supplementary Information
Table 2-S1: Hydrostatic midpoint of collapse for engineered Ana GVs used in acoustic
multiplexing experiments (Figure 2-2b). The data was fitted with a Boltzmann sigmoid
function of the form f (p) = (1+ e(p pc )/ p) 1 with pc representing the average midpoint of
collapse. Fit parameters and R2 values for each of the GV variants are provided in the table.
Table 2-S2: Hydrostatic midpoint of collapse for engineered Ana GVs used in acoustic
multiplexing experiments (Figure 2-2c). The data was fitted with a Boltzmann sigmoid
function of the form f (p) = (1+ e(p pc )/ p) 1 with pc representing the average midpoint of
collapse. Fit parameters and R2 values for each of the GV variants are provided in the table.
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Figure 2-S1: SDS-PAGE analysis confirming the complete removal of GvpC from native
Ana GVs (lane 13) and the re-addition of engineered proteins (lane 14-15). Quantification
of re-added GvpC on urea-stripped Ana GVs was done by comparison against a standard
curve (200 - 1000 ng) of the pure proteins (lanes 2-6 for WT-GvpC and lanes 7-11 for
 N&C-GvpC). The number of re-added GvpC molecules was determined to be 1980 per
GV for GvpCWT and 877 per GV for  N&C-GvpC respectively.
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Figure 2-S2: Midpoint of collapse (hydrostatic) plotted as a function of re-added GvpC
concentration for the  N&C variant. The midpoint of collapse was determined by fitting
the raw data with a Boltzmann sigmoid function of the form f (p) = (1+ e(p pc )/ p) 1 with
pc representing the average midpoint of collapse. Fit parameters and R2 values for each
of the GV variants are provided. The saturation curve was plotted by fitting the data to a
bimolecular binding function of the form f (x) = C1 ⇤ x/(Kd + x) + C2.
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Figure 2-S3: Midpoint of collapse (hydrostatic) plotted as a function of re-added GvpC
concentration for the GvpCWT variant. The midpoint of collapse was determined by fitting
the raw data with a Boltzmann sigmoid function of the form f (p) = (1+ e(p pc )/ p) 1 with
pc representing the average midpoint of collapse. Fit parameters and R2 values for each
of the GV variants are provided. The saturation curve was plotted by fitting the data to a
bimolecular binding function of the form f (x) = C1 ⇤ x/(Kd + x) + C2.
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Figure 2-S4: Matrix of coe cients used for generating spectrally unmixed images shown
in Figure 2-2g from the pixel-wise ultrasound signal intensities in Figure 2-2f (I), before
and after exposing the GV samples to three sequentially increasing acoustic pressures (Pi).
  represents the measured di erential signals with  i = I(Pi 1)   I(Pi), while ↵ is the
matrix containing the acoustic collapse spectrum for each GV variant (↵i, j). C represents
the contribution of each GV variant to the observed signal, with Cj calculated by the matrix
operation: C = ↵ 1 .
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Figure 2-S5: Clustal Omega sequence alignment of all the genetically engineered GvpC
proteins used in our study. Colors highlight important features and are set to match the
schematic illustration in Figure 2-5a.
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Figure 2-S6: Optical density measurements of engineered Ana GVs as a function of
hydrostatic pressure. The data was fitted with the Boltzmann sigmoid function f (p) =
(1 + e(p pc )/ p) 1 and the table provides the midpoint of collapse as well as other fit
parameters and R2 values. The data show that the collapse profile is unaltered even after
reacting the ST-GVs with SC-mNG fluorescent protein.
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Figure 2-S7: SDS-PAGE quantification of SpyTag functionalities on the surface of engi-
neered Ana GVs. Comparison of ST-Ana GVs (lane 10) against a standard curve comprising
GvpC-ST concentrations ranging from 100-1000 ng (lanes 2-8) shows that each modified
GV has ⇠1000 SpyTag functionalities. Stripped Ana GVs used for GvpC-ST re-addition
(lane 9) have negligible amount of native GvpC.
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Figure 2-S8: SDS-PAGE analysis confirms SpyTag-SpyCatcher bond formation (yellow)
upon a one-hour incubation of ST-GVs having an outer layer of GvpC-SpyTag (red) with
SpyCatcher-mNeonGreen (green). Incubation of Ana GVs containing an outer layer of
WT-GvpC (purple) with SC-mNG, followed by buoyancy purification to remove unreacted
fluorescent molecules results in GVs that are not fluorescent as shown in Figure 2-5g (left
bottom panel). This also highlights the specificity of the SpyTag-SpyCatcher reaction
and confirms that all the unreacted fluorescent molecules are completely removed during
buoyancy purification.
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C h a p t e r 3
RECOMBINANTLY EXPRESSED GAS VESICLES AS
NANOSCALE CONTRAST AGENTS FOR ULTRASOUND AND
HYPERPOLARIZED MRI
This chapter is in large part a reformatted version of the manuscript entitled “Re-
combinantly Expressed Gas Vesicles as Nanoscale Contrast Agents for Ultrasound
and Hyperpolarized MRI” published by Farhadi, A., Ho, G.H., Kunth, M., Ling,
B., Lakshmanan, A., Lu, G., Bourdeau, R.W., Schröder, L., and Shapiro M.G., in
AIChE Journal1. Under the supervision of Mikhail Shapiro, my contributions to
this work was to conceive, design and conduct the experiments, and analyze and
interpret the data, and write the manuscript. Thanks to Gabrielle Ho, Bill Ling,
Anupama Lakshmanan, George Lu, and Raymond Bourdeau for the assistance with
sample preparation and data collection, and Martin Kunth and Lief Schröder for
collecting and analyzing the hyperpolarized 129Xe-MRI.
3.1 Abstract
Ultrasound and hyperpolarized magnetic resonance imaging enable the visualization
of biological processes in deep tissues. However, few molecular contrast agents are
available to connect these modalities to specific aspects of biological function. We
recently discovered that a unique class of gas-filled protein nanostructures known
as gas vesicles could serve as nanoscale molecular reporters for these modalities.
However, the need to produce these nanostructures via expression in specialized
cultures of cyanobacteria or haloarchaea limits their broader adoption by other
laboratories and hinders genetic engineering of their properties. Here, we describe
recombinant expression and purification of Bacillus megaterium gas vesicles using
a common laboratory strain of Escherichia coli, and characterize the physical,
acoustic and magnetic resonance properties of these nanostructures. Recombinantly
expressed gas vesicles produce ultrasound and hyperpolarized 129Xe MRI contrast at




Optical reporters such as organic dyes and fluorescent and luminescent proteins
have enabled many biological discoveries. However, the poor penetration of light
into tissue limits the use of these reporters in intact animal models and human pa-
tients2. In contrast, noninvasive imaging techniques such as ultrasound and magnetic
resonance imaging (MRI) are capable of visualizing deep tissues, but have fewer
molecular reporters to connect them to specific biological phenomena3. Ultrasound
is among the most widely used biomedical imaging modalities, o ering high spatial
and temporal resolution (⇠100 µm and sub-millisecond) while penetrating deep into
the organism4. Ultrasound contrast is produced by sound wave scattering at inter-
faces between materials with di erent density or sti ness. Likewise, MRI is capable
of whole-body imaging with spatial resolution on the order of 100 µm, and uses a
variety of contrast mechanisms arising from nuclear spin behavior5. Among these
mechanisms, hyperpolarized MRI provides particularly high molecular sensitivity
by using nuclei, such as 129Xe, prepared with non-equilibrium polarization several
orders of magnitude higher than that available under equilibrium conditions6. Hy-
perpolarized 129Xe can be administered through inhalation or injection for in vivo
imaging.
Hyperpolarized MRI and ultrasound have few molecular reporters for bio-
logical imaging. Conventional ultrasound contrast agents comprise microbubbles,
which are limited by their micron scale and physical instability to imaging primarily
intravascular targets7,8. Nanoscale synthetic reporters for this modality are in devel-
opment,9–11 but have not reached wide- spread use. Meanwhile, common contrast
agents for hyperpolarized 129Xe-MRI comprise organic cage compounds which re-
versibly bind xenon and produce contrast through hyperpolarized chemical exchange
saturation transfer (HyperCEST)12–15. Most such molecules, while detectible, have
relatively low solubility in water and can be di cult to deliver to tissues.
To address these limitations, we recently introduced a unique class of air-filled
protein nanostructures called gas vesicles (GVs) as genetically encodable reporters
for ultrasound and hyperpolarized MRI16–21. GVs are naturally expressed in aqueous
photosynthetic bacteria and archaea as a means to achieve buoyancy22,23. GVs have
dimensions on the order of 100 nm, comprising a 2-nm-thick protein shell that allows
gas to freely di use in and out of their hollow interior while preventing water from
condensing into a liquid in their core (Figure 3-1a). The contents of GVs reflect
the gases dissolved in surrounding liquid media. The GV shell is primarily formed
from gas vesicle protein A or B (gvpA/B), and in some species is supported by an
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Figure 3-1: Recombinantly expressed Mega GVs. (a) Schematic of Mega gas vesicles,
hollow protein nanostructures that allow gas to di use through the protein shell but keep
water from condensing in the core. (b) Mega GVs are heterologously expressed in E. coli,
purified and declustered for characterization as ultrasound and hyperpolarized MRI contrast
agents. (c) Transmission electron micrograph of purified recombinant GVs, (left) Mega GVs
form micron sized clusters upon cell lysis, which can be declustered using 6M urea (center).
(Representative image of mature Mega GV recombinantly expressed in E. coli (right). Scale
bars are 500 nm for left and center images, and 100 nm for right image.) (d) Hydrodynamic
diameter of clustered Mega GVs are 1.7 µm and upon declustering, Mega GVs are 164 nm.
(N=4 independent preparations for clustered Mega GVs and N=5 independent preparations
for Mega GVs.) (e-f) Histogram of length and width of Mega GVs using TEM analysis.
(Measurements represent 3487 particles from N=4 independent biological preparations.)
(g) Zeta potential measurements of Mega GVs and clustered Mega GVs. (N = 4, error bars
are ± SEM).
external sca olding protein known as gas vesicle protein C (gvpC). In addition, 7-11
assembly factor genes are required for GV formation.
We recently demonstrated that GVs purified from native host cells such as An-
abaena flos-aquae (Ana) and Halobacterium NRC-1 (Halo) can be used as biomolec-
ular reporters for both ultrasound and hyperpolarized 129Xe-MRI16,17,20. The former
capability arises from the ability of GVs to scatter sound waves via non-linear inter-
actions with the acoustic field19,21. The latter contrast arises from the ability of GVs
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to act as hosts for hyperpolarized 129Xe, allowing their detection using HyperCEST
pulse sequences. Building on these initial discoveries, we have developed methods
to engineer the sca olding protein of Ana GVs to modify their acoustic and target-
ing properties18, and devised optimized pulse sequences for improved ultrasound
contrast21. GVs produce ultrasound contrast when injected in circulation or in the
gastrointestinal tract of the mammalian host.16,18,21,24 However, this work has uti-
lized GVs expressed in their native hosts, which require special culture conditions
not available in all laboratories, and are more cumbersome to engineer genetically
than conventional laboratory bacterial species. To overcome these limitations, we
set out to establish a system for producing GVs in a common laboratory strain of E.
coli and characterize their essential properties as nanoscale reporters for ultrasound
and hyperpolarized 129Xe-MRI.
3.3 Results and Discussions
Recombinant Expression and Physical Characterization. As a starting point for
recombinant GV production, we chose a GV gene cluster from Bacillus megaterium
(Mega) that was previously shown to be compatible with E. coli expression in a
study where the GVs were not purified to examine their properties25. We cloned
this gene cluster into a high copy E. coli expression plasmid, downstream of a
T7-LacO inducible promoter. A bacterial strain used for protein overexpression,
Rosetta 2(DE3)pLysS, was transformed with the plasmid and induced to express
Mega GVs for 22 hours. After gentle lysis, GVs could be separated from cellular
debris through buoyancy purification (Figure 3-1b).
Immediately after purification, Mega GVs were clustered, as observed by trans-
mission electron microscopy (TEM) (Figure 3-1c). Dynamic light scattering (DLS)
revealed a mean hydrodynamic diameter of 1733 ± 113 nm (Figure 3-1d). Hypoth-
esizing that the clustering is mediated by a denaturable non-covalent interaction
involving proteins, we attempted to de-cluster the Mega GVs by treating them with
6M urea, based on previous findings that urea treatment can remove surface proteins
from Ana GVs without compromising their shells18,26. Urea treatment resulted in
declustered GVs with an average hydrodynamic diameter of 164 ± 19 nm (Figure
3-1d). Quantitative analysis of TEM data revealed that Mega GVs have diameters
of 59 ± 9 nm and lengths of 129 ± 70 nm (Figure 3-1e-f). Assuming a tapered cylin-
drical shape, this corresponds to a single-GV volume of 0.2 attoliter (0.054-0.48
attoliter), which is approximately 32 times smaller than for Ana and Halo GVs20.
Individual Mega GVs had an average zeta potential of -32.8 ± 10 mV (Figure 3-1g).
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A zeta potential of -24.8 ± 4 mV in clustered Mega GVs indicated that positively
charged molecules were associated with negatively charged GVs in the cluster.
Based on the average dimensions and geometry of GVs observed by TEM
(cylindrical with conical tips), an assumed shell thickness of 18 Å based on GvpA
homology to Ana23, and a protein density of 1.4 g/ml, we calculated the average
molecular weight of Mega GVs to be 71.7 MDa. Because GVs scatter light, it
is practically convenient to measure their molar concentration using their optical
density at 500 nm (OD500). To establish the relationship between OD500 and
concentration, the protein concentration of Mega GVs was measured using a Pierce
660-nm assay to be 145 µg/mL per OD500. Using the average molecular weight,
this corresponds to a molar concentration of 2.03 nM/OD500. When Mega GVs are
clustered, they scatter light more strongly, with declustering leading to an average
6-fold reduction in light scattering. Thus, the concentration of clustered Mega GVs
can be estimated as 338 pM/OD500.
A key property of GVs useful in both ultrasound and MR imaging applications
is their ability to irreversibly collapse under specific amounts of pressure (Figure
3-2a). This enables background-subtracted and multiplexed imaging, and provides
convenient experimental controls, since collapsed GVs cease to produce contrast.
Upon collapse, GVs also lose their ability to scatter light, causing opaque GV
solutions to become clear (Figure 3-2b). To characterize the critical collapse pressure
of Mega GVs, we measured the optical scattering of GV suspensions as a function of
applied hydrostatic pressure. Clustered and unclustered Mega GVs had hydrostatic
collapse midpoints of 660 kPa and 767 kPa, respectively (Figure 3-2c).
Ultrasound Contrast. The gaseous core of GVs allows these structures to
function as ultrasound contrast agents16,18,19,21. To evaluate the ability of Mega
GVs to serve this function, these nanostructures were embedded in acoustically
transparent agarose phantoms and imaged with ultrasound at 18 MHz, a frequency
within the range commonly used for preclinical imaging. Mega GVs produced B-
mode ultrasound contrast at concentrations as low as 40 pM, with stronger contrast
at increasing concentrations (Figure 3-3a-b). Given their larger size, we expected
micron-sized clusters of GVs to produce stronger ultrasound contrast than the nano-
sized Mega GVs, since both of them are small enough relative to the wavelength
to be in the Rayleigh scattering regime19. At equal concentrations, clustered Mega
GV contrast was 54% stronger.
Acoustic pressures above critical collapse points allow GVs to be collapsed in
situ, enabling background subtraction and multiplexing in imaging experiments16,18.
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Figure 3-2: Hydrostatic collapse of recombinant Mega GVs. (a) Representative TEM
image of Mega GVs (left) under hydrostatic pressure beyond critical collapse causes the gas
vesicle wall to unravel (right). (Scale bars are 100 nm.) (b) Intact Mega GVs scatter light
when in suspension (left) and become clear upon collapse as their gaseous core dissolves
in solution (right). (c) Optical density measurement of clustered Mega and Mega GVs
as a function of hydrostatic pressure. Data is fit to a Boltzmann sigmoid function of the
form f (p) = (1 + e(p pc )/ p) 1 with pc representing average midpoint of collapse and  p
representing the slope (N=4, error bars are ± SEM).
These acoustic collapse mid-points can be significantly higher than their hydrostatic
counterparts due to the microsecond kinetics of gas exchange through the GVs
shell27: while under hydrostatic conditions, gas molecules have time to escape
through the GV wall during compression, the microsecond cycles of ultrasound
are too rapid, resulting in gas staying in the shell and contributing to deformation
resistance under pressure19,21. To establish the critical mid-points for Mega GVs,
we imaged them with ultrasound while applying increasing acoustic pressures at 18
MHz. The resulting collapse mid-points were 2.2 and 1.9 MPa for Clustered Mega
and Mega GVs, respectively (Figure 3-3c). These pressures provide ample range
for the GVs to be imaged with relatively strong acoustic excitation, while being low
enough for most ultrasound transducers to be able to collapse them.
Hyperpolarized 129Xe-MRI Contrast. Dissolved xenon can partition in and
out of the gaseous GV interior (Figure 3-1a). The distinct chemical environment
of this compartment results in a specific chemical shift of the 129Xe magnetic
resonance frequency, enabling sensitive imaging of GVs using 129Xe HyperCEST
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Figure 3-3: Recombinant Mega GVs as ultrasound contrast agents. (a) B-mode ul-
trasound images of Mega GVs (top row) and clustered Mega GVs (bottom row) showing
increased intensity as a function of concentration (40, 203, 1015, and 4060 pM GV parti-
cles) in 1% agarose phantom using a 18 MHz imaging transducer under 0.91 MPa acoustic
pressure. Ultrasound images of 4060 pM Mega GVs (top right) and clustered Mega GVs
(bottom right) after 4.2 MPa ultrasound insonation. (Representative images from N=4 in-
dependent preparations. Scale bars are 1 mm.) (b) Graph of average ultrasound intensities
for Mega GVs and clustered Mega GVs as a function of concentration (N=4 independent
preparations, error bars are ± SEM.) (c) Acoustic collapse measurements of Mega GVs and
clustered Mega GVS as a function of acoustic pressure. Data is fit to a Boltzmann sigmoid
function of the form f (p) = (1 + e(p pc )/ p) 1 with pc representing average midpoint of
collapse and  p representing the slope (N=4, error bars are SEM).
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MRI6,17. To evaluate the MRI performance of Mega GVs, we imaged them at 9.4
Tesla in a phantom bubbled with 129Xe gas that was hyperpolarized using spin-
exchange optical pumping20,28 (Figure 3-4a). Using the distinct chemical shift
of 129Xe in the GV interior, the gas atoms can be selectively saturated with on-
resonance radio frequency (RF) pulses, while exchanging with 129Xe in solution,
resulting in a decrease in the overall 129Xe signal (Figure 3-4b). A stepwise sweep of
the saturation frequency while monitoring the remaining total polarization allowed
us to identify a saturation peak for the xenon in Mega GVs at -174 ppm relative
to free dissolved xenon. Ten second saturation pulses at this frequency produced
significant HyperCEST e ects for Mega GVs at concentrations as low as 40.6
pM (Figure 3-4c). The intensity of the HyperCEST e ect with respect to the
GV concentration followed an exponential relationship (Figure 3-4d). This can
be understood as the increasing GV concentration causing a linear increase in the
Lorentzian-shaped depolarization rate of xenon, with the set saturation time causing
an added exponential weighting29–31.
3.4 Conclusions
Recombinant expression of Mega GVs in E. coli provides a convenient platform
for the simple and rapid production of gas-filled protein nanostructures for applica-
tions in molecular imaging, within which GVs o er unique advantages alongside
other emerging nanoscale and protein-based reporters3,5,9,32. In future studies, this
expression system could also facilitate the genetic engineering of GV properties.
Compared to the more established Ana and Halo GVs, Mega GVs are 32-times
smaller by volume, but nevertheless able to produce significant ultrasound and
129Xe-MRI contrast. Their nanoscale size may facilitate the use of Mega GVs as
targeted contrast agents following systemic administration. At the same time, the
natively clustered form of Mega GVs has greater ultrasound contrast per GV, which
may be also useful in certain applications. Overall, we anticipate that the unique
properties of Mega GVs, together with their convenient heterologous expression and
purification, will help these proteins rise to the top as a starting point for developing
GV-based nanotechnologies.
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Figure 3-4: Hyperpolarized 129Xe-MRI of recombinant Mega GVs. (a) Illustration of
HyperCEST MRI phantom used to bubble hyperpolarized 129Xe gas in solution containing
Mega GVs during MRI acquisition. (b) Representative axial images of 325 pM Mega GVs
acquired with o -resonant saturation at +174 ppm (top left) or on-resonant saturation at
-174 ppm (top right), and their normalized di erence (bottom right). Proton-MRI depicts
axial plane containing GVs in PBS (bottom left). (Scale bars are 5 mm.) (c) Representative
HyperCEST z-spectra (RF cw-saturation of 35 µT for 10 s) for Mega GVs at a concentration
of 325 pM (blue circles) or 81 pM (red squares) in PBS at room temperature. Each
data set was fitted to an exponential-Lorentzian. (d) The percent HyperCEST e ect as a
function of Mega GV concentration. Data was fitted to an exponential function of the form




Mega Gas Vesicle Expression and Purification. The pST39 plasmid containing
the GV gene cluster from Bacillus megaterium (Addgene ID 91696) was trans-
formed into Rosetta 2(DE3)pLysS chemically competent E. coli (EMD Millipore,
Temecula, CA) and cultured in Luria Broth (LB) supplemented with 1% glucose,
100 µg/mL ampicillin, and 25 µg/mL chloramphenicol at 37°C and 250 rpm shaking
overnight. At confluency, 2.5 mL of starter culture was inoculated into 250 mL LB
supplemented with 0.2% glucose, 100 µg/mL ampicillin, and 25 µg/mL chloram-
phenicol at 37°C and 250 rpm shaking until OD600 reached 0.4 to 0.6. Gas vesicle
expression was induced with 20 µM Isopropyl  -D-1-thiogalactopyranoside (IPTG)
and continued to grow at 30°C and 250 rpm shaking for 22 hours. The cultures
were then centrifugated at 600g for 1 hour and the mid-natant between the buoyant
cell fraction and pellet was removed. The whole cell population was then lysed by
the addition of 10% SoluLyse-Tris reagent (Genlantis, San Diego, CA), 250 µg/ml
lysozyme (Sigma-Aldrich, St. Louis, MO) and 10 µg/ml DNAseI (New England
Biolabs, Ipswich, MA) and rotated gently for 20 minutes at room temperature. GVs
then underwent four rounds of buoyancy purification, which consisted of isolating
the buoyant layer via centrifugation, followed by resuspension in phosphate bu ered
saline (PBS). Some of the purified GV were then declustered with the addition of
urea to a final concentration of 6M and purified again in PBS via 3 rounds of buoy-
ancy isolation. Protein concentration was measured using the Pierce 660 nm protein
assay (Thermo Fischer Scientific, Waltham, MA).
Electron Microscopy. GV samples were diluted to OD500 ⇠0.2 in 10 mM
HEPES bu er and spotted on Formvar/Carbon 200 mesh grids (Ted Pella, Red-
ding, CA), which were rendered hydrophilic by glow discharging (Emitek K100X).
Unclustered Mega GVs were negatively stained using 2% uranyl acetate. Images
were acquired using the Tecnai T12 LaB6 120 kV transmission electron microscope
(TEM) equipped with a Gatan Ultrascan 2k x 2k CCD camera.
Dynamic Light Scattering and Zeta Potential Measurement. Hydrody-
namic diameter and Zeta potential of GVs were measured with a Zeta-PALS analyzer
(Brookhaven Instruments Corporation, Hotsville, NY). GVs were diluted to OD500
of 0.2 in 50 µL for DLS measurements. The reported hydrodynamic diameter for
each sample was taken using 5 measurements of well-mixed samples. Zeta potential
measurements were taken of GVs mixed in 1.5 mL of double-distilled water at a
conductance of 100 µS.
Pressurized Absorbance Spectroscopy. GV samples were diluted to OD500
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of 0.5 and loaded into a flow-through, 1 cm path-length quartz cuvette (Hellma
Analytics, Plainview, NY) that was connected to a N2 cylinder through a pressure
controller (Alicat Scientific, Tucson, AZ). The pressure was increased stepwise in 50
kPa increments up to 1 MPa, followed by 100 kPa increments up to 1.2 MPa, and the
OD500 at each step was measured using a spectrophotometer (EcoVis, OceanOptics,
Winter Park, FL). The absorbance reading at 0 MPa and the lowest OD500 were used
as the maximum and minimum, respectively, for normalization.
Ultrasound Imaging. Imaging phantoms were made from 1% agarose in
PBS casted using a custom 3D printed inverted 96 well mold. GVs were prepared at
twice the imaging concentration in PBS and mixed at 1:1 volume with 1% agarose at
65°C, then loaded in the wells of the agarose phantom. The phantom was positioned
to allow imaging of the axial plane. Ultrasound images were acquired using a
L22-14V 128-element linear array transducer and programmable scanner (Vantage,
Verasonics, Kirkland, WA). The transducer was mounted on a computer-controlled
3D translation stage (Velmex, Bloomfield, NY). For imaging, the transducer and
phantoms were submerged in PBS for acoustic coupling, and the center of the wells
was placed at a 7.5 mm depth relative to the transducer face. B-mode ultrasound
images for the concentration series were acquired using 0.91 MPa peak positive
acoustic pressure, at 18 MHz frequency, with a f-number of 2.0. Maximal collapse
was achieved with exposure to 4.2 MPa peak positive acoustic pressure. Acoustic
collapse measurements were acquired at 0.46 MPa after the GVs were insonated
with the indicated ultrasound pressures. Ultrasound images are displayed with
square-root compression and decompressed for data analysis. Ultrasound data was
analyzed using a custom MATLAB script to select the region of interest (ROI) of
each image and calculate the average pixel intensity. Data represent four biological
replicates for each sample (N=4), with representative images shown in the figures.
Hyperpolarized Xe Spectroscopy and Imaging. A gas mixture of 5% 129Xe
(26.4% of natural abundance), 10% N2 and 85% He was hyperpolarized by spin-
exchange optical pumping under continuous flow using a custom-designed polarizer
(150 W line-narrowed infrared laser; full-width-at-half-maximum of 0.5 nm)28.
GVs were diluted in PBS to concentrations ranging from 650 pM to 20.32 pM.
Hyperpolarized Xe was bubbled through the solution at an overpressure of 50 kPa
(total pressure of 150 kPa) with a flow rate of 20 mL/min. All experiments were
conducted at 20°C at 9.4 Tesla. Hyperpolarized 129Xe-MR images were acquired
using a rapid acquisition with relaxation enhancement (RARE) pulse sequence mod-
ified for saturation transfer using the magnetization transfer module in ParaVision
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6 (Bruker, Billerica, MA). Each GV sample was measured with hyperpolarized
Xe-MRI separately, starting with the sample containing the highest GV concentra-
tion (to adjust RF cw-saturation pulse parameters to transfer saturation to 100%
accordingly). All HyperCEST experiments used RF cw-saturation of 35 µT for 10
seconds. The HyperCEST e ect was quantified as the fractional change in signal
following on-resonance saturation compared to o -resonance saturation.
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C h a p t e r 4
ULTRASOUND IMAGING OF GENE EXPRESSION IN
MAMMALIAN CELLS
This chapter is in large part a reformatted version of the manuscript entitled “Ultra-
sound Imaging of Gene Expression in Mammalain Cells” published by Farhadi, A.,
Ho, G.H., Sawyer, D.P., Bourdeau, R.W., and Shapiro, M.G., in Science1. Under
the supervision of Mikhail Shapiro, my contributions to this work were to conceive,
design and conduct the experiments, analyze and interpret the data, and write the
manuscript. Thanks to Gabrielle Ho and Daniel Sawyer for assistance with the
experiments, and Raymond Bourdeau assistance in the DNA sequence designs.
4.1 Abstract
The study of cellular processes occurring inside intact organisms requires methods to
visualize cellular functions such as gene expression in deep tissues. Ultrasound is a
widely used biomedical technology enabling noninvasive imaging with high spatial
and temporal resolution. However, no genetically encoded molecular reporters are
available to connect ultrasound contrast to gene expression in mammalian cells. To
address this limitation, we introduce mammalian acoustic reporter genes. Starting
with a gene cluster derived from bacteria, we engineered a eukaryotic genetic
program whose introduction into mammalian cells results in the expression of
intracellular air-filled protein nanostructures called gas vesicles, which produce
ultrasound contrast. Mammalian acoustic reporter genes allow cells to be visualized
at volumetric densities below 0.5% and permit high-resolution imaging of gene
expression in living animals.
4.2 Introduction
The study of cellular function within the context of intact living organisms is a
grand challenge in biological research and synthetic biology2. Addressing this
challenge requires imaging tools to visualize specific cells in tissues ranging from the
developing brain to tumors, and to monitor gene- and cell-based therapeutic agents
in vivo3. However, most common methods for imaging cellular processes such as
gene expression rely on fluorescent or luminescent proteins, which have limited
performance in intact animals due to the poor penetration of light in biological
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tissue4,5. On the other hand, ultrasound easily penetrates most tissues, enabling
deep noninvasive imaging with excellent spatial and temporal resolution (⇠100 µm
and ⇠1 ms, respectively)3,6. These capabilities, along with its safety, portability and
low cost, have made ultrasound a widely used technology in biomedicine. Despite
these advantages, to date ultrasound has played a relatively small role in cellular
imaging due to the lack of appropriate genetically encoded reporters.
Recently, biomolecular contrast agents for ultrasound were introduced based
on gas vesicles, air-filled protein nanostructures which evolved in certain waterborne
bacteria and archaea to provide cellular buoyancy7,8. Gas vesicles comprise a 2 nm-
thick protein shell enclosing a gas compartment with dimensions on the order of 100
nm. The acoustic impedance mismatch between their gas interior and surrounding
aqueous media allows gas vesicles to strongly scatter sound waves and thereby
serve as ultrasound contrast agents9–13. In their native organisms, gas vesicles are
encoded by clusters of 8-14 genes, including one or two primary structural proteins,
and several other essential genes encoding putative assembly factors or minor shell
constituents.
The use of gas vesicles as reporter genes requires the heterologous expression of
their cognate multi-gene operon in a new cellular host, ensuring proper transcription
and translation of each gene, functional folding of each corresponding protein and
appropriate stoichiometry and co-localization of the constituents for gas vesicle
assembly. Recently, a genetic engineering e ort succeeded in expressing gas vesicles
as acoustic reporter genes (ARGs) in commensal bacteria, allowing their imaging in
the mouse gastrointestinal tract14. If ARGs could be developed for mammalian cells,
this would enable the study of how such cells develop, function and malfunction
within the context of model organisms and enable the in vivo imaging of mammalian
cells engineered to perform diagnostic or therapeutic functions15–17. However,
developing ARGs for mammalian cells represents an even greater synthetic biology
challenge due to the di erences in transcription, translation, co-localization and
protein folding between prokaryotes and eukaryotes18–20. To our knowledge, no
genetic operon larger than 6 genes has been moved between these domains of life21.
4.3 Results and Discussions
Here, we describe the expression of ARGs in mammalian cells to enable
ultrasound imaging of mammalian gene expression. To identify a set of genes
capable of encoding gas vesicle assembly in mammalian cells, we synthesized
individual gas vesicle genes from three di erent microbial species using codons
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Figure 4-1: Engineering of mammalian acoustic reporter genes. (a) Schematic of the
transient co-transfection assay used to identify combinations of genes capable of producing
gas vesicles in mammalian cells. (b) Schematic of nine genes from B. megaterium capable
of encoding gas vesicle expression in mammalian cells. Thin arrow denotes CMV promoter.
polyA denotes SV40 polyadenylation element. (c) Representative TEM image of purified
gas vesicles expressed in HEK293T cells. (d) Gene cassettes comprising the mammalian
acoustic reporter gene construct, mARG. (e) Representative TEM image of gas vesicles
purified from HEK293T cells transiently transfected with mARGs for 72 hours. All scale
bars represent 500 nm.
optimized for human expression, cloned each gene into a separate monocistronic
plasmid and transiently co-transfected mixtures of the genes from each species into
HEK293T cells (Fig. 4-1a). After allowing 72 hours for protein expression, we
gently lysed the cells ( 2x106 cells per sample), and centrifugated the lysate to enrich
for buoyant particles, which would include any gas vesicles. The top fraction of the
centrifugated lysate was then screened for gas vesicles using transmission electron
microscopy (TEM). These experiments took advantage of the intrinsic stochasticity
of transient transfection – in terms of the ratios of genes and the overall DNA
quantity delivered to each cell – to simultaneously sample a broad range of gene
stoichiometries and expression levels without prior knowledge of solutions leading
to gas vesicle formation.
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The co-transfection of the gas vesicle genes from Halobacterium salinarum and
Anabaena flos-aquae did not lead to the formation of detectable gas vesicles. How-
ever, the co-transfection of 9 gas vesicle-forming genes from Bacillus megaterium
(Fig. 4-1b) resulted in the production of unmistakable gas vesicles as evidenced
by their appearance in TEM images (Fig. 4-1c). The 9 genes originate from an
eleven-gene B. megaterium gene cluster previously used to express gas vesicles in E.
coli14,22, with the exception of GvpR and GvpT, which were found to be unnecessary
for gas vesicle formation (Fig. 4-S1).
Using the 9 genes identified in our stochastic screen, we set out to construct
a polycistronic mammalian operon for consistent gas vesicle expression by joining
these genes using the viral co-translational self-cleavage peptide P2A23. Having
determined that all genes except GvpB could tolerate P2A peptide additions (Fig.
4-S2 and Table 4-S1), we constructed a polycistronic plasmid containing the 8 P2A-
tolerant gas vesicle genes connected by P2A sequences, and co-transfected it into
HEK293T cells together with a plasmid encoding GvpB. Unfortunately, this did
not result in the production of gas vesicles. We hypothesized that one or more of
the genes in our polycistronic plasmid was expressed at an insu cient level, and
used a complementation assay to identify GvpJ, GvpF, GvpG, GvpL and GvpK as
bottleneck genes (Fig. 4-S3). This led us to construct a polycistronic “booster”
plasmid containing these five genes, ordered to minimize P2A modifications to
GvpJ and GvpK, which were found to be most limiting. The co-transfection of the
booster plasmid together with the two plasmids above (Fig. 4-1d) enabled robust
expression of gas vesicles in cells (Fig. 4-1e). We named this set of three genetic
constructs mammalian acoustic reporter genes, or mARGs.
After establishing polycistronic constructs for mammalian gas vesicle assem-
bly, we used an integrase24,25 to incorporate them into the cellular genome for stable
expression under a doxycycline-inducible TRE3G promoter, with fluorescent pro-
teins added to each construct as transfection indicators (Fig. 4-2a). We transfected
these plasmids into HEK293-tetON cells and used flow cytometry to sort cells ac-
cording to their expression level of each fluorescent reporter. We found that the
cell population combining the strongest expression of each construct produced the
largest quantity of gas vesicles (Fig. 4-2b, Fig. 4-S4a-d). To ensure that mARG
expression was not limited to HEK293 cells, we also transfected Chinese hamster
ovary cells (CHO-K1), and obtained similar results (Fig. 4-S4e-g).
To generate a stable monoclonal cell line expressing mARGs for detailed anal-
ysis, we sorted individual high-expression HEK293-tetON cells for monoclonal
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growth (Fig. 4-2c), producing 30 cell lines, which we screened for viability, fluores-
cence and gas vesicle formation (Fig. 4-2d, Table 4-S2). The number of gas vesicles
per cell was then estimated from TEM images, and a cell line yielding the largest
quantity of gas vesicles was selected and named mARG-HEK. When induced for 72
hours with 1 µg/mL of doxycycline and 5 mM sodium butyrate (to reduce epigenetic
silencing), this cell line produced on average 45 gas vesicles per cell (Fig. 4-2e).
Using thin-section TEM, gas vesicles could clearly be seen in the cytosol of indivi-
Figure 4-2: (Caption on next page.)
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Figure 4-2: Formation, properties and non-toxicity of gas vesicles in cells with genome-
integrated mammalian acoustic reporter genes. (a) Schematic of mARG constructs used
for genomic integration into cells with the piggyBac transposase system. ITR, inverted
terminal repeat; Ch GI, Chicken beta-globin insulator; GFP, Emerald green fluorescent
protein; BFP, enhanced blue fluorescent protein 2. (b) Representative TEM image of
buoyancy-enriched lysate from HEK293-tetON cells transfected with the constructs in (a)
and sorted for high expression of all three operons. (c) Fluorescence-activated cell sorting
of HEK293-tetON cells transfected with the constructs in (a). Red circles denote individual
cells selected by sorting to form monoclonal cell lines. (d) Selection process for monoclonal
cell lines, including assays for viability, fluorescence intensity and gas vesicle yield. (e)
Number of gas vesicles expressed by monoclonal HEK293-tetON cells after 72 hours of
induced expression, as counted in lysates using TEM. Bar represents the mean and the shaded
area represents SEM (n=3, each from two technical replicates). (f) Representative TEM
image of a 60-nm section through an mARG-HEK cell showing an angled slice through two
bundles of gas vesicles in the cytosol. (g) Representative TEM image of gas vesicles purified
from mARG-HEK cells. (h) Size distribution of gas vesicles expressed in mARG-HEK cells.
The mean and standard deviation of both distributions is illustrated as a circle and with error
bars. (n=1828) (i) Phase contrast images of mARG-HEK and mCherry-HEK cells 72 hours
after induction with 1 µg/mL doxycycline and 5 mM sodium butyrate. (j) Cell viability of
mARG-HEK cells relative to mCherry-HEK cells after 72 hours of gene expression. Error
bars indicate SEM. (k) Fraction of mARG-HEK cells in co-culture with mARG-mCherry
cells seeded in equal numbers over 6 days of gene expression (n=3 biological replicates,
each from 4 technical replicates, with darker symbols showing the mean). Scale bars in (b),
(f), (g) represent 500 nm. Scale bar in (i) represents 20 µm.
dusal mARG-HEK cells (Fig. 4-2f). From TEM images of cell lysates, we measured
the average dimensions of gas vesicles produced in this cell line to be 64 ± 12 nm
wide (standard deviation, n=1828) and 274 ± 212 nm long (standard deviation,
n=1828), with some reaching lengths greater than 1 micron (aspect ratios greater
than 30) (Fig. 4-2g-h). This corresponds to an average gas vesicle volume of 0.605
attoliters. Together, the 45 gas vesicles expressed in an average mARG-HEK cell
are expected to occupy just 0.0027% of the cell’s cytosolic volume.
The expression of gas vesicles did not change the gross morphology of mARG-
HEK cells (Fig. 4-2i), and was non-toxic as determined by three di erent assays
(Fig. 4-2j), as compared to a similarly prepared control cell line (mCherry-HEK)
(Fig. 4-S5a-b). During a 6-day co-culture, mARG-HEK cells showed only a minor
growth disadvantage compared to mCherry-HEK cells (Fig. 4-2k). As expected,
both engineered cell lines grew more slowly than wild-type HEK293T cells (Fig.
4-S6).
Having engineered mARG-HEK cells, we sought to image their expression
of acoustic reporters with ultrasound. Gas vesicles encoded by the B. megaterium
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gene cluster are expected to produce linear ultrasound scattering22. However, since
mammalian cells themselves also produce significant linear contrast, detecting gas
vesicles expressed in such cells using linear methods is challenging. To enable more
selective imaging of mARG-expression, we took advantage of the ability of gas vesi-
cles to collapse irreversibly above specific ultrasound pressure thresholds9,10,14,22.
A switch in the incident ultrasound pressure from below to above such a threshold
results in a strong transient signal from the gas vesicles, which decays to a lower
level in the next ultrasound frame due to immediate dissolution of their gas contents
and the elimination of ultrasound scattering (Fig. 4-3a-b). Meanwhile, background
tissue scattering rises with the increase in incident pressure and remains constant at
the new level. Thus, images formed by taking the di erence in signal between the
collapsing and post-collapse frames reveal specifically the presence of gas vesicles.
We implemented this collapse-based imaging approach using an amplitude
modulation pulse sequence11, which we found to provide the best cancellation of
non-gas vesicle signals. When hydrogels containing mARG-HEK cells were imaged
using this technique at 18 MHz, they were easily distinguishable from mCherry-
HEK controls based on their contrast dynamics (Fig. 4-3c). Critically, while this
imaging paradigm requires the collapse of gas vesicles inside cells, this does not
a ect cell viability (Fig. 4-3d).
To determine whether mARGs can faithfully monitor circuit-driven gene ex-
pression26,27, we measured the dynamic ultrasound response of mARG-HEK cells
under the control of a doxycycline-inducible promoter (Fig. 4-3e). After induction
with 1 µg/mL doxycycline, the cells showed a gradual buildup of ultrasound signal,
with clear contrast appearing on day two and increasing over the next 4 days (Fig.
4-3e). These kinetics are similar to those observed with fluorescent indicators (Fig.
4-S7a). When the gene circuit was driven using a range of inducer concentrations,
the ultrasound contrast followed the expected transfer function of the promoter (Fig.
4-3g, Fig. 4-S7b).
To determine how sensitively mARG-expressing cells could be detected in a
mixed cell population, we combined mARG-HEK cells with mCherry-HEK cells at
varying ratios. We were able to detect the presence of mARG-expressing cells in
these mixtures down to 2.5% of total cells (Fig. 4-3h), corresponding to less than
0.5% volumetric density, or approximately 3 cells or 135 gas vesicles per voxel with
dimensions of 100 µm. A similar voxel-averaged concentration of gas vesicles was
detectable in a monoculture of mARG-HEK cells induced to express 1.4 ± 0.6 gas
vesicles per cell (Fig. 4-S8).
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Figure 4-3: Ultrasound imaging of mammalian gene expression in vitro. (a) Illustration
of the collapse-based ultrasound imaging paradigm used to generate gas vesicle-specific
ultrasound contrast from mARG-expressing cells. (b) Representative non-linear signal
recorded during a step change in the incident acoustic pressure, from 0.27 MPa in the white-
shaded region to 1.57 MPa in the grey-shaded region. (c) Representative collapse and post-
collapse ultrasound images of mARG-HEK and mCherry-HEK cells acquired during this
ultrasound imaging paradigm and their di erence, indicating gas vesicle-specific contrast.
(d) Cellular viability after being insonated under 3.2 MPa acoustic pressures, as measured
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Figure 4-3: (continued from above) using the MTT assay. (e) Schematic of a chemically
inducible gene circuit with mARG expression as its output. All three mARG cassettes
in mARG-HEK cells are under the control of the doxycycline-inducible TRE3G promoter
(TRE), with expression triggered by incubation with doxycycline. (f) Representative ul-
trasound images and contrast measurements in mARG-HEK cells as a function of time
following induction with 1 µg/mL of doxycycline and 5 mM sodium butyrate (n=6, with the
darker dots showing the mean). (g) Representative ultrasound images and contrast measure-
ments in mARG-HEK cells as a function of doxycycline induction concentrations. Cells
were allowed to express gas vesicles for 72 hours in the presence of 5 mM sodium butyrate.
(n=6, with the darker dots showing the mean). A sigmoidal function is fitted as a visual
guide. (h) Representative ultrasound images and contrast measurements in mARG-HEK
cells mixed with mCherry-HEK cells in varying proportions. Cells were induced with 1
µg/mL of doxycycline and 5 mM sodium butyrate for 72 hours prior to imaging. (n=4,
with the darker dots showing the mean) (i) Schematic and representative ultrasound im-
ages from mARG-HEK cells in Matrigel re-expressing gas vesicles after acoustic collapse.
Cells were induced with 1 µg/mL of doxycycline and 5 mM sodium butyrate for 72 hours
before and after 3.2 MPa acoustic insonation. Ultrasound images were acquired after an
additional 72 hours in culture following collapse. (j) Ultrasound contrast in mARG-HEK
and mCherry-HEK cells after initial expression, after collapse, after re-expression and after
second collapse. (n=7, with the darker dots showing the mean). GV, gas vesicles. All scale
bars represent 1 mm.
In many imaging experiments, the output of a gene circuit is read out only once.
However, in some cases it may be desirable to track gene expression over time. We
therefore tested whether mARG-expressing cells in which the gas vesicles have
been collapsed during imaging could re-express these reporters to allow additional
imaging. mARG-HEK cells cultured a nutrient-supported hydrogel produced clear
ultrasound contrast 3 days after induction, and were able to re-express their acoustic
reporters over 3 additional days (Fig. 4-3i-j).
Having engineered mammalian cells to stably express gas vesicles and charac-
terized their ability to produce ultrasound contrast in vitro, we next tested the ability
of mARG expression to be visualized in vivo with high spatial resolution. We formed
model tumor xenografts in immunocompromised mice by inoculating mARG-HEK
cells in Matrigel subcutaneously in their left flanks (Fig. 4-4a). In the same mice,
the right flanks were inoculated with mCherry-HEK control cells. We induced
reporter gene expression in both tumors for 4 days through systemic injections of
doxycycline and sodium butyrate (Fig. 4-4b). We expected these nascent tumors to
be mostly vascularized at their perimeter, resulting in the strongest inducible gene
expression at the tumor periphery (Fig. 4-4a). Ultrasound, with its sub-100-µm spa-
tial resolution (at 18 MHz), should be able to discern this gene expression pattern,
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whereas attaining such resolution would be challenging with optical techniques.
After 4 days of induction, we observed clear ultrasound contrast in the flank
inoculated with mARG-HEK cells, which was absent from the contralateral side
(Fig. 4-4c-d). As expected, the pattern observed with ultrasound revealed mARG
expression at the perimeter of the tumor, while the core remained dark, and the
imaging of adjacent ultrasound planes revealed this pattern of gene expression to
persist across the tumor mass (Fig. 4-4e, Fig. 4-S9).
The ultrasound-observed spatial distribution of gene expression was consistent
with the low vascularity in the tumor core, as observed with Doppler ultrasound (Fig.
4-S10). The peripheral gene expression pattern was confirmed with subsequent
histological examination of the tissue (Fig. 4-4f, Fig. 4-S11). In comparison,
our in vivo fluorescence images just showed the presence of signal somewhere
in the tissue and not its precise distribution (Fig. 4-4g). These results, which
were consistent across 5 animals (Fig. 4-S12a), demonstrate that mARGs enable
gene expression imaging in vivo and highlight the ability of ultrasound to visualize
intricate patterns of gene expression noninvasively. We imaged 3 of the animals
again after an additional 4 days to look for re-expression of the collapsed gas vesicles,
and observed ultrasound contrast in each case (Fig. 4-S12b).
4.4 Conclusions
Our results establish the ability of an engineered genetic construct encoding prokaryote-
derived gas vesicles to serve as a mammalian reporter gene for ultrasound, providing
the ability to monitor cellular location and function inside living organisms. mARGs
provide many of the capabilities associated with established genetically encoded op-
tical reporters, including imaging cellular dynamics via promoter-driven expression
and mapping cellular populations in complex samples. While optical reporter genes
mainly provide these capabilities in culture and surgically accessed tissues, mARGs
enable gene expression to be resolved noninvasively in vivo.
While the genetic constructs described in this work should be immediately
useful in a variety of contexts, significant scope exists for further optimization to
make acoustic reporter genes as widely useful as GFP6,13. For example, accelerating
mARG expression beyond the day-scale kinetics shown in this study and developing
sensitive imaging paradigms that do not require gas vesicle collapse would enable
the imaging of more dynamic cellular processes. In addition, while this study
demonstrated essential mARG functionality with clonally selected cell lines, the
expression of mARGs in primary cells, their delivery to endogenous cells via viral
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Figure 4-4: (Caption on the next page.)
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Figure 4-4: Ultrasound imaging of mammalian gene expression in vivo. (a) Diagram
of a mouse implanted with a subcutaneous tumor model, and the expected spatial pattern
of vascularization and doxycycline-induced reporter gene expression. (b) Experimental
timeline. (c) Representative ultrasound image of tumors containing mARG-HEK cells
after 4 days of doxycycline administration. mARG-specific contrast shown in the hot
colormap is overlaid on an anatomical B-mode image showing the background anatomy. (d)
Representative ultrasound image of tumors containing mCherry-HEK cells after 4 days of
doxycycline administration. (e) Ultrasound images of adjacent planes in the mARG-HEK
tumor acquired at 1 mm intervals. The minimum and maximum values of color bars in C-E
are 4000 and 40000 au, respectively. (f) Representative fluorescence image of a histological
tissue section of an mARG-HEK tumor. Blue color shows the TO-PRO3 nucleus stain, green
color shows GFP fluorescence and red color shows mCherry fluorescence. (g) Fluorescence
image of a mouse implanted with mARG-HEK and mCherry-HEK tumors on the left and
right flanks, respectively, after 4 days of expression. Scale bars for are 1 mm for (c-f) and 1
cm for (g).
vectors, and their expression in transgenic animals would greatly expand the utility
of this technology. To facilitate such uses, it would be helpful to further condense the
mARG constructs. For example, genes could be consolidated into fewer clusters,
and preliminary experiments show that gvpB can be combined with the 8-gene
polycistron encoding gvpN-gvpU via an internal ribosome entry sequence (IRES)
(Fig. 4-S13). In addition, the total length of the coding sequence contained in mARG
could be reduced from 7.6 kb to 4.8 kb by eliminating the need for redundant booster
genes, relying instead on non-coding elements such as di erent-strength promoters
to tune expression stoichiometry. Further optimization of mARG genetic constructs
is also needed to reduce epigenetic silencing and metabolic burden28–30. Just as the
engineering of GFP over many years yielded brighter and more colorful reporters
enabling new uses of fluorescence microscopy, further engineering of the genetic
constructs comprising mARGs would help cellular ultrasound penetrate and enable
new areas of mammalian biology and biomedicine.
4.5 Methods
Chemicals, cell lines and synthesized DNA. All chemicals were purchased from
Sigma Aldrich unless otherwise noted. HEK293T and CHO-K1 cell lines were
ordered from American Type Culture Collection (ATCC) and HEK293-tetON cells
and CHO-tetON cells were purchased from Clontech (Takara Bio). Synthetic DNA
was ordered from Twist Bioscience.
Cloning. Monocistronic plasmids used for transient transfection of HEK293T
cells of gas vesicle genes used the pCMVSport backbone. Codon optimized gas vesi-
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cle genes were assembled in each plasmid using Gibson assembly. To test the e ect
of N- and C-terminal P2A modification each B. megaterium gas vesicle gene on the
pNL29 plasmid (addgene 91696) was individually cloned using standard mutagen-
esis techniques. To test the N-terminal modification, the CCT codon was inserted
following the start codon. To test the C-terminal modification, a linker-P2A sequence
(GGAGCGCCAGGTTCCGGG-GCTACTAACTTCAGCCTCCTTAAACAGGCC
GGCGACGTGGAAGAGAATCCTGGC) was inserted upstream of the stop codon
for each gene.
The polycistronic plasmid containing GvpN, GvpF, GvpG, GvpL, GvpS, GvpK,
GvpJ, GvpU and Emerald GFP (EmGFP) were codon optimized, and synthesized
in three fragments. The three fragments were Gibson assembled in the pCMVSport
plasmid. The booster plasmid was assembled by multi-fragment Gibson assembly
from PCR amplified fragments of the above plasmid.
The piggyBac transposon system (System Biosciences) was used to genomi-
cally integrate the mARG cassettes. To clone the mARG cassettes to the piggyBac
transposon backbone, the plasmid was first digested using the SpeI and HpaI restric-
tion enzymes and the mARG cassettes were Gibson assembled in the backbone. For
doxycycline-inducible expression, the CMV promoter upstream of the gas vesicle
genes was replaced with the TRE3G promoter. Internal ribosome entry site (IRES)
and mCherry were cloned downstream GvpB as a marker for genomic integra-
tion. For the booster plasmid, CMVmin followed by enhanced BFP2 (eBFP2) and a
polyadenylation element were cloned in the reverse direction upstream of the TRE3G
promoter (creating a bi-directional doxycycline-inducible promoter) and used as a
marker for genomic integration. A piggyBac transposon plasmid containing TRE3G
and mCherry was Gibson assembled similarly to above.
Cell culture, transient transfection and TEM analysis. HEK293T and CHO-
K1 cells were cultured in DMEM with 10% FBS and penicillin/streptomycin and
seeded in a 6-well plate for transfection experiments. When the cells reached 70-80%
confluency, 2 µg of total DNA (comprising the indicated mixtures of plasmids) was
complexed with 2.58 µg polyethyleneimine (PEI-MAX; Polysciences Inc.) per µg of
DNA, added to the cell culture, and incubated for 12-18 hours. The transfection of
monocistronic plasmids encoding Halobacterium salinarum, Anabaena flos-aquae
and Bacillus megaterium were all at equal molar ratios. Thereafter, the media
containing the PEI-DNA complex was changed with fresh media. Cells were allowed
to express the recombinant proteins for 72 hours.
To look for gas vesicles, fully confluent cells cultured in 6-well plates were
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lysed with 400 µL of Solulyse-M (Genlantis Inc) per well for one hour at 4°C. The
lysate was then transferred to 2 mL tubes, diluted with 800 µL of 10 mM HEPES
bu er at pH 8.0 and centrifugated overnight at 300 g and 8°C. Then, 60 µL of
the supernatant was transferred to a fresh tube to be analyzed using transmission
electron microscopy (TEM).
From this top fraction, 2 µL of sample was added to Formvar/carbon 200
mesh grids (Ted Pella) that were rendered hydrophilic by glow discharging (Emitek
K100X). The samples were then stained with 2% uranyl acetate. The samples were
imaged on a FEI Tecnai T12 transmission electron microscope equipped with a
Gatan Ultrascan CCD.
To estimate gas vesicle yield and analyze size distribution, the cells were seeded
in 6-well plates and gas vesicle expression was induced with 1 µg/mL of doxycycline
and 5 mM sodium butyrate for 72 hours. The cells were lysed using Solulyse-M and
buoyancy enriched at 300 g at 8°C overnight. The top fraction of the supernatant
was mixed with 2M urea and spotted on Formvar/carbon grids. The TEM grids
were washed with water before staining with 2% uranyl acetate. To calculate gas
vesicle yield per cell, the total number of gas vesicles per sub-grid on the TEM grid
was manually counted and related via lysate volume to the number of source cells.
Gas vesicle size distribution was quantified using FIJI31.
To visualize gas vesicles inside cells, mARG-HEK cells were seeded in 6-well
plates and allowed to express gas vesicles for 72 hours. The cells were fixed in
1.25% glutaraldehyde in PBS, post-fixed in 1% aqueous osmium tetroxide, reduced
with ferrocyanide and block-stained in 1% uranyl acetate (all reagents from Electron
Microscopy Sciences). The material was then dehydrated through a graded ethanol
series and embedded in Eponate12 (Ted Pella). Sections were cut 60 nm thin onto
formvar-filmed copper grids, stained with 2% uranyl acetate and Reynolds lead
citrate, and imaged at 80 kV in a Zeiss EM10C (Oberkochen) equipped with an
ES1000W Erlangshen CCD camera (Gatan).
Genomic integration and FACS. HEK293-tetON and CHO-tetON cells were
used for genomic integration of the mARGs. The cells were cultured in a 6-
well plate containing 2 mL DMEM with 10% tetracycline-free FBS (Clontech)
and penicillin/streptomycin. Cells were transfected with the piggyBac transposon
backbone containing the mARGs and the piggyBac transposase plasmid at a transpo-
son:transposase molar ration of 2.5:1. Transfection was conducted using parameters
mentioned above and the cells were allowed to incubate for 72 hours. Cells were
induced with 1 µg/mL of doxycycline 24 hours prior to FACS (BD FACSAria III).
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Polyclonal subpopulations of mARG-expressing HEK293-tetON cells were sorted
into the following four bins: (subtype 1) cells with eBFP2 fluorescence greater than
104 and EmGFP fluorescence greater than 104 and mCherry fluorescence greater
than 2x104 au, (subtype 2) cells with eBFP2 fluorescence between 3x103 and 2x104
and EmGFP fluorescence between 2x103 and 2x104 and mCherry fluorescence be-
tween 2x103 and 2x104 au, (subtype 3) cells with eBFP2 fluorescence between 103
and 6x103 and EmGFP fluorescence between 2x102 and 103 and mCherry fluo-
rescence greater than 2x104 au, (subtype 4) cells with eBFP2 fluorescence greater
than 104 and EmGFP fluorescence greater than 2x104 and mCherry fluorescence
between 2x103 and 2x104 au. CHO-tetON cells were transfected with mARGs and
the piggyBac transposase plasmid similar to above. mARG-expressing CHO-tetON
cells with eBFP2 fluorescence greater than 104, EmGFP fluorescence greater than
104 and mCherry fluorescence greater than 2x104 au were sorted.
For monoclonal cell lines, naïve HEK293-tetON cells were transfected with
mARGs and the piggyBac transposase similar to above. mARG-expressing cells
with eBFP2 fluorescence greater than 104, EmGFP fluorescence greater than 104
and mCherry fluorescence greater than 2x104 au were sorted. 576 cells were sorted
in individual wells of 96-well plate and the surviving 30 cells were analyzed for gas
vesicle expression as described above.
To generate mCherry-HEK cells, HEK293-tetON cells were transfected with
piggyBac transposon plasmid containing TRE3G promoter driving mCherry and
the transposase plasmid similar to above. mCherry-HEK cells were sorted from
cells with mCherry fluorescence between 1.5x104 and 105 au.
Monoclonal cell lines (mARG-HEK and mCherry-HEK cells) were maintained
in tetracycline-free media without butyrate and all imaging and toxicity experiments
were conducted with cells that were less than 16 generations.
In vitro toxicity assays. The viability of the mARG-expressing cells was deter-
mined using three di erent assays involving cellular metabolic activity (resazurin re-
duction, MTT assay), quantification of cellular ATP content (CellTiter-Glo, Promega
Corp.), and dye exclusion (Trypan Blue, Caisson Labs). The measurements were
all quantified as percent viability compared to control cells that expressed mCherry
only (mCherry-HEK). For the MTT and CellTiter-Glo assays, cells were grown in
96-well plates and induced with 1 µg/mL doxycycline and 5 mM sodium butyrate
for 72 hours. They were then treated with reagents according to the manufacturers’
protocols. Luminescence (CellTiter-Glo) and absorbance at 540 nm (MTT) was
measured using a SpectraMax M5 spectrophotometer (Molecular Devices). For
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the Trypan Blue assay, the cells were first grown in 6-well plates and treated with
1 µg/mL doxycycline and 5 mM sodium butyrate for 72 hours. They were then
trypsinized and resuspended in media before being stained 1:1 with Trypan Blue
dye. Ten µL of the solution was loaded in a disposable hemocytometer (C-chip
DHC S02, Incyto) and total cell count and blue-stained dead cells were quantified
by bright field microscopy. Cellular morphology was imaged from mARG-HEK
and mCherry-HEK cells after 3 days of expression with 1 µg/mL doxycycline and
5 mM sodium butyrate. Phase images were acquired using a Zeiss Axio Observer
with a 20x objective. For the co-culture cell competition assay, cells were counted
and 2x105 cells from each type were mixed together and seeded in 6-well plates.
One day after seeding, cells were induced with 1 µg/mL doxycycline and 5 mM
sodium butyrate and the media was exchanged daily. At each time point, cells
were trypsinized and sorted using the MACSQuant VYB Flow Cytometer (Miltenyi
Biotech) to quantify relative cell ratios. At one day and three days post induction,
cells were passaged to ensure continuous exponential growth.
In vitro ultrasound imaging. To create phantoms for in vitro ultrasound
imaging, wells were casted with molten 1% w/v agarose in PBS using a custom 3D-
printed template. mARG-HEK and mCherry-HEK cells were allowed to express
their transgenes using the specified inducer concentrations and expression duration.
They were then trypsinized and counted via disposable hemocytometers in bright
field microscopy. Next, cells were mixed at a 1:1 ratio with 50°C agarose and loaded
into the wells before solidification. The volume of each well was 60 µl and contained
6x106 cells. The phantoms were submerged in PBS, and ultrasound images were
acquired using a Verasonics Vantage programmable ultrasound scanning system
and L22-14v 128-element linear array transducer with a 0.10-mm pitch, an 8-mm
elevation focus, a 1.5-mm elevation aperture, and a center frequency of 18.5 MHz
with 67% -6 dB bandwidth (Verasonics, Kirkland, WA). Each frame was formed
from 89 focused beam ray lines, each with a 40-element aperture and 8 mm focus.
A 3-half-cycle transmit waveform at 17.9 MHz was applied to each active array
element. For each ray line, the amplitude modulation (AM) code was implemented
using one transmit with all elements in the active aperture followed by 2 transmits
in which first the odd- and then the even-numbered elements are silenced11. Each
image captured a circular cross-section of a well with a 4-mm diameter and center
positioned at a depth of 8 mm. In AM mode, the signal was acquired at 0.27 MPa
(2V) for 10 frames and the acoustic pressure was increased to 1.57 MPa (10V) to
collect 46 additional frames. Ultrasound images were constructed by subtracting
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the collapsing frame by frame 4 post-collapse.
For Fig. 4-3f-h, the high gas vesicle content of some samples resulted in
acoustic shielding and a residual amount of gas vesicles remained intact after 46
frames of insonation at 1.57 MPa. To fully collapse all the gas vesicles and collect
the background signal, the acoustic pressure was increased to 3.2 MPa (25V), then
a second set of images was acquired with 10 frames at 0.27 MPa and 46 frames
at 1.57 MPa. Gas vesicle-specific signal was determined by subtracting the total
ultrasound signal from the 46 frames acquired before 3.2 MPa ultrasound by the
total ultrasound signal from the 46 frames post collapse.
Cytotoxicity assay on cells exposed to ultrasound. mARG-HEK and mCherry-
HEK cells were cultured on custom made Mylar-bottom 24-well plates. Cells were
cultured on fibronectin-coated Mylar films until they reached 80% confluency and
induced for gas vesicle expression (1 µg/mL doxycycline and 5 mM sodium bu-
tyrate) for 3 days. The cells were then insonated from the bottom using an L22-14v
128-element linear array transducer (Verasonics). The transducer was mounted on
a computer-controlled 3D translatable stage (Velmex). The bottom of the plates
was acoustically coupled to the transducer with water and positioned 8 mm away
from the transducer face. The cells were exposed to 3.2 MPa of pressure and the
transducer was translated at a rate of 3.8 mm/s. The plates were returned to the
incubator for 24 hours. Cytotoxicity was then assayed using resazurin reduction
(MTT) on cells exposed to ultrasound and compared to non-insonated control cells.
3D cell culture and in vitro acoustic recovery after collapse. mARG-HEK
and mCherry-HEK cells were mixed in Matrigel (Corning) containing 1 µg/mL of
doxycycline and 5 mM sodium butyrate. The cell-laden hydrogels were placed in a
1% w/v agarose base to prevent cell migration out of the hydrogel and to separate
the cells away from the bottom of the plates during imaging. Cells were cultured for
total of 6 days and imaged every 3 days from the top using an L22-14v 128-element
linear array transducer (Verasonics). The transducer was wiped with 70% ethanol,
and imaging was conducted in a laminar flow biosafety cabinet to preserve sterility.
After imaging, to ensure complete collapse of all gas vesicles in the cells, the entire
hydrogel was exposed to 3.2 MPa ultrasound and the transducer was translated three
times across the gel at a rate of 1-2 mm/s. The culture media was changed daily and
contained 1 µg/mL of doxycycline and 5 mM sodium butyrate.
In vivo expression of gas vesicles and ultrasound imaging. All in vivo
experiments were performed on NOD SCID mice (NOD.CD17 Prkdcscid/NCrCrl;
Charles River), aged 10-15 weeks, under a protocol approved by the Institutional
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Animal Care and Use of Committee of the California Institute of Technology.
mARG-HEK and mCherry-HEK cells were cultured in tetracycline-free media in
T225 flasks. 1-1.2x107 cells were trypsinized and the 200 µl cell-pellet was mixed
with 200 µl Matrigel (Corning) containing 5 mM sodium butyrate. The mixture of
mARG-HEK cells and Matrigel was injected subcutaneously in the left flank of mice
and the mixture of mCherry-HEK cells and Matrigel was injected subcutaneously
in the right flank of mice. Starting from the day of tumor inoculation, mice we
interperitoneally injected with 200 µl of saline containing 75 µg doxycycline and
25 mg of sodium butyrate daily. The lower half of mice were depilated to allow for
fluorescence imaging and ultrasound coupling.
For ultrasound imaging, the mice were anesthetized with 2% isoflurane and
maintained at 37°C using a heating pad. Ultrasound imaging was carried out using
the pulse sequence described above with an L22-14v transducer attached to a custom-
made manual translation stage. Using B-mode ultrasound imaging, the center of
the tumor was positioned approximately 8 mm from the surface of the transducer,
and gas vesicle-specific ultrasound images were acquired. The transducer was
translated laterally with 1 mm steps to collect ultrasound images of most of the
tumor. High framerate ultrasound datasets for Doppler imaging were acquired with
the same ultrasound transducer and scanner. The Doppler pulse sequence consisted
of 11 tilted plane wave transmissions (varying from -10 to 10 degrees) at a 5.5 kHz
framerate, leading to a 500 Hz framerate after coherent compounding. Plane wave
transmissions lasted 0.5 s (or 250 frames). A power Doppler image representing
blood flow was computed from each ensemble of 250 frames using a singular value
decomposition filter that separates clutter from red blood cell echoes32.
To obtain tissue samples after the mice were euthanized, tumors were resected
and placed in 3.7% formaldehyde solution (4°C) for 24 hours and transferred to
sterile 30% sucrose for an additional 24 hours. Tumors were embedded in OCT
compound (Tissue-Tek), flash frozen and sectioned to 60 µm slices using a Cryostat
(Leica CM3050). Sections were stained with TO-PRO3 nucleus stain, mounted




1. Farhadi, A., Ho, G. H., Sawyer, D. P., Bourdeau, R. W. & Shapiro, M. G.
Ultrasound imaging of gene expression in mammalian cells. Science 365,
1469–1475 (2019).
2. Tsien, R. Y. Imagining imaging’s future. Nature Reviews Molecular Cell Bi-
ology 4, SS16–SS21 (2003).
3. Piraner, D. I. et al. Going Deeper: Biomolecular Tools for Acoustic and Mag-
netic Imaging and Control of Cellular Function. Biochemistry 56, 5202–5209
(2017).
4. Chu, J. et al. A bright cyan-excitable orange fluorescent protein facilitates
dual-emission microscopy and enhances bioluminescence imaging in vivo.
Nat Biotech 34, 760–767 (2016).
5. Santos, E. B. et al. Sensitive in vivo imaging of T cells using a membrane-
bound Gaussia princeps luciferase. Nature Medicine 15, 338–344 (2009).
6. Maresca, D. et al. Biomolecular Ultrasound and Sonogenetics. Annu Rev Chem
Biomol Eng 9, 229–252 (2018).
7. Pfeifer, F. Distribution, formation and regulation of gas vesicles. Nat Rev
Microbiol 10, 705–15 (2012).
8. Walsby, A. E. Gas vesicles. Microbiol Rev 58, 94–144 (1994).
9. Shapiro, M. G. et al. Biogenic gas nanostructures as ultrasonic molecular
reporters. Nature Nanotechnology 9, 311–316 (2014).
10. Lakshmanan, A. et al. Molecular Engineering of Acoustic Protein Nanostruc-
tures. ACS Nano 10, 7314–7322 (2016).
11. Maresca, D. et al. Nonlinear ultrasound imaging of nanoscale acoustic biomolecules.
Applied Physics Letters 110 (2017).
12. Maresca, D., Sawyer, D. P., Renaud, G., Lee-Gosselin, A. & Shapiro, M. G.
Nonlinear X-Wave Ultrasound Imaging of Acoustic Biomolecules. Physical
Review X 8 (2018).
13. Lu, G. J., Farhadi, A., Mukherjee, A. & Shapiro, M. G. Proteins, air and water:
reporter genes for ultrasound and magnetic resonance imaging. Curr Opin
Chem Biol 45, 57–63 (2018).
14. Bourdeau, R. W. et al. Acoustic reporter genes for noninvasive imaging of
microorganisms in mammalian hosts. Nature 553, 86–90 (2018).
15. Davis, M. M., Tato, C. M. & Furman, D. Systems immunology: just getting
started. Nature Immunology 18, 725–732 (2017).
16. Marblestone, A. H. et al. Physical principles for scalable neural recording.
Front Comput Neurosci 7, 137 (2013).
86
17. Schroeder, T. Imaging stem-cell-driven regeneration in mammals. Nature 453,
345–51 (2008).
18. Gradinaru, V. et al. Molecular and cellular approaches for diversifying and
extending optogenetics. Cell 141, 154–165 (2010).
19. Shieh, Y. W. et al. Operon structure and cotranslational subunit association
direct protein assembly in bacteria. Science 350, 678–80 (2015).
20. Natan, E., Wells, J. N., Teichmann, S. A. & Marsh, J. A. Regulation, evolution
and consequences of cotranslational protein complex assembly. Curr Opin
Struct Biol 42, 90–97 (2017).
21. Close, D. M. et al. Autonomous bioluminescent expression of the bacterial
luciferase gene cassette (lux) in a mammalian cell line. PLoS One 5, e12441
(2010).
22. Farhadi, A. et al. Recombinantly Expressed Gas Vesicles as Nanoscale Contrast
Agents for Ultrasound and Hyperpolarized MRI. AIChE J 64, 2927–2933
(2018).
23. Szymczak, A. L. & Vignali, D. A. A. Development of 2A peptide-based
strategies in the design of multicistronic vectors. Expert Opinion on Biological
Therapy 5, 627–638 (2005).
24. Ding, S. et al. E cient transposition of the piggyBac (PB) transposon in
mammalian cells and mice. Cell 122, 473–83 (2005).
25. Wilson, M. H., Coates, C. J. & George A. L., J. PiggyBac transposon-mediated
gene transfer in human cells. Mol Ther 15, 139–45 (2007).
26. Elowitz, M. B. & Leibler, S. A synthetic oscillatory network of transcriptional
regulators. Nature 403, 335–8 (2000).
27. Gardner, T. S., Cantor, C. R. & Collins, J. J. Construction of a genetic toggle
switch in Escherichia coli. Nature 403, 339–42 (2000).
28. Gaidukov, L. et al. A multi-landing pad DNA integration platform for mam-
malian cell engineering. Nucleic Acids Res 46, 4072–4086 (2018).
29. Jusiak, B. et al. Comparison of Integrases Identifies Bxb1-GA Mutant as the
Most E cient Site-Specific Integrase System in Mammalian Cells. ACS Synth
Biol 8, 16–24 (2019).
30. Neville, J. J., Orlando, J., Mann, K., McCloskey, B. & Antoniou, M. N. Ubiq-
uitous Chromatin-opening Elements (UCOEs): Applications in biomanufac-
turing and gene therapy. Biotechnol Adv 35, 557–564 (2017).
31. Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis.
Nature methods 9, 676–682 (2012).
32. Demené, C. et al. Spatiotemporal clutter filtering of ultrafast ultrasound data
highly increases Doppler and fUltrasound sensitivity. IEEE transactions on
medical imaging 34, 2271–2285 (2015).
87
4.6 Supplementary Information
Figure 4-S1: GvpR and GvpT genes in the B. megaterium gene cluster are not neces-
sary for gas vesicle formation. Schematic of bacterial gas vesicle gene clusters used for
heterologous expression of gas vesicles in E. coli (top). Representative whole cell TEM
images of E. coli Rosetta 2(DE3)pLysS cells after expression of gas vesicles genes for 22
hours (bottom). Scale bars represent 500 nm. Expression performed as in Farhadi et al.22
and TEM imaging as in Bourdeau et al.14.
Figure 4-S2: Assay for tolerability of P2A peptide additions. Illustration of gas vesicle
gene cluster with N- or C-terminal modifications of each gene to test tolerability of P2A
peptides, tested one-by-one in E. coli.
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Figure 4-S3: Identification of bottleneck genes on the polycistronic gas vesicle gene
plasmid. (a) Schematic of the experiment. To test the e ciency with which gas vesicles
could be formed when a given gene was supplied only on the polycistronic plasmid, and
thereby identify “bottleneck” genes, cells were co-transfected with a monocistronic plasmid
containing GvpB, 7 other monocistronic plasmids including all but the gene being assayed,
and the polycistronic plasmid. (b) Qualitative estimate of the relative number of gas vesicles
produced when each indicated gene was supplied solely by the polycistronic plasmid. (c)
Representative TEM images of gas vesicles in the lysate of HEK293T cells for all 8 assays.
Scale bars represent 500 nm. These results suggest that GvpN, GvpS and GvpU supplied
in either monocistronic or polycistronic form supported abundant gas vesicle assembly.
However, the production of gas vesicles was significantly reduced when GvpJ, GvpF, GvpG,
GvpL or GvpK was supplied from the polycistronic vector. We therefore suspected that
these genes represented a bottleneck in gas vesicle formation.
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Figure 4-S4: Fluorescence activated cell sorting of HEK293-tetON and CHO-tetON
cells transfected with integrating mARG constructs. (a) Diagram of the integrating
constructs used to generate polyclonal cell lines. (b) FACS of mARG-expressing HEK293-
tetON cells. Colored data indicate cells sorted for each group and gray dots are unsorted
population. (c) Illustration of the four polyclonal subtypes sorted to study the impact of
polycistron stoichiometry on gas vesicle expression. Red bars indicate mCherry expression;
cyan bars indicate EmGFP and eBFP2 expression. (d) Approximate gas vesicle yield from
polyclonal cells in each subtype. (e) FACS of mARG-expressing CHO-tetON cells. Colored
data indicate cells sorted in subtype 1 and gray dots are unsorted cells. (f) Representative
TEM image of buoyancy-enriched lysate from CHO-tetON cells sorted as indicated in (e).
Scale bar represents 500 nm. (g) Approximate gas vesicle yield for the sorted mARG-
expressing CHO-tetON cells.
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Figure 4-S5: Genetic construct and sorting of mCherry-HEK cell line. (a) Genetic
construct for stable genomic integration of mCherry containing a TRE3G promoter upstream
and SV40 polyadenylation element downstream of mCherry. (b) FACS of mCherry cells,
with selected cells indicated with blue dots.
Figure 4-S6: Co-culture of reporter gene expressing cells with HEK293T cells. Fraction
of mARG-HEK cells in co-culture with HEK293T cells (blue) or mARG-mCherry cells in
co-culture with HEK293T cells (red) seeded in equal numbers over 6 days of gene expression
(n=3 biological replicates, each from 4 technical replicates, with darker dots showing the
mean).
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Figure 4-S7: Fluorescence measurements of gene expression as a function of time and
inducer concentration in mARG-HEK cells. (a) mCherry fluorescence of mARG-HEK
cells induced with 1 µg/mL doxycycline and 5 mM sodium butyrate at the indicated times
after induction (n=4, with the darker dots showing the mean). (b) mCherry fluorescence
of mARG-HEK cells with the indicated inducer concentration and 5 mM sodium butyrate
after 72 hours of induction (n=7, with the darker dots showing the mean).
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Figure 4-S8: Dependence of ultrasound contrast on gas vesicle density. Relative ultra-
sound contrast produced by mARG-HEK cells in hydrogel as a function of the estimated
average number of gas vesicles (GV) per nanoliter present after a monoculture of mARG-
HEK cells was induced with di erent concentrations of doxycycline, or after fully-induced
mARG-HEK cells were mixed with mCherry-HEK cells at di erent ratios. Blue symbols
represent results from mARG-HEK cells induced with 1 µg/mL doxycycline for 3 days
(producing on average 45 gas vesicles per cell) mixed with mCherry-HEK cells (expressing
no gas vesicles) in varying proportions, as presented in Fig. 4-3H. Red symbols represent
results from mARG-HEK cells induced with 0.01, 0.05, 0.1 and 1 µg/mL doxycycline for
3 days; expressing on average 0.01 ± 0.004, 1.4 ± 0.4, 3.5 ± 0.3, 45 ± 5.1 (mean ± SEM)
gas vesicles per cell, respectively, as quantified by TEM. All cells were cultured with 5
mM sodium butyrate during expression. The number of gas vesicles was quantified after
72 hours of induced expression, as counted in lysates using TEM. Ultrasound contrast was
normalized to the maximum in each type of titration. Dark symbols show the mean of
ultrasound contrast for 4 replicates. Error bars represent SEM of 4 biological replicates
for 0.01, 0.05, 0.1 µg/mL induction and n=3 biological replicates (each from two technical
replicates) for 1 µg/mL samples.
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Figure 4-S9: Additional examples of in vivo ultrasound images of adjacent planes in
mARG-HEK tumors acquired at 1 mm intervals. For each imaging slice the di erence
heatmap of nonlinear signal between frame 1 and frame 4 is overlaid on grayscale anatomical
scale. Minimum and maximum values of color bar are 4000 and 40000, respectively. Scale
bars are 1 mm.
94
Figure 4-S10: Representative Doppler ultrasound images of tumors containing mARG-
HEK cells. Doppler ultrasound images were acquired using 250 frames of ultrafast
planewaves at 25V and used to reconstruct vascular maps plotted as normalized power
doppler signal overlaid on anatomical images in grayscale. Scale bars represent 1 mm.
Figure 4-S11: Representative histology sections of tumors containing mARG-HEK
cells. For each mouse, two neighboring sections are presented. Blue color indicates cell
nuclear staining using TO-PRO-3, green color represents GFP fluorescence and red color
represents mCherry fluorescence. All scale bars are 1 mm.
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Figure 4-S12: Biological replicates of in vivo ultrasound imaging of gene expression.
(a) The left column shows ultrasound images of tumors containing mARG-HEK cells
after 4 days of doxycycline administration. The right column shows ultrasound images of
tumors containing mCherry-HEK cells after 4 days of doxycycline administration. After
imaging the tumors were insonated with 3.2 MPa of ultrasound to collapse the expressed gas
vesicles. (b) The left column shows ultrasound images of tumors containing mARG-HEK
cells re-expressing gas vesicles after an additional 4 days of doxycycline administration.
The right column shows ultrasound images of tumors containing mCherry-HEK cells after
an additional 4 days of doxycycline administration. Di erence heatmap of nonlinear signal
between frame 1 and frame 4 is overlaid on a grayscale anatomical ultrasound image. Min
and max on color bar represent 4000 and 40000, respectively. Scale bars represent 1 mm.
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Figure 4-S13: Consolidated mARG construct comprising 2 gene cassettes enables
mammalian gas vesicle expression. (a) Schematic of two gene cassettes integrated to the
genome of HEK293-tetON cells. In the top construct GvpB is separated from GvpN by an
internal ribosome entry sequence (shown in purple). (b) Representative TEM image of GVs
in the lysate of HEK293-tetON cells transfected with the constructs in (a) and induced with
1 µg/mL doxycycline.
Table 4-S1: Tolerability of P2A peptide additions to B. megaterium gas vesicle genes.
Each gene of the B. megaterium gene cluster was modified with an N-terminal proline after
the start codon or with a linker and P2A peptide at the C-terminus, resulting in a total of
21 unique GV gene clusters as illustrated in Fig. 4-S2. E. coli were transformed with each
plasmid and gas vesicles were induced for expression for a total of 22 hours and assayed
for the presence of gas vesicles using TEM. The table indicates whether gas vesicles were
observed by TEM. Expression and TEM imaging performed as in Farhadi et al.22.
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Table 4-S2: Selection funnel for monoclonal mARG-HEK cells. The numbers indicate
the number of cells or cell lines selected at each stage.
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C h a p t e r 5
ACOUSTICALLY MODULATED MAGNETIC RESONANCE
IMAGING OF GAS-FILLED PROTEIN NANOSTRUCTURES
This chapter is in large part a reformatted version of the manuscript entitled “Acous-
tically modulated magnetic resonance imaging of gas-filled protein nanostructures”
published by Lu, G., Farhadi, A., Szablowski, J.Z., Lee-Gosselin, A., Barnes, S.R.,
Lakshmanan, A., Bourdeau, R.W., and Shapiro, M.G., in Nature Materials1. Under
the supervision of Mikhail Shapiro, my contributions to the work was to help design
and conduct the experiments in addition to analyzing and interpreting the data, in
particular experiments related to cluster-based MRI sensors.
5.1 Abstract
Noninvasive biological imaging requires materials capable of interacting with deeply
penetrant forms of energy such as magnetic fields and sound waves. Here, we show
that gas vesicles, a unique class of gas-filled protein nanostructures with di erential
magnetic susceptibility relative to water, can produce robust contrast in magnetic
resonance imaging (MRI) at sub-nanomolar concentrations, and that this contrast
can be inactivated with ultrasound in situ to enable background-free imaging. We
demonstrate this capability in vitro, in cells expressing these nanostructures as ge-
netically encoded reporters, and in three model in vivo scenarios. Genetic variants of
gas vesicles, di ering in their magnetic or mechanical phenotypes, allow multiplexed
imaging using parametric MRI and di erential acoustic sensitivity. Additionally,
clustering-induced changes in MRI contrast enable the design of dynamic molecu-
lar sensors. By coupling the complementary physics of MRI and ultrasound, this
nanomaterial gives rise to a distinct modality for molecular imaging with unique
advantages and capabilities.
5.2 Introduction
The imaging of cellular and molecular processes inside living animals and patients
requires contrast agents compatible with noninvasive imaging modalities such as
magnetic resonance imaging (MRI) and ultrasound. Ideally, such contrast agents
should be non-toxic, possess the smallest possible dimensions, enable detection at
sub-nanomolar concentrations, be expressible by cells through genetic encoding, and
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produce dynamic contrast in response to local molecular signals. Existing contrast
agents for MRI, primarily based on heavy metal chelates2, superparamagnetic iron
oxides3, metalloproteins4,5, and molecules with chemically exchangeable nuclei6–8,
do not fully satisfy these reporter requirements. Here, we show that a unique class
of gas-filled, genetically encoded, nanoscale reporters produce robust MRI contrast
via di erential magnetic susceptibility and can be erased with ultrasound to enable
background-free molecular imaging at sub-nanomolar concentrations.
These reporters are based on gas vesicles (GVs), gas-filled protein nanostruc-
tures expressed in certain photosynthetic microbes as flotation devices to maintain
optimal access to light and nutrients9,10. GVs possess a hollow gas interior, a few
hundred nanometers in size, enclosed by a 2 nm protein shell that is permeable to gas
but excludes liquid water (Fig. 5-1a, b). GVs are physically stable under ambient
conditions, and can be collapsed with pressure above genetically determined thresh-
olds of 2-6 atmospheres, leading to the rapid dissolution of their gaseous contents9.
As a genetically encoded nanomaterial, GVs can be expressed heterologously11,12
and have their properties modified through genetic engineering13.
Air is a well-known source of contrast in MRI due to its positive magnetic
susceptibility compared to diamagnetic water, as seen in image artefacts near gas-
filled organs such as the lungs14. We reasoned that the air inside GVs would also
produce susceptibility-based MRI contrast, which could be observed by T2/T2*-
weighted imaging and quantitative susceptibility mapping (QSM). Additionally,
because GVs can be collapsed with acoustic pressure13,15, we hypothesized that the
MRI contrast produced by GVs could be erased remotely in situ using ultrasound,
an orthogonal noninvasive modality. Such acoustically modulated reporters would
overcome a major challenge in MRI posed by background contrast from endogenous
sources16 by allowing reporters to be identified specifically based on their acoustic
responses. Moreover, this imaging mechanism would be complementary to other
recent uses of GVs15,17, creating possibilities for multimodal imaging. In this
study, we set out to test these fundamental hypotheses through in vitro and in vivo
experiments and computational modelling. In addition, we sought to demonstrate
that the unique material properties of GVs could enable multiplexed, functional and
genetically encoded molecular imaging.
5.3 Results and Discussions
GVs produce susceptibility-based MRI contrast. To assess the ability of GVs to
produce susceptibility-based MRI contrast, we performed computational modelling
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Figure 5-1: Gas vesicles (GVs) produce susceptibility-based MRI contrast. a, Trans-
mission electron microscopy (TEM) image of a GV from Anabaena flos-aquae (Ana) b,
Schematic drawing of a GV, whose air-filled interior has magnetic susceptibility (red) dif-
ferent from that of surrounding H2O (blue). c, Finite element model of the magnetic field
gradient produced by a single air-filled Ana GV in water exposed to a 7 Tesla horizontal
magnetic field (B0). d, Finite element model of the magnetic field gradient produced by
a cylindrical sample of 1 nM Ana GVs embedded in an agarose phantom. e, Quantitative
susceptibility map (QSM), T2*-weighted (T2*w) and T2-weighted (T2w) images of wells
containing Ana GVs at concentrations ranging from 0 to 1.1 nM. The color schemes for
QSM (red hot), T2*w (grey) and T2w (grey) images are used across all figures. The QSM
color scale ranges linearly from -2 to +50 parts per billion (ppb), and T2*w and T2w images
at echo time (TE) = 144 msec have linear scales adjusted for optimal contrast. f, g, h,
Magnetic susceptibility, T2* relaxation rate and T2 relaxation rate, respectively for di erent
concentrations of Ana GVs. The value and the standard error of the slope from the linear
regression fitting are shown for each plot and corresponds to molar susceptibility (f), r2* re-
laxivity (g) and r2 relaxivity (h). N = 9 independent samples in (f, g) and N = 6 independent
samples in (h). Error bars represent SEM. Scale bars represent 150 nm (a), 300 nm (c) and
3 mm (d).
and in vitro imaging experiments. The air contents of the GV interior have an
expected magnetic susceptibility of +0.37 ppm, di ering significantly from water,
which is diamagnetic at -9.0 ppm (Fig. 5-1b). As a result of this mismatch, indi-
vidual GVs in aqueous media under a uniform magnetic field are predicted by finite
element modelling to produce nanoscale magnetic field gradients (Fig. 5-1c). The
proton nuclear spins on water molecules experiencing such gradients are expected to
dephase, leading to enhanced T2/T2* relaxation and a concomitant reduction of local
signal intensity in T2- and T2*-weighted images, which can be acquired with widely
used spin-echo and gradient-echo MRI pulse sequences18. In addition, macroscale
volumes containing GVs have a di erent average susceptibility than surrounding
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voxels, producing macroscale field gradients (Fig. 5-1d), which should cause a pat-
terned change of spin phase beyond the site of the GVs (Supplementary Fig. 5-S1).
These phase changes can be decoded by QSM algorithms to produce contrast maps
with additional sensitivity beyond magnitude-only T2/T2* images19,20.
To test the ability of GV nanostructures to produce these forms of contrast,
we purified GVs from the cyanobacterium Anabaena flos-aquae (Ana GVs) and
imaged them in agarose phantoms with a 7 Tesla MRI scanner. As predicted, GVs
produced robust contrast in T2*- and T2-weighed images and QSM maps (Fig. 5-
1e). Quantification of this MRI contrast revealed T2* and T2 relaxivities of 1.19
± 0.23 nM-1 s-1 and 0.67 ± 0.11 nM-1s-1, respectively, and molar susceptibility of
18.53 ± 0.91 parts-per-billion (ppb) nM-1 (Fig. 5-1f-h and Supplementary Table
5-S1), wherein the nanomolar concentration refers to GV particles. The lowest
tested concentration of Ana GVs, at 230 pM, or 73 µg/mL protein, was readily
detectable by QSM (p = 0.0014, unpaired t-test, the first two data points of Fig.
5-1f, degrees of freedom (d.f.) = 11.86). This protein concentration is within the
range of other protein-based MRI reporters such as haem-containing cytochromes,
ferritin, aquaporin and chemical exchange saturation transfer polypeptides21. At
these concentrations, GVs produce negligible T1 contrast (Supplementary Fig. 5-
S2), and have an insignificant e ect on proton density due to water exclusion (< 0.1%
v/v), preserving these contrast modes for use by orthogonal reporters or anatomical
imaging. GVs purified from Halobacterium salinarum NRC-1 (Halo GVs) and GVs
formed by expressing a GV gene cluster from Bacillus megaterium in Escherichia
coli (Mega GVs) produced similar contrast to Ana GVs (Supplementary Fig. 5-S2).
Background-free acoustically modulated imaging. Conventional T2 and
T2*contrast agents such as superparamagnetic iron oxide nanoparticles (SPIONs)
are widely used in MRI applications such as in vivo cell tracking22. However,
the specificity with which they can be detected in biological tissues is sometimes
confounded by the presence of background contrast from endogenous sources such
as blood vessels and tissue interfaces16. MR pulse sequences and post-processing
methods designed to selectively acquire signals only from SPIONs23–25 often sac-
rifice molecular sensitivity, while alternative imaging approaches such as magnetic
particle imaging (MPI) and 19F-MRI lack tissue context26–29. Unlike SPIONs, GVs
have a built-in mechanism by which their identity as the source of any given MRI
contrast can be ascertained. Namely, the collapse of their gaseous interior under
pressure should eliminate GV’s susceptibility mismatch with water (Fig. 5-2a),
allowing GV-specific contrast to be revealed by di erential imaging. Importantly,
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Figure 5-2: Background-free acoustically modulated imaging. a, TEM images and
simulated magnetic field profiles generated by intact and collapsed Mega GVs. Scale bars
represent 100 nm. b, Magnetic susceptibility maps of wells containing phosphate-bu ered
saline (PBS) or 4.9 nM Mega GVs before and after the application of ultrasound, and the
resulting di erence image. c, T2*-weighted images of a phantom containing wells with 8.1
and 4.9 nM Mega GVs alongside background hyperintense contrast from wells with PBS
in low-percentage agarose and hypointense susceptibility artefact from the nearby 40 µm
(inner diameter) capillary tubes containing 500 mM NiSO4, before and after the application
of ultrasound, and the resulting di erence image. The diagram outlines the di erent regions
of the phantom.
such pressure can be applied remotely using ultrasound, rendering the entire imaging
paradigm noninvasive and depth-unlimited.
We tested this concept by acquiring QSM images of samples containing Mega
GVs or bu er before and after acoustic collapse with ultrasound. Subtraction of the
pre-collapse image from the image acquired after collapse resulted in background-
free contrast specific to the GVs (Fig. 5-2b). To demonstrate that this method
can distinguish GVs from susceptibility artefacts in T2*-weighted imaging, we
prepared a phantom containing GVs, regions with lower concentration of agarose
and capillary tubes filled with paramagnetic nickel. While GVs are di cult to
distinguish from other hyper- and hypo-intense regions in the raw initial image,
acoustic collapse and background subtraction enable the specific observation of
GVs even at concentrations that were initially di cult to spot by naked eye (Fig.
5-2c). This di erential contrast is positive because GV collapse leads to a longer
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T2*.
To test the acoustically modulated molecular imaging paradigm in vivo, we
began by stereotaxically injecting Ana GVs in the striatum of adult C57 mice and
imaging them using T2*-weighted MRI (Fig. 5-3a). We then collapsed the GVs
in situ using brief pulses of MRI-guided focused ultrasound30 and acquired a post-
collapse MRI image. The resulting di erential image, overlaid on a separately
acquired anatomical reference, shows specific background-free contrast from the
brain region injected with GVs (Fig. 5-3b, c). A contralateral injection of phosphate-
bu ered saline (PBS) without GVs, subjected to the same MRI and ultrasound
pulses, produced no significant contrast. The mean collapse-dependent contrast in
the GV-injected region was 23.5 ± 3.8% (Mean ± SEM, N = 9) compared to 0.4
± 2.6% for PBS (Mean ± SEM, N = 6, p = 0.0002, unpaired t-test, d.f. = 12.73).
Although we mainly used T2*-weighted images for in vivo background-free imaging
due to their convenience, QSM-processed susceptibility maps also visualized GVs
with a high contrast-to-noise ratio (Supplementary Fig. 5-S3).
Next, we tested the ability of GVs to be imaged in vivo after intravenous
(IV) administration. GVs injected into the bloodstream are e ciently taken up by
the liver15, a tissue whose ability to clear particles from circulation serves as an
important indicator of hepatic health and tumor diagnosis31. Because the liver and
surrounding tissues also have high endogenous contrast, hepatic imaging serves as
a good test bed for background-subtracted imaging techniques. After administering
GVs to mice (Fig. 5-3d), we performed T2*-weighted imaging before, during and
after applying focused ultrasound to the liver. A dynamic jump in average signal
intensity in the insonated region was readily observed in mice injected with GVs,
but not in mice injected with PBS (Fig. 5-3e), producing a clear spot of background-
subtracted contrast (Fig. 5-3f). The mean collapse-dependent signal change in the
GV-injected mice was 5.4 ± 1.4% compared to 0.1 ± 0.1% for PBS (Mean ± SEM,
N = 8, p = 0.0068, unpaired t-test, d.f. = 7.14) (Fig. 5-3g).
Acoustically modulated imaging of gene expression. After establishing the
basic acoustically modulated imaging capabilities of GVs in vitro and in vivo, we
tested the ability of these genetically encoded nanostructures to act as reporters of
gene expression in living cells. In particular, given the great interest in imaging the
mammalian microbiome and bacterial infections32, we assessed whether GVs could
image inducible gene expression in the model bacterium E. coli. Heterologous
expression of a recently developed GV variant comprising a combination of genes
from A. flos-aquae and B. megaterium12 (A2C) was placed under the control of a
104
Figure 5-3: Background-free imaging of GVs in mammalian tissues. a, Diagram of
the in vivo experiment in the living mouse brain. GVs or PBS bu er (sham control) were
injected into contralateral striatum. T2*-weighted images taken before the insonation were
subtracted from those taken after, and di erence images were calculated to reveal contrast
specific to the GVs, giving rise to a background-free image. b, Representative T2*-weighted
images (TE = 15 msec) of a mouse injected with 2 µL GVs (AnaWT, 3.4 nM) or PBS,
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Figure 5-3: (continued from above.) acquired before and after ultrasound was applied to
the site of injection. The resulting di erence images are overlaid on anatomical images. c,
Changes in signal intensity upon insonation at the sites of injection (N = 9 and 6 injections
for GV and PBS, respectively, in a total of 8 mice) normalized by the intensity of the sur-
rounding brain region. d, Diagram of dynamic imaging of the mouse liver after intravenous
administration of GVs. 200 µL PBS with or without 13.7 nM GVs (Ana C, clustered form)
were injected. After allowing 1 min for the biodistribution of GVs to the liver, mice were
euthanized, and T2*-weighted images (1.9 sec/frame) were acquired continuously before,
during and after a 5-second application of ultrasound pulses to a spot in the liver. e, Rep-
resentative time course of signal intensity at an insonated spot (1 mm radius) of mouse
liver after intravenous injection with GVs or PBS. f, Di erence in intensity between images
acquired before and after ultrasound application, overlaid on anatomical images. g, Average
signal intensity change in the insonated region upon the application of focused ultrasound
to the liver tissue (N = 8 spots for each condition in a total of 8 mice). a.u. denotes arbitrary
units. Error bars represent SEM, and scale bars represent 3 mm (b) and 10 mm (e).
promoter inducible by isopropyl b-D-1-thiogalactopyranoside (IPTG, Fig. 5-4a).
Overnight induction resulted in GV expression and robust, acoustically erasable
QSM contrast that was absent from cells that were not induced or cells induced to
express a control fluorescent protein (Fig. 5-4b, c). Notably, the E. coli concentration
in the phantom, estimated from OD600 to be about 14 g/L wet cellular weight33,
indicates that the GV-containing cells can be detected while comprising less than
1.4% of the imaged volume.
Acoustically modulated multiplexing. Many imaging applications in biomedicine
would benefit from the ability to image multiple molecular or cellular signals in the































Figure 5-4: Acoustically modulated reporter gene imaging in living cells. a, Diagram of
the inducible expression of GV genes in E. coli leading to the intracellular formation of GVs
and the generation of susceptibility-based MRI contrast. b, Representative background-
subtracted QSM image of agarose phantom containing E. coli expressing GVs or a green
fluorescent protein (GFP) under the control of an IPTG-inducible promoter, in the presence
or absence of the inducer, compared to a well containing bu er. c, Mean di erential
susceptibility values relative to bu er. N = 6 biological replicates. Error bars represent
SEM. All bacterial cells were loaded in the phantom at a final OD600 of 8.0.
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tially di erent acoustic pressures13,15, this suggests the possibility of performing
acoustically modulated imaging in multiplex by collapsing one population of GVs
at a time with ultrasound while acquiring a sequence of MR images (Fig. 5-5a).
Voxel-wise intensity changes between successive images should then encode the
signal corresponding to each multiplexed GV population.
GVs with di erent collapse pressures can be obtained by isolating genetically
distinct variants or by modifying their shell13. Here, we used a variant of Ana
GVs (referred to as Ana C) whose acoustic collapse pressure has been lowered by
removing its outer sca olding protein, GvpC13 (Fig. 5-5b). Since GvpC removal
does not alter the morphology of the GV, Ana C produces MRI contrast equivalent to
wildtype Ana GVs (AnaWT). To demonstrate multiplexing, we prepared a phantom
with three wells containing Ana C, AnaWT and a 1:1 mixture (Fig. 5-5c). We then
acquired three sequential MR images interspersed by ultrasound pulses at Ana C-
and AnaWT-collapsing pressures. Changes in the measured magnetic susceptibility
of each voxel between the relevant pairs of images revealed the contents of each
sample (Fig. 5-5, c-d).
Next, to test the multiplexing paradigm and demonstrate the imaging of bacte-
rial gene expression in vivo, we injected Ana C GVs and E. coli cells expressing A2C
GVs subcutaneously and acquired sequential MR images interspersed by ultrasound
pulses selectively collapsing, first Ana C GVs, then A2C GVs, at each location (Fig.
5-5e). Di erence images revealed significant signal for Ana C GVs only upon low-
pressure collapse, since few GVs were left intact to be collapsed at high pressure
(Fig. 5-5f and Supplementary Fig. 5-S4). In contrast, E. coli expressing the more
mechanically robust A2C GVs produced a signal change specifically in response
to higher pressure. Subtracting the signal change generated by low-pressure ultra-
sound from the change generated by high-pressure ultrasound enables quantitative
assignment of the contrast source (Fig. 5-5, g-h). Ana C GVs and A2C-expressing
E. coli cells yield positive and negative values, respectively, with +9.0 ± 2.7% for
Ana C and -8.5 ± 3.3% for A2C GVs (Mean ± SEM, N = 4, p = 0.0072, unpaired
t-test, d.f. = 5.73).
Multiparametric MRI multiplexing. In addition to acoustic multiplexing, we
hypothesized that GVs with di erent shapes and sizes could be distinguished on the
basis of their di erential e ects on T2 and QSM contrast. GV morphology should
alter the nanoscale magnetic field patterns generated by a given quantity of gas,
a ecting T2 relaxation35. In contrast, the magnetic susceptibility calculated from








































































































DifferenceIntact Low Collapsed High Collapsede
Figure 5-5: Acoustically multiplexed magnetic resonance imaging. a, Schematic of
the pressure-scanning paradigm, wherein sequential ultrasound pulses are applied between
MR images. The low-pressure ultrasound (Low US) selectively collapses Ana C GVs and
eliminates their MRI contrast; subsequently, high-pressure ultrasound (High US) collapses
AnaWT GVs. b, Acoustic collapse measurement of Ana C and AnaWT. N = 3 independent
samples for each point. Fitted curves represent a sigmoid function obtained by nonlinear
least-square fitting. c, Representative QSM images taken before ultrasound application
(Pre), after the low-pressure ultrasound (Low) and after high-pressure ultrasound (High)
of wells containing AnaWT, Ana C or a 1:1 mixture of the two, as indicated, followed by
di erence images obtained by pairwise subtraction, color mapped to distinguish variants
collapsing at di erent pressures, followed by an overlay of the two di erence images. The
total GV concentrations were 1.37 nM in all three samples and the images were displayed
from -10 to +50 ppb. d, Average susceptibility of each sample type relative to PBS bu er
at each stage of the pressure-scanning paradigm. N = 4 independent samples. Complete
collapse of GV specimens resulted in slightly negative susceptibility relative to the PBS
solution, as expected since proteins are more diamagnetic than water. e, Diagram of the in
vivo multiplexing experiment in the living mouse lower abdomen. f, Maps of changes in
MRI signal intensity in insonated regions overlaid on anatomical MR image. The insonated
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Figure 5-5: (continued from above) regions are outlined in white, while the subcutaneously
injected areas are outlined in blue or orange, corresponding to their contents. g, Map of the
di erential change in the change in signal intensity after the application of Low US relative
to High US. h, Average signal change at 8 injection sites (4 of each type from a total of
4 mice). a.u. denotes arbitrary units. Error bars represent SEM (b, d, h), and scale bars
represent 10 mm (f, g).
of its nanoscale arrangement. Each type of GV should therefore have its own
parametric fingerprint. We tested this hypothesis using Ana GVs, GVs purified
from E. coli expressing a GV gene cluster from B. megaterium11 and GVs purified
from Halobactrium salinarum (Halo) (Fig. 5-6a). After measuring the T2 relaxivity
and molar susceptibility values for each molecule (Fig. 5-6a, Supplementary Fig.
5-S2), we used Mega and Halo GVs to demonstrate multiplexed imaging. Each
GV type had a distinct appearance under susceptibility contrast relative to its T2
relaxivity (Fig. 5-6b), and voxel-wise unmixing of susceptibility (  ) and relaxation
















revealed the quantities of the two GV types in each sample, C↵ and C  (Fig. 5-6c).
This multiparametric MRI paradigm36 has the advantage of being non-destructive
compared to acoustic multiplexing, but is statistically less accurate (Supplementary
Fig. 5-S5).
Clustering-based molecular sensors. In addition to contrast agents report-
ing their location, there is considerable interest in the development of dynamic
molecular sensors37–40. For example, superparamagnetic nanostructures that clus-
ter in response molecular signals of interest can increase or decrease T2 or T2*
contrast37,40,41. We hypothesized that GVs would also produce di erential MRI
contrast based on clustering. In particular the size and magnetic character of GVs
places them in the so-called motional averaging regime35,42–44 of T2/ T2* relaxation,
such that their clustering in response to a target analyte should result in an increase
in both T2* and T2 relaxivity. We tested this hypothesis using biotin-functionalized
Ana GVs mixed with tetrameric streptavidin (Fig. 5-6d and Supplementary Fig.
5-S6). At appropriate streptavidin concentrations, GVs form micron-size clusters
(Fig. 5-6e), predicted to produce a magnetic field profile with correspondingly large
spatial dimensions (Fig. 5-6f-g). Upon clustering, T2*- and T2-weighted images
showed dramatic relaxation enhancement compared to controls lacking biotinylation
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Figure 5-6: Multiparametric MRI fingerprinting and clustering-based molecular sen-
sors. a, TEM images and magnetic susceptibility and r2 relaxivitiy values for Mega, Ana and
Halo GVs. The molar susceptibility (  ) values are referenced to blank PBS bu er. Error
bars represent the standard error of the slope from linear regression fitting (Supplementary
Fig. 5-S2). b, Representative susceptibility map (QSM), T2 relaxivity map (T2) and calcu-
lated GV concentrations (Conc.) of three samples that contain Halo GVs, Mega GVs or a 1:1
mixture of both GV types. The concentration of Mega (magenta) and Halo (cyan) GVs were
pixel-wise calculated and displayed in overlay. c, GV concentrations calculated from MRI
images in N = 6 independent samples. Black bars represent the expected GV concentration.
d, Diagram of the clustering experiment using biotinylated Ana GVs and streptavidin (SA).
e, Dynamic light scattering (DLS) measurement of the size distributions of biotinylated GVs
with SA (magenta), biotinylated GVs without SA (cyan) and non-biotinylated GVs with SA
(orange). f, g, Finite element model of the magnetic field pattern expected from individual
(f) and clustered (g) GVs. Scale bars represent 2 µm (f) and 4 µm (g). h, Representative
T2*-weighted (T2*w) and T2-weighted (T2w) images and QSM maps of agarose phantom
wells containing GVs with the indicated biotinylation state and presence or absence of SA.
i, j, k, Average change in R2* (i), R2 (j) and   (k) relative to PBS bu er. N = 4 independent
samples. Error bars represent SEM. All the GV samples contained Ana GVs at 0.57 nM.
or streptavidin (Fig. 5-6h), with R2* and R2 increasing approximately 15- and 5-fold,
respectively (Fig. 5-6i-j). Remarkably, the QSM image was largely unaltered (Fig.
5-6k), as expected given the conservation of total air between the three samples; this
allows a change in clustering to be distinguished from an increase in the number of
particles, thereby enhancing sensing robustness.
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5.4 Conclusions
Our results establish GV as protein-based acoustically modulated MRI contrast
agents, using the combination of ultrasound and MRI to enable background-free
and multiplexed molecular imaging. This imaging modality takes advantage of the
material properties of GVs, including both, the magnetic susceptibility of their inte-
rior as a perturbation of the magnetic field in liquid media, and the mechanics of their
protein shell allowing collapse at specific acoustic pressures. Acoustically modu-
lated reporters should be particularly useful in imaging scenarios with confounding
background contrast16,45–47.
The distinct size, shape and mechanical properties of genetic variants of GVs
provide opportunities for future molecular engineering. For example, GV mor-
phology could be optimized to maximize spin dephasing and T2/T2* contrast, or
to facilitate multiplexing of several GV types on the basis of di erential relaxivity.
At the same time, engineering GV shells with a greater variety of critical collapse
pressures could expand multiplexing ability using acoustic collapse. Between these
two modes of multiplexing, non-acoustic multiplexing has the advantage of not
requiring an ultrasound system. However, the acoustic approach is more accurate
in distinguishing GV concentrations, and is independent of the microscale spatial
arrangement of GVs. Genetic or chemical engineering of the GV shell13,48 also
provides a route to designing targeted MRI reporters and sensors, the delivery of
which may be facilitated by engineering GVs with smaller sizes10,49. In parallel,
engineered genetic circuits incorporating GV reporter genes could be used to image
bacteria in vivo.
Several limitations must be addressed in future studies to establish the wider
applicability of GVs as acoustically modulated susceptibility contrast agents. First,
while the three mouse experiments presented in this study provide proofs of concept
for the in vivo implementation of acoustically modulated GV imaging, additional
work is needed to demonstrate applications of this technique in biomedically useful
scenarios. Such applications could include evaluating hepatic health by imaging the
uptake of intravenously injected GVs, labelling specific endothelial or extra-vascular
biomarkers or monitoring bacterial biodistribution. To facilitate such applications,
additional experiments are needed to establish the tolerability and immunogenicity
of injected GVs. Mice injected with repeated doses of GVs over several days in
our study did not exhibit any behavioural abnormality, consistent with previous
veterinary assessments15. However, more detailed histological and biochemical
studies are needed.
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In addition, the acoustically modulated imaging protocol can be simplified to
replace focused ultrasound with an unfocused source, allowing larger areas of the
specimen to experience GV collapse. Unlike ultrasound imaging, which requires
sound wave coherence for image reconstruction, acoustically modulated MRI only
requires enough ultrasound pressure to reach tissues to collapse GVs, facilitating
transmission through bone and providing flexibility in instrument design. Finally,
the expression of GVs is currently limited to bacterial hosts. Making mammalian
cells capable of producing GVs is an active area of ongoing research.
Together with other recent literature, this study establishes GVs as a tri-modal
imaging agent. GVs have recently been explored for ultrasound imaging based on
their ability to scatter sound waves15, and for hyperpolarized 129Xe CEST imaging
based on the ability of xenon gas to exchange across the GV shell17. Compared with
pulse-echo ultrasound, acoustically modulated MRI has an advantage in accessing
bone-enclosed structures such as the brain. It is also much simpler to implement
than hyperpolarized 129Xe imaging, which requires specialized procedures for gas
hyperpolarization and delivery. Nevertheless, the ability of GVs to be visualized
with multiple modalities increases their appeal as a molecular imaging nanomaterial.
5.5 Methods
Expression and purification of gas vesicles. Ana and Halo GVs were purified after
expression in their respective host bacteria. Anabaena flos-aquae (CCAP strain
1403/13F) was cultured in Gorham’s media supplemented with BG-11 solution
(Sigma, St. Louis, MO) and 10 mM NaHCO3 at 25°C, 100 rpm shaking and
1% CO2 under a 14 h light 10 h dark cycle and confluency was reached in ⇠ 2
weeks. Halobacteria NRC-1 (Carolina Biological Supply, Burlington, NC) were
cultured at 42°C in ATCC medium 2185 under ambient light and with shaking
at 100 rpm. Confluency was reached in ⇠ 1 week. Both types of cultures were
transferred to sterile separating funnels. The buoyant cells were allowed to float
to the top over a 48 h period. The subnatant was discarded and the floating cells
were collected. Anabaena cells were lysed with 500 mM sorbitol and 10% Solulyse
solution (Genlantis, San Diego, CA), and Halobacteria cells were hypotonically
lysed with the addition of excess low-salt TMC bu er (10 mM Tris, pH = 7.5, 2.5 mM
MgCl2, 2mM CaCl2). GVs were separated from cell debris by repeated centrifugally
assisted floatation followed by resuspension in 1x PBS (Teknova, Hollister, CA).
The centrifugation speed was carefully controlled to avoid the hydrostatic collapse
of GVs. To prepare solution for in vivo experiments, purified GVs were dialyzed
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overnight in 1 x PBS solution. The concentration of gas vesicles (GVs) was estimated
based on the pressure-sensitive optical density at 500 nm (OD500,PS) due to the ability
of intact GVs to scatter light9.
Ana C was prepared by treating Ana GVs with a solution of 6 M urea and 20
mM Tris-HCl (pH = 8.0). Two rounds of centrifugally assisted buoyancy purification
were performed to remove GvpC. The solution was then dialyzed overnight in 1x
PBS bu er to remove urea.
GVs from Bacillus megaterium (Mega) were heterologously expressed in E. coli
RosettaTM2(DE3)pLysS (EMD Millipore, Billerica, MA). The pNL29 region of the
Mega GV gene cluster11 was cloned into the pST39 plasmid for expression under the
control of the T7 promoter17. The transformed cells were grown at 30°C in LB media
supplemented with 0.2% glucose. 20 µM isopropyl  -D-1-thiogalactopyranoside
(IPTG) was added at OD600 between 0.4 and 0.6 to induce the expression of GVs,
and the cells were grown overnight before harvesting by centrifugation. The clear
subnatant was removed by a syringe, while both the floating and the pelleted cells
were collected. The cells were lysed in 10% Solulyse (Genlantis, San Diego, CA),
250 µg/ml lysozyme and 10 µg/ml DNaseI. Centrifugally assisted floatation and
OD500 measurement followed the procedure used for Halo and Ana GV. Mega GVs,
which are natively clustered after purification from bacteria, were unclustered using
the same urea treatment, buoyancy purification and dialysis procedure described for
the preparation of Ana C GVs. Gas vesicle concentrations were determined using
the relationships summarized in Supplementary Table 5-S1 ref.48.
Reporter gene expression. For reporter gene experiments, the gene cluster
encoding a hybrid GV variant named A2C12 was cloned into pET28a plasmid
(Novagen, Temecula, CA), and the resulting plasmid was transformed into BL21(A1)
cells (Thermo Fisher Scientific, Waltham, MA). The transformed cells were first
grown overnight at 30°C in LB media supplemented with 1% glucose, and this
starter culture was subsequently diluted 1:100 into LB media supplemented with
0.2% glucose. When OD600 reached between 0.4 and 0.6, 400 µM IPTG and 0.5%
arabinose were added to induce expression of GVs. The control green fluorescent
protein mNeonGreen50 was inserted into the same plasmid and followed the identical
culturing protocol.
Cell density was measured after collapsing any intracellular GVs to eliminate
their contribution to optical scattering (Supplementary Fig. 5-S7). A sample of each
E. coli specimen at OD600 ⇠ 1.0 was loaded onto a flow-through, 1 cm path-length
quartz cuvette (Hellma Analytics, Plainview, NY), which was pressurized by an
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N2 cylinder and a digital pressure controller (Alicat Scientific, Tucson, AZ). The
pressure was incremented in 20 kPa steps from 0 to 1.2 MPa and OD600 was recorded
using a spectrophotometer (EcoVis, OceanOptics, Winter Park, FL). OD600 at 1.2
MPa was used to measure cell density. Prior to the preparation of MRI phantoms,
the cells were concentrated by centrifugation to the indicated density. For in vivo
imaging, the buoyant fraction of cells was concentrated and collected after several
rounds of centrifugation at 350 g (4 hrs).
Transmission electron microscopy (TEM). GVs at OD500,PS ⇠ 0.2 were pre-
pared in a bu er of 10 mM HEPES, 150 mM NaCl (pH 8) and spotted on For-
mvar/Carbon 200 mesh grids (Ted Pella) that were rendered hydrophilic by glow
discharging (Emitek K100X). GV samples were negatively stained using 2% uranyl
acetate. Images were acquired using a Tecnai T12 LaB6 120kV TEM.
In vitro MRI and relaxometry. Purified GVs or E. coli cells were embedded in
agarose phantoms. 1% agarose stock solution was prepared in PBS and maintained
at 60°C until use. The size of the phantom was ⇠18 ◊ 6 ◊ 4 cm (length ◊ width
◊ height). Using a custom 3D-printed caster, the bottom half was first cast with
cylindrical wells of the size 3 ◊ 5 mm (diameter ◊ depth) separated by 3 mm. The
cylindrical geometry perpendicular to B0 was chosen to ensure a homogeneous field
in the sample wells to facilitate susceptibility-based imaging. The gel was allowed
to solidify and exposed to air for 1 h for gas equilibration. Two-times concentrated
GVs or E. coli cells in PBS were mixed 1:1 with the melted agarose stock solution
and immediately loaded into the wells. Subsequently, the top half of the phantom
was cast so that all the wells were surrounded by agarose. Care was taken to avoid
bubbles.
MRI was performed on a 7T horizontal bore Bruker-Biospin scanner, using a
7.2 cm diameter volume coil for transmit and receive. T2* relaxivity was measured
with 3D Multi Gradient Echo (MGE) experiments with the following parameters:
repetition time (TR) = 500 ms, 32 echos, echo spacing (TE) = 9.0 ms, field of view
(FOV) = 12 ◊ 6 ◊ 0.8 cm3, spatial resolution = 0.25 ◊ 0.25 ◊ 0.25 mm3 and 1 average.
T2 relaxometry was performed by 2D Multi Slice Multi Echo (MSME) spin echo
experiments with the following parameters: TR = 2500 ms, 16 echos, TE = 16.0 ms,
FOV = 8 ◊ 6 cm2, and spatial resolution = 0.25 ◊ 0.25 mm2. Slice thickness = 1 mm
and 16 averages were used for multiparametric multiplexing experiments and 0.5
mm and 4 averages for all other experiments. T1 relaxometry was performed by 2D
Rapid Acquisition with Relaxation Enhancement with Variable TR (RAREVTR)
with the following parameters: E ective TE = 9.68 ms, RARE factor = 12, FOV = 8
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◊ 6 cm2, spatial resolution = 0.25 ◊ 0.25 mm2, slice thickness = 0.5 mm, 2 average
and 8 variable TR times including: 126.4, 738.4, 1461.2, 2344.1, 3478.7, 5068.5,
7746.6, 20000.0 ms.
For data analysis, a circular region of interest (ROI) was drawn for each well
using Fiji51. The average intensity of the ROI was imported into Matlab for expo-
nential fitting to derive the T2*, T2 and T1 values. Voxel-wise T2* and T2 maps
were generated by ImageJ plugin, MRI Processor, using Simplex fitting. For T2*
relaxometry, the ROI excluded the rim of the wells. Multiparametric multiplexing















where the concentrations of the two GV species, c↵ and c , were the two unknowns.
r2,↵ and r2,  were the r2 relativity and   m,↵ and   m,  were the molecular suscepti-
bility of the GVs, and R2exp and   exp were the experimentally measured relaxation
rate and susceptibility (Supplementary Table 5-S1).
Quantitative susceptibility mapping. Magnitude and phase images of 3D
MGE or 3D fast low angle shot (FLASH) experiments were obtained in ParaVision
5.1 (Bruker), and the images from a single echo served as the input to the Sus-
ceptibility Mapping and Phase artifacts Removal Toolbox (SMART) (MRI Institute
for Biomedical Research, Detroit, MI). This software performed phase unwrap-
ping using the 3D-SRNCP algorithm52, background field removal by the SHARP
algorithm53 and susceptibility map generation using the SWIM algorithm54. The
resulting QSM images were analyzed in Fiji51. Unless specified otherwise, all QSM
images were processed from the 5th echo (TE = 45.0 ms) of a 3D MGE experiment.
Gas vesicle clustering. Purified Ana GVs were biotinylated using a 105 molar
excess of EZ-Link Sulfo-NHS-LC-biotin (Thermo Scientific, Rockford, IL) for 4
h in PBS bu er. The excess biotin was removed by two rounds of overnight dial-
ysis in PBS bu er. Biotinylated or control GVs at OD500,PS = 10 were incubated
with streptavidin (Geno Technology, St. Louis, MO) at the ratio specific to each
experiment for 30 minutes at room temperature before loading into MRI phan-
tom. Dynamic light scattering measurements were performed using a Zeta-PALS
instrument (Brookhaven Instruments, Hotsville, NY) at a concentration equivalent
to OD500,PS = 0.2 in PBS.
In vitro acoustic collapse. Acoustic GV collapse was performed outside the
MRI scanner for in vitro experiments. Multiplexing experiments were performed
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with a single element immersion transducer (Olympus) with transmit frequency =
2.25 MHz, element size = 0.75 inch, focal length = 1.5 inch, pulse duration = 10 µs,
duty cycle = 0.1%. A waveform generator (Model WS8352, Tabor Electronics, Tel
Hanan, Israel) and a power amplifier (Model 3100LA, Electronics & Innovation,
Rochester, NY) were used to drive the transducer. The input voltages to the trans-
ducer were 57 V and 131 V for collapsing Ana C and AnaWT GVs in the agarose
phantom, respectively. The output peak positive pressures were estimated by a fiber
optic hydrophone (Precision Acoustics, Dorchester, UK) to be 0.74 MPa and 1.41
MPa, respectively. For collapsing the intracellular GVs in E. coli, a Verasonics
Vantage programmable ultrasound scanning system using the L11-4v 128-element
linear array transducer (Verasonics, Kirkland, MA) was used with the following
parameters: transmit frequency = 6.25 MHz, transmit voltage = 15 V.
Acoustic collapse curves were measured with ultrasound as described previ-
ously13. Briefly, Ana C at OD500 = 1, AnaWT at OD500 = 1, buoyancy-enriched
A2C-expressing E. coli at OD600 = 1, and clustered Ana C at OD500 = 0.5 (mea-
sured prior to clustering) were prepared in agarose phantoms. An 128-element linear
array transducer (L22-14v, Verasonics, Kirkland, MA) was used at f-number 2.0
to collapse GVs, and to determine the intact fraction via backscattered ultrasound
signal intensity. A ray line script with 15.625 MHz transmit frequency was used for
both collapsing GVs and acquiring ultrasound images. To achieve uniform collapse
at each acoustic pressure, a mechanical motor system was used to move the trans-
ducer over a 6-mm vertical distance at the speed of 0.2 mm/sec for 6 repetitions to
cover the depth of the agarose well. In addition to the imaging plane, two additional
planes spaced ± 300 µm along the azimuth were subjected to acoustic collapse to
ensure completeness. Transducer output pressure was calibrated by a fiber optic
hydrophone (Precision Acoustics, Dorchester, UK).
In vivo injections, MRI and acoustic collapse. All animal experiments
were approved by the Institutional Animal Care and Use Committee (IACUC) of the
California Institute of Technology. Animals were randomized between experimental
groups; blinding was not necessary. Mice were anesthetized using 1-2.5% isoflurane
in all the injection procedures. For intracranial injection, 2 µL PBS bu er with or
without 3.4 nM AnaWT GVs was injected into the striatum or the thalamus of
male C57BL6J mice between 12 and 18 weeks of age (Jackson Laboratory, Bar
Harbor, ME) using a Nanofil blunt-end 35g needle coupled with a motorized pump
(World Precision instruments, Sarasota, FL) at 100 nL/min using a stereotaxic frame
(Kopf, Tujunga, CA). The coordinates of the two pairs of sites with respect to the
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bregma were: +1 mm anterior-posterior, ±2 mm medio-lateral, -3.25 to -3.5 mm
dorso-ventral and -2.5 mm anterior-posterior, ±1.5 mm medio-lateral, -3.25 mm
dorso-ventral. The needles remained in place after injection for 5 minutes to avoid
backflow along the needle tract. OD500,PS of the GV solution inside the syringe was
measured post-injection to confirm GV integrity. For intravenous injection, female
Nu/J mice 8-20 weeks of age (Jackson Laboratory, Bar Harbor, ME) were infused
with 200 µL PBS bu er with or without clustered Ana C (13.7 nM, measured before
clustering) using 29G syringe (BD, Franklin Lakes, NJ) at a flow rate of 75 µL/min.
The mice were euthanized by cervical dislocation 1 minute after the end of infusion
to enable imaging of the liver without respiratory motion artefacts. For multiplexing
experiments, PBS solution containing clustered Ana C (13.7 nM, measured before
clustering) or E. coli cells expressing A2C GVs (OD600 = 150 measured without
collapse) were chilled on ice and mixed 1:1 v/v with Matrigel HC (Corning Inc.,
Corning, NY), then injected subcutaneously into the lower abdomen of female Nu/J
mice 8-20 weeks of age using 21G syringes in volumes of approximately 200 µl
before live-animal imaging.
For imaging, live mice were anaesthetized using 1-2% isoflurane and were
placed in an acrylic cradle where respiration and body temperature were continu-
ously monitored using a pressure transducer (Biopac Systems) and fiber optic rectal
thermometer (Neoptix). Warm air was circulated to maintain body temperature at
30°C. For brain imaging, a 72 mm diameter volume coil was used for RF transmis-
sion and a 30 mm diameter surface coil for detection. T2*-weighted images were
acquired by 2D or 3D FLASH experiments with the following parameters: TE =
15.0 ms, TR = 50.6 ms, flip angle = 20°, FOV = 40 ◊ 28 mm2, spatial resolution =
0.1 ◊ 0.1 mm2, slice thickness = 1.0 mm and 64 averages (2D) or 64 averages and
1 average (3D). Anatomical images were acquired by 2D RARE experiments with
the following parameters: e ective TE = 19.98 ms, RARE factor = 8, TR = 300 ms,
FOV = 140 ◊ 512 mm2, spatial resolution = 0.1 ◊ 0.1 mm2, slice thickness = 1.0 mm
and 1 average. For liver imaging, 2D FLASH experiments were repeated at the rate
of 1.9 sec per image with the following parameters: TE = 8.0 ms, TR = 23.4 ms, flip
angle = 21°, FOV = 64 ◊ 40 mm2, spatial resolution = 0.5 ◊ 0.5 mm2, slice thickness
= 2.5 mm and 1 averages. For multiplexing experiment, 3D MGE experiments were
performed with the following parameters: TR = 46.8 ms, 8 echos, first echo time
3.66 ms, TE = 4.78 ms, FOV = 128 ◊ 40 ◊ 48 mm3, spatial resolution = 0.5 ◊ 0.5
◊ 0.5 mm3 and 1 average. The T2*-weighted images from the 7th echo (TE = 32.3
ms) were used to calculate the change of intensity upon acoustic collapse.
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In situ collapse of GVs was achieved using an MRI-guided focused ultrasound
system comprising an 8-channel signal generator, a motorized MRI-compatible
transducer positioning system and an annular array transducer operating at 1.5
MHz (Image Guided Therapy, Pessac, France). For brain imaging, two ultrasound
pulse schemes were used to transcranially collapse Ana GVs, with the following
parameters: (1) pulse length (PL) = 10 µs, duty cycle = 0.01%, peak positive
pressure (PPP) = 5.7 MPa, 10 to 200 shots; (2) PL = 50 ms, duty cycle = 5%, PPP
= 3.0 MPa, 100 to 600 shots. Both schemes were capable of collapsing GVs and
were tested for both the GV and the control PBS injection sites. For liver imaging,
focused ultrasound pulses were applied at a single lateral position, with 5 axial spots
1 mm apart from each other (using electronic focusing without movement of the
transducer) using the following parameters: PL = 10 µs, duty cycle = 0.1%, PPP
= 2.3 MPa and 100 shots for each spot. For multiplexing experiments, regions of
interest sized 3.5 x 5 mm or 5 mm x 5 mm laterally were insonated at an average
lateral density of 7 focal spots per mm2. Each lateral spot received 1 or 2 pulses
at each of 6 di erent electronically focused axial depths, set apart by 1 mm. The
pulse parameters were PL = 1 ms, duty cycle = 5%, PPP = 1.3 MPa for Ana C
and PPP = 3.2 MPa for A2C. All PPPs were measured by a fibre optic hydrophone
(Precision Acoustics, Dorset, UK) in degased water. 18% attenuation was assumed
for the mouse skull55 in brain imaging, and no attenuation was assumed for the other
experiments.
Data analysis was performed in Fiji51. For brain imaging quantification, an
elliptical ROI was manually drawn for the hypointense region containing GVs. An-
other concentric ROI with twice the radius was drawn, and the intensity of the region
between the two ROI was used to measure the intensity of the background tissue.
The intensity of the GV region normalized by the background was used to calcu-
late the percentage contrast change upon ultrasound exposure. For liver imaging,
a circular ROI of 1 mm in radius was drawn at the focal point of the ultrasound
for quantification. To obtain the di erence images, 50 frames of the 2D-imaging
sequence acquired before and after ultrasound application were averaged, and the
post-collapse average was subtracted from the pre-collapse average. For quantifi-
cation, the average intensity change of the pixels within each ROI was divided by
that of the post-collapse image, resulting in the percentage signal intensity change.
For the multiplexing experiment, images acquired after ultrasound application (av-
erages of 3 neighbouring planes reconstructed from 3D imaging) were subtracted
from the immediately preceding images, and ROIs were drawn corresponding to the
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insonated areas. To normalize the signal intensity of pre- and post-collapse images,
the average intensity of the pixels in an oval area of 20 ◊ 28 mm (width ◊ length)
that encompassed the majority of the mouse body was first subtracted from that in
each ROI before the change of signal intensity within ROIs upon insonation was
calculated. To obtain the percentage of the    signal intensity, the average intensity
change of the pixels within each ROI was divided by that of the post-collapse image,
and the resulting percentage of   signal intensity of low-pressure insonation was
subtracted by that of high-pressure insonation.
Finite element simulations. The magnetic field simulation was performed
in Finite Element Method Magnetics (FEMM) version 4.2 (ref.56). GVs were
simulated as an axisymmetric object with its longitudinal axis aligned parallel to the
magnetic field. The ratio of the susceptibility between inside and outside ( in/ out)
of the GVs was taken to be 1 + 9.395 ◊10-6, which corresponds to the susceptibility
di erence between air and water. For the inside of the cylindrical well, GVs were
assumed to be homogenously distributed, and the ratio of the susceptibility between
inside and outside of the well ( in/ out) was set to be 1 + 3.426◊10-8, which was
the volume-weighted average for 0.36% air in water, the amount expected for 1 nM
concentration of Ana GVs. Then the cylindrical well in an agarose phantom was
simulated as a circle in a 2D planar domain. Similarly, the GV cluster was simulated
as a single sphere in the axisymmetric domain occupying a volume equivalent of
200 GVs packed at 20% density and ( in/ out) of 1 + 1.879 ◊10-6 for 20% air. In all
cases, the external field was set at 7.0 T to correspond to the experimental condition.
Monte Carlo simulation for multiplexing accuracy. The simulation was per-
formed in MATLAB, with N = 100 points simulated for each condition. For simple
acoustic multiplexing (Supplementary Fig. 5-S6a), the apparent concentration of
each GV type was calculated from simulated data using the simple multiplexing
assumptions that all GVs of type ↵ were collapsed by low-pressure ultrasound,
while all GVs of type   were collapsed only by high-pressure ultrasound. Under
this assumption of complete segregation, the molar concentration of the two types









where   m,↵ and   m,  were the molecular susceptibilities of GVs of types ↵ and  
(Supplementary Table S1), and   exp
low and   
exp
high were the simulated experimental
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measurements of susceptibility change upon the application of low-pressure and
high-pressure ultrasound. These values were simulated according to:
  exp
low =   m,↵ ⇤ c↵ ⇤ ( f↵,low +   f↵,low) +   m,  ⇤ c  ⇤ ( f ,low +   f ,low) +   low
  exp
high =   m,↵ ⇤ c↵ ⇤ ( f↵,high +   f↵,low) +   m,  ⇤ c  ⇤ ( f ,high +   f ,low) +   high
f↵,low, f↵,high, f ,low and f ,high were values corresponding to the fractions of GV
types ↵ and   that were collapsed specifically upon the application of low- and
high-pressure ultrasound with the assumption that f↵,low + f↵,high = 1 and f ,low +
f ,high = 1, and   f↵,low and   f ,low were random numbers generated based on
the standard deviations of the collapsed fractions of Ana C and AnaWT at low-
pressure ultrasound (Fig. 5-5b), assuming high-pressure ultrasound was su ciently
strong to collapse all GVs.   low and   high were independent random numbers
generated according to the standard deviation observed in regression fitting of   
measurements (Supplementary Fig. 5-S1a).
Note that, in reality, a fraction of GV type   collapses at the low pressure, while
a fraction of GV type ↵ is left over to be collapsed at the high pressure, leading
to a systematic error in the apparent concentration (Supplementary Fig. 5-S6a).
This error can be reduced with linear spectral unmixing, which takes into account
knowledge of the unique acoustic collapse profile of each GV type13 (Supplementary
Fig. 5-S6b). In this case, the apparent molar concentrations of the two types of
















Finally, for multiparametric multiplexing (Supplementary Fig. 5-S6c), the















where r2,↵ and r2,  were r2 relaxivities of GVs of types ↵ and  , and R2exp and
  exp were the simulated experimental measurements of R2 and susceptibility of
the sample, simulated according to:
R
exp
2 = c↵xr2,↵ + c xr2,  +  R2
 exp = c↵ ⇤  m,↵ + c  ⇤   2,  +   2
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where    and  R2 were normally distributed random numbers using standard devia-
tions observed in    and R2 measurements. In simulating the multiplexing between
Halo and Mega GVs,    and  R2 represented weighted averages of the standard
deviations for Halo and Mega GVs (Supplementary Fig. 5-S1) according to c↵
(representing Halo GVs) and c  (representing Mega GVs).
Statistical Analysis. Sample sizes were chosen on the basis of preliminary
experiments so as to have su cient power for the reported statistical comparisons.
Unless stated otherwise, statistical comparisons used two-tailed heteroscedastic t-
tests with Welch’s correction.
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5.6 Supplementary Information
Theoretical consideration of the T2/T2* relaxation produced by gas vesicles.
Relaxation theory35,42–44,57–59 describes the T2/T2* relaxation of water near a con-
trast agent in three primary regimes: (1) the motional averaging regime, where
 !r · ⌧D ⌧ 1; (2) the static dephasing regime, where  !r · ⌧D   1; and (3) the in-
termediate regime, where !r ·⌧D ⇠ 1. Here !r is the root-mean-square frequency
shift at the surface of the contrast agent and ⌧D is the time for a water molecule to
di use across the distance of the contrast agent’s radius. Considering a single gas
vesicle (GV) at high field (Fig. 5-1b), we obtain  !r ⇡    ·  B0 ⇡ 103Hz and
⌧D ⇡ 10 6sec; therefore T2/T2* relaxation on the nanoscale (e.g., everywhere inside
an agarose well containing GVs) occurs in the motional averaging regime. At the
same time, the macroscale  B field around a millimetre-sized agarose well contain-
ing GVs (at a volume fraction of 0.01%) (Fig. 5-1d) has a predicted  !r ⇡ 10 1Hz
and ⌧D ⇡ 103sec, resulting in T2/T2* relaxation in the static dephasing regime.
These relaxation regimes are manifest in the T2-weighted and T2*-weighted
images shown in Supplementary Fig. 5-S1. The spin relaxation at the centre of the
well is predominantly a result of the nanoscale  B field, while the spin relaxation
near the rim of the wells results from the macroscale  B field. The rim usually
appears darker than the centre of the well in T2*-weighted images because of the more
e cient relaxation of water 1H in the static dephasing regime than in the motional
averaging regime. On the other hand, the rim of the wells lacks hypointense contrast
in T2-weighted images, since ⇡ pulses can e ectively refocus the dephasing of 1H
spins in the static dephasing regime.
Relaxation theory also sheds light on the behaviour of clustered GVs. The
micron-size GV clusters are predicted to have ⌧D ⇡ 10 3sec and are therefore shift-
ing the water 1H relaxation from the motional averaging regime to the intermediate
regime, resulting in strong enhancement of both T2* and T2 relaxation (Fig. 5-6).
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Figure 5-S1: Representative images of GV-containing well in the agarose phantom. a,
T2*-weighted (T2*w) and b, T2-weighted (T2w) images at echo time TE = 45 msec. c, T2*
and T2 map, where pixel-wise T2/T2* relaxation times are plotted. The rim of the wells is
marked by the hypointense contrast in the T2*w image and T2* map (a, c) and the absence
of the contrast in the T2w image and T2 map (b, d). In all the images, B0 fields are along

























































Figure 5-S2: Molar magnetic susceptibility and T2*, T2 and T1 relaxivities of the three
types of GVs used in this study. a-c, susceptibility in the unit of parts per billion (ppb),
d-f, T2* relaxometry, g-i, T2 relaxometry and j-l T1 relaxometry measurements on GVs
from Bacillus megaterium (Mega, a, d, g, j), Anabaena flos-aquae (Ana, b, e, h, k) and
Halobacterium salinarum (Halo, c, f, i, l). Error bars represent SEM. N = 9 independent
samples for all susceptibility and R2* measurements. For T2 and T1 measurements, N = 6
independent samples for Mega and Ana GVs and N = 9 for Halo GVs. Relaxivity values
calculated from linear regression fitting of the slope are listed in Supplementary Table 5-S1.
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Figure 5-S3: Quantitative susceptibility mapping (QSM) of GV contrast in vivo. a,
T2*-weighted image of a coronal slice from a 3D multi gradient echo (MGE) image of the
mouse brain. The hypointense contrast inside the brain tissue corresponds to the site of GV
injection. b, The same slice rendered from QSM processing of the 3D image.























Figure 5-S4: Acoustic collapse measurement of clustered Ana C and E. coli expressing
A2C GVs. Ultrasound images were acquired after sequentially exposing the samples to
insonation at increasing acoustic pressures, and the collapse of GVs were monitored as a
decrease of the image intensity. N = 3 independent samples, and the error bars represent
SEM. Sigmoidal collapse curve was obtained by nonlinear least-square fitting.
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Figure 5-S5: Monte Carlo simulation of error distributions in the two multiplexing
methods. a-b, Simulated distribution of apparent GV concentrations calculated by (a) simple
acoustic multiplexing or (b) acoustic multiplexing with the help of spectral unmixing, based
on experimental values in Fig. 5-5c-d. c, Simulated distribution of apparent GV concen-
trations by multiparametric multiplexing using the inputs derived from the experimentally
measured values in Fig. 5-6b-c. Black plus signs represent true values of GV concentra-
tions, and individual dots (magenta, cyan or black) represent individual simulations with
randomized input of errors. Details of the simulation are provided in Methods.
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Figure 5-S6: Impact of streptavidin to gas vesicle (SA-to-GV) stoichiometry on T2/T2*
relaxation. a-c,  R2*,  R2 and   , respectively, of samples with various SA-to-GV ratios
and the two control samples that lack either SA or biotin. The SA-to-GV ratios are listed
below the graph, and the values of susceptibility are relative to sample containing PBS
bu er. N = 3 independent samples. Error bars represent SEM. d, e, Representative TEM
images of clustered and unclustered GV, respectively. A large number of GVs were observed
inside each cluster, while the clusters were distributed much more sparsely than single GVs
on the TEM grid. Scale bars represent 4 µm.
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Figure 5-S7: Representative hydrostatic collapse measurement of E. coli cells. E. coli
cells at optical density at 600 nm (OD600) ⇠ 1.0 were loaded into a sealed cuvette with path
length 1.00 cm. Hydrostatic pressure was ramped stepwise from 0 to 1.2 MPa and OD600
was recorded in each step. Cells expressing A2C GVs (magenta) showed a sigmoidal drop
in OD600, characteristic of the collapse of intracellular GV. Cells that do not contain GV,
such as those expressing the green fluorescent protein (GFP), did not show a drop in OD600.
The ratios of post- to pre-collapse optical density were between 0.806 and 0.853 (N = 6
independent samples), and the post-collapse OD600 of each sample was used for quantifying
cell density for preparing MRI phantoms.
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Table 5-S1: Summary of the geometrical, optical and magnetic properties of three
types of gas vesicles (GVs). Although the size and shape of GVs are determined primarily
by the genotype, each type possesses certain degree of heterogeneity. For example, Ana
GVs has length distribution with a standard deviation of 35% of the mean10. Errors of GV
geometry represent SEM. The protein concentrations of GVs were measured by Pierce 660
nm protein assay (N = 4, 5, 3 measurements of independent samples of Mega, Ana and Halo
GVs, respectively). Molar susceptibility and relaxivity correspond to the slopes from linear
regression fitting of the MRI measurements in Supplementary Fig. 5-S2, and the errors are
the standard error of the slope. r2* relaxivity was quantified from the center of the agarose
wells and excluded the high contrast at the rim of the wells (Supplementary Figure 5-1).
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Table 5-S2: MRI measurements of E. coli in agarose phantom. All the values were
normalized by those of PBS samples. Errors represent SEM, and N = 6 independent
samples.
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C h a p t e r 6
GENETICALLY ENCODED PHASE CONTRAST AGENTS FOR
DIGITAL HOLOGRAPHIC MICROSCOPY
This chapter is in large part a reformatted version of the manuscript entitled “Ge-
netically Encoded Phase Contrast Agents for Digital Holographic Microscopy” by
Farhadi, A., Bedrossian, M., Lee, J., Ho, G.H., Shapiro, M.G., Nadeau, J.L. currently
under peer-review1. Under the supervision of Mikhail Shapiro and Jay L. Nadeau,
Manuel Bedrossian and I contributed equally to this work. Manuel, Mikhail, Jay and
I conceived and planned the experiments. With the help of Justin Lee and Gabrielle
Ho, I prepared the biological samples. I assisted Manuel and Jay collect the digital
holographic data. All the authors analyzed the data. Manuel, Mikhail, Jay and I
wrote the manuscript with input from all authors.
6.1 Abstract
Quantitative phase imaging and digital holographic microscopy have shown great
promise for visualizing the motion, structure and physiology of microorganisms
and mammalian cells in three dimensions. However, these imaging techniques
currently lack molecular contrast agents analogous to the fluorescent dyes and
proteins that have revolutionized fluorescence microscopy. Here we introduce the
first genetically encodable phase contrast agents based on gas vesicles, a unique class
of air-filled protein nanostructures derived from buoyant microbes. The relatively
low index of refraction of the air-filled core of gas vesicles results in optical phase
advancement relative to aqueous media, making them a “positive” phase contrast
agent easily distinguished from organelles, dyes, or microminerals. We demonstrate
this capability by identifying and tracking the motion of gas vesicles and gas vesicle-
expressing bacteria using digital holographic microscopy, and by imaging the uptake
of engineered gas vesicles by mammalian cells. These results give phase imaging
a biomolecular contrast agent, greatly expanding the capabilities of this powerful
technology for three-dimensional biological imaging.
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6.2 Introduction
Precise acquisition of 4-dimensional data, comprising spatial coordinates and time,
is important for studying many microscopic processes in biology. However, con-
ventional optical microscopy su ers from a narrow depth of field due to its reliance
on focusing lenses to encode spatial depth. Volumetric information is only ob-
tained through step-wise acquisition of points or planes, and the resulting sequential
acquisition typically necessitates low resolution in at least one of the 4 dimen-
sions. Digital holographic microscopy (DHM), an inherently volumetric recording
technique, provides an alternative for instantaneous sampling of thick volumes. Suc-
cessful applications have been made to studies of microbial motility, chemotaxis,
flow of ions through ion channels, and migration of cancer cells2–8.
With DHM, optical interferometry is used to record a series of holograms at
frame rates limited only by the camera. O -line reconstruction yields plane-by-
plane images of image intensity (brightfield) and phase. In DHM, as in other forms
of quantitative phase imaging (QPI), phase contrast at any point x, y is related to the
di erence in indices of refraction between the medium (nm) and objects in the light




h(x, y)(nm   nc(x, y)).
Because the typical values of nc for the cytoplasm and organelles are approximately
1.38, which is very close to the nm of 1.33 for water, it is challenging for DHM to
visualize cells, particularly when they are small10. This challenge could be over-
come with suitable contrast agents or reporter genes, which would make cells more
visible or highlight subcellular features and processes. In fluoresce microscopy,
this function is provided by targeted small-molecule dyes and fluorescent proteins,
which have revolutionized the utility of this technique in biological research11–14.
Unfortunately, these same molecules are not e ective as phase contrast agents due
to their small refractive index di erence relative to H2O and its similarity to other
intracellular materials15–19. An ideal phase contrast agent would have a more dra-
matically di erent index of refraction, and preferably one that is lower than that of
H2O to be categorically distinguishable from other cellular components.
Here we introduce genetically encodable contrast agents for phase imaging.
These contrast agents are based on a unique class of hollow protein nanostructures
called gas vesicles (GVs). GVs are all-protein nanostructures natively expressed in
a number of waterborne microorganisms as a means to regulate their buoyancy20,21.
GVs are air-filled compartments with dimensions on the order of 200 nm, enclosed
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by a 2 nm-thick protein shell (Fig. 6-1a), which is permeable to dissolved gas but pre-
vents water from condensing into a liquid in the GV core. GVs have previously been
described as contrast agents for ultrasound22 and magnetic resonance imaging23–25,
but have not been applied to optical microscopy. Recently, the genes encoding GVs
have been heterologously expressed in commensal bacteria (e.g. Escherichia coli
Nissle 1917 and Salmonella typhimurium)24,26 and mammalian cells27.
Figure 6-1: Gas vesicles as phase contrast agents. (a) Schematic of a single GV, indicating
the index of refraction, n, inside the GV and in typical aqueous media. (b) Schematic of
common path DHM system used in this work, and an illustration of the inherent volumetric
imaging of DHM compared to conventional microscopy. (c) Biotinylated GVs purified
from Anabaena flos-aquae can be clustered using streptavidin. Shown are a schematic and
representative transmission electron micrograph of biotinylated GVs (top) and clustered
GVs (bottom). Scale bars 100 nm and 500 nm, respectively. (d) Representative DHM
images of clustered GVs and alumina beads. Scale bars represent 10 µm. (e) Histogram of
phase change observed from clustered GVs with apparent diameters from 0.6-2.2 µm.
In this work, we test the hypothesis that the large di erence in the index
of refraction of GVs’ gaseous interior (n = 1.0) relative to water and cytoplasm
would produce strong positive phase contrast. We use a DHM system capable of
providing sub-micron resolution to visualize the phase contrast produced by purified
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GVs, allowing 4-dimensional tracking of their motion. In addition, we show that
S. typhimurium cells expressing GVs as a genetically encoded reporter produce
a unique pattern of phase contrast reflecting the sub-cellular distribution of these
nanostructures. Furthermore, we demonstrate the use of GVs as targeted molecular
contrast sources in mammalian cells by visualizing the uptake of engineered GVs
into a mammalian cell line. This work establishes GVs as a tool for molecular
and genetically encodable phase contrast, greatly expanding the utility of DHM and
related methods.
6.3 Results and Discussions
Gas vesicles produce positive phase contrast. To establish the ability of GVs
to produce phase contrast, we imaged GVs purified from Anabaena flos-aquae.
These nanostructures are approximately 120-140 nm wide and 200-800 nm long as
measured by transmission electron microscopy (TEM) (Fig. 6-1a). Individually,
purified GVs were too small to resolve on our DHM system, which uses numerical
aperture (NA) of 0.3 aspheric lenses to achieve a spatial resolution of 0.8 µm (Fig.
6-1b). We therefore assembled GV clusters by biotinylation of the GVs followed
by the addition of streptavidin. This yielded clusters with hydrodynamic diameters
of 690±56 nm (Fig. 6-1c and Supplemental Fig. 6-S1). Holograms were collected
of GV clusters and of comparably sized alumina beads (1524±470 nm diameter
as measured by dynamic light scattering) suspended in phosphate-bu ered saline
(PBS). We reconstructed these holograms into phase images as described in the
supplementary text and Supplemental Fig. 6-S2. The phase shifts from the GV
clusters and alumina beads were opposite in sign, with the GV clusters exhibiting
positive phase contrast, while the alumina beads exhibited negative phase contrast
(Fig. 6-1d). The average phase shift produced by the GV clusters was 0.4±0.32⇡
(Fig. 6-1e). GV phase contrast could be erased by irreversibly collapsing the GVs
with hydrostatic pressure28, providing a convenient internal control. After collapse,
the positive phase contrast of GVs was eliminated (Supplemental Fig. 6-S3).
Having established GVs as phase contrast agents, we sought to determine if
DHM could be used to distinguish them and track their motion in a mixed particle
population. First, we tracked the motion of both GV clusters and alumina beads
in a 1 mm-deep well. The average speed of GV clusters rising along the depth
axis due to their buoyancy was 0.43±0.58 µm s 1 (95% C.I.) (Fig. 6-2a-c), while
alumina beads sank with an average speed of –0.47±1.02 µm s 1 (95% C.I.) (Fig.
6-2d-f). When GV clusters and alumina beads were mixed together and tracked, the
138
Figure 6-2: Volumetric tracking of particles in a mixed population suspension. (a) 3D
trajectory plots of tracked GVs over 60 seconds. (b) Clustered GVs rise in solution (Top).
Histogram of the z-component velocities of clustered GVs (Bottom). (c) Two example
3D tracks of clustered GVs. Each trajectory is color-coded with respect to time. (d) 3D
trajectory plots of tracked alumina beads over 60 seconds. (e) Alumina beads sink over
time (Top). Histogram of z-component velocities of alumina particles (Bottom). (f) Two
example 3D tracks of alumina beads. Each trajectory is color-coded with respect to time.
(g) 3D trajectory plots of the mixed population over 60 seconds. (h) Mixed population of
clustered GVs and alumina beads. (i) Velocity histograms show two velocity populations,
one for GVs and another for alumina beads. (j) Example trajectory of a rising and another of
sinking particle chosen at random from (g). (k) Phase images of the two particles from (j).
The buoyant particle has a positive phase contrast while the particle sinking has a negative
phase contrast. Scale bars represent 5 µm.
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two particle types were readily distinguished (Fig. 6-2g-j), with the particles that
were rising having positive phase contrast and the particles that were sinking having
negative phase contrast (Fig. 6-2k). This demonstrated the ability of GVs to serve
as a categorical contrast agent for 4-dimensional DHM.
Engineered gas vesicles serve as targeted contrast agents. Among the ad-
vantages of GVs as phase contrast agents is their ability to be genetically engineered
to modify their surface biochemical properties and enable molecular targeting28,29.
To demonstrate that engineered, targeted GVs could be used for phase imaging
in living cells, we used a fusion of the A. flos-aquae sequence to a polyarginine
(R8) peptide. This peptide is a mimic of the human immunodeficiency virus 1
trans-activating (HIV-1 TAT) peptide and allows tagged proteins and particles to
penetrate into mammalian cells (Fig. 6-3a)30. Polyarginine-modified GVs were
purified and added to Chinese hamster ovary (CHO) cells at 114 pM for 45 minutes,
washed and imaged by a DHM system. This allowed for rapid 3-dimensional recon-
struction of GV location on the surface of and within the cells (Fig. 6-3b & 6-3c).
GVs were fluorescently labeled with Alexa Fluor 488-NHS ester dyes to indepen-
dently confirm the location of GV labeling on the cells (Fig. 6-3d & 6-3e). These
experiments demonstrate the ability of GVs to label living cells for 3-dimensional
phase imaging.
Gas vesicles as genetically expressed contrast agents in Salmonella ty-
phimurium. Following the characterization of GVs as targeted DHM contrast
agents, we tested the ability of genetically encoded GVs to act as phase contrast
reporter genes in living bacteria. A recently developed gene cluster encoding
GVs, comprising a combination of genes from Anabaena flos-aquae and Bacillus
megaterium26, was used to heterologously express GVs in Salmonella typhimurium
(Fig. 6-4a). Upon induction with N-( -ketocaproyl)-L-homoserine lactone (AHL),
Salmonella formed numerous intracellular GVs, which were visualized under TEM
and seen to typically cluster into distinct subcellular regions (Fig. 6-4b). This
pattern was expected to perturb the electromagnetic wavefront passing through a
GV-expressing Salmonella cell so as to produce a distinct pattern in phase images,
as shown in simulated holograms (Fig. 6-4c, Supplemental Text).
As expected, under DHM, GV-expressing Salmonella exhibited clear phase
contrast that was di erent from control cells in which the GVs had been collapsed
with hydrostatic pressure28. Phase values of interior cellular regions of 50 GV-
expressing salmonella cells were analyzed and found to exhibit an average phase
value of 0.06±0.05⇡ (95% C.I., n = 50 cells) (Fig. 6-4d & 6-4f). The subcellular
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Figure 6-3: DHM imaging of mammalian cells labeled with engineered gas vesicles.
(a) Diagram of engineered GVs genetically functionalized with R8 peptides for attachment
to and internalization by mammalian cells. Illustration of mammalian cells labeled with
R8-GVs. (b) DHM phase image of CHO cells labeled with R8-GVs. Scale bar represents
25 µm. (c) Pseudocolored 3D rendering of GVs decorating CHO cells. For details see
supplemental text. (d) Phase image of CHO cells labeled with Alexa Fluor 488 conjugated
R8-GVs under the high power DHM showing positive phase contrast in correspondence
with (e) a fluorescence image of the same CHO cells. All scale bars represent 25 µm.
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regions of these cells which contained high GV concentrations exhibited even higher
phase values of 0.42±0.10⇡ (95% C.I., n = 110 sub-cellular regions). The phase
values of interior cellular regions of 50 GV-expressing Salmonella cells after their
GVs were hydrostatically collapsed were measured to be -0.06±0.10⇡ (95% C.I.,
n = 50 cells) (Fig. 6-4e & 6-4f). The histogram of all pixels in Salmonella cells with
and without GVs illustrates increased phase contrast due to GV-expression (Fig. 6-
4g). GV-expression increased the average signal to noise ratio of Salmonella cells in
phase images by more than three-fold, making the cells easier to detect in solution.
Our results demonstrate that GVs serve as molecular and genetically encod-
able contrast agents for phase imaging due to the large di erence in their index
of refraction compared with aqueous media and organelles, resulting in positive
phase contrast. The opposite sign of their refractive index di erence from water
compared to most other biological structures is especially beneficial for studying
small samples such as microorganisms or subcellular features. The rapid volumetric
image acquisition of DHM makes it possible to identify and dynamically track GVs
in a mixed solution containing other particles. In addition, the modular protein
make-up of GVs enables protein engineering to confer novel targeting properties for
cellular imaging. This may facilitate future studies of cell-nanoparticle interactions
and other dynamic cellular processes. Furthermore, introducing GV gene encoded
phase contrast allows cells to activate the expression of these reporter genes and
to be distinguished from cells without reporter expression. These studies result
in a QPI toolkit that will permit specific labeling in a large number of biological
scenarios.
6.4 Conclusions
While the results presented in this study provide the key scientific evidence support-
ing the ability of GVs to serve as genetically encoded reporters for phase imaging,
future work is needed to apply these agents to specific biological problems. To
enable such applications, there exists significant scope for improvement and opti-
mization. In using GVs as a contrast agent for arbitrary samples, phase wrapping
must be considered. In a typical QPI system, phase measurements are constrained
to a modulo-2⇡ (e.g. -⇡ to ⇡). As a result, samples that introduce a phase shift
of   = 2⇡ + m, will only be seen to show a phase shift of m. Targeted e orts in
the development of robust phase unwrapping algorithms will aid in the use of GVs
in arbitrarily thick samples, eliminating the loss of contrast due to aliasing31–36.
Given the ability of GVs to be collapsed with acoustic pressure, additional contrast
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Figure 6-4: Gas vesicles as genetically encoded phase contrast agents in Salmonella.
(A) Schematic of engineered GV gene cluster comprising genes from Anabaena flos-aquae
(orange genes) and Bacillus megaterium (blue genes) that enable heterologous expression
of GVs in Salmonella typhimurium. (B) Representative transmission electron micrograph
of S. typhimurium expressing GVs. Inset is a 2x zoom in of a GV containing region of
the salmonella cell. Scale bar represents 1 µm. (C) Numerical simulation of phase images
of a GV-expressing Salmonella cell. Scale bar represents 1 µm. (D) Representative phase
images of GV-expressing S. typhimurium cells under DHM. Two examples of zoomed in
images are shown on the right. Scale bars for full field of view are 25 µm, and 5 µm for the
zoomed in images. (E) Representative phase images of GV-expressing S. typhimurium cells
after collapsing GVs using 1.2 MPa of hydrostatic pressure. Two examples of zoomed in
images are shown on the right. Scale bars for full field of view are 25 µm, and 5 µm for the
zoomed in images. (F) Quantified average phase contrast from S. typhimurium cells with
intact GVs compared with collapsed GVs (n = 50 cells). (G) Histogram of quantified phase
contrast from all pixels in S. typhimurium cells with intact GVs (n = 50 cells) compared
with collapsed GVs (n = 50 cells).
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specificity could be obtained by integrating the ability to apply ultrasound waves
to DHM samples in situ and monitoring the resulting change in phase24,26,28. In
addition, the engineering of GV variants that collapse under di erent applied pres-
sures may enable multiplexed phase contrast imaging. Furthermore, while genetic
encoding facilitates the use of GVs to study genetically tractable organisms, there is
also substantial interest in using DHM for field studies, taking advantage of the mi-
croscopes’ robust solid-state design37. In such studies, the relevant microorganisms
may be genetically intractable, requiring the development of targeting moieties to
bind GVs to such species. Such labeling would additionally facilitate the application
of machine learning algorithms to the detection of microorganisms in 4-dimensional
data, where low image contrast is currently a challenge38. We anticipate that the
development of dedicated molecular and genetically encodable contrast agents will
usher in a new phase in holographic microscopy.
6.5 Methods
Digital holographic microscopy. Two instruments were used: a “high power”
instrument and a “low power” instrument. The design of the “high power” micro-
scope was a modified Mach-Zehnder as described previously39, containing identical
objective lenses in the object and reference beams. The objective lenses used were
Mitotoyo 100x, NA=0.7 dry long working distance objectives, infinity-corrected to
an achromatic field lens (200 mm focal length), which was used to form the image
on a digital CCD camera (Baumer TXG50-P). The e ective magnification of this
instrument was 78x. The di raction-limited lateral resolution was roughly 0.3 µm
with a 405 nm illumination source. Illumination was through a single-mode fiber
coupled diode laser that was collimated before the first beamsplitter.
The design of the “low power” microscope was a common path Mach-Zehnder
as described previously37,40. The objectives were simple aspheric lenses (Aspheri-
con) with NA=0.3. The e ective magnification was 19.6x with a di raction limited
lateral resolution of 0.8 µm. The wavelength used in this work for both DHM
instruments was 405 nm, supplied by a diode laser (Thorlabs S1FC405).
DHM images of GV-labeled mammalian cells were acquired using the “high
power” microscope and all other DHM data were collected using the “low power”
microscope.
Gas vesicle expression, purification and clustering. Anabaena flos-aquae
(CCAP strain 1403/13F) was cultured for 2 weeks in Gorham’s media supplemented
with BG-11 solution (Sigma) and 10 mM NaHCO3 at 25°C, 100 rpm under 1% CO2
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and a 14 hours light/10 hours dark cycle29. At confluency, the buoyant cell fraction
was isolated by floating to the top of a separating funnel over a 48h period, after which
the subnatant was discarded. The collected cells were then lysed using 500 mM
sorbitol and 10% Solulyse solution (Genlantis). GVs were purified through repeated
rounds of isolating the buoyant fraction through centrifugation and resuspension in
PBS.
GV clusters were prepared by first biotinylating purified GVs with 105 molar
excess of EZ-Link Sulfo-NHS-LC-biotin (Thermo Scientific) in PBS for 4 hours.
Afterwards, the sample underwent two rounds of overnight dialysis in PBS. The
biotinylated GVs were then clustered by incubation with streptavidin (Geno Tech-
nology) for 30 minutes at room temperature at a streptavidin to GV molecular ratio
of 100:1.
Dynamic light scattering. The hydrodynamic size of the GVs, GV clusters
and alumina beads was measured in 50 µL samples at OD500=0.2 using a Zeta-PALS
analyzer (Brookhaven Instruments). Samples were mixed thoroughly and measured
five times for each reported hydrodynamic diameter.
Engineered gas vesicles for cell labelling. Genetically engineered GVs were
prepared using a previously described protocol28. In brief, the GvpC DNA sequence
from Anabaena flos-aquae was codon-optimized for E. coli expression and cloned
into a pET28a(+) plasmid (Novagen) with an N-terminal hexahistidine-tag and C-
terminal GSGRRRRRRRR sequence. Plasmids were transformed into BL21(DE3)
cells (Invitrogen), which were induced to express the recombinant GvpC for 6 hours
at 30°C. GvpC contained in inclusion bodies was purified by lysing the cells using
10% Solulyse (Genlantis) supplemented with DNaseI (10 µg/mL) and lysozyme (400
µg/mL) at room temperature. Inclusion bodies were recovered by centrifugation at
27,000g for 15 min. The inclusion body pellets were resuspended in 20 mM Tris-
HCl bu er with 500 mM sodium chloride and 6 M urea (pH=8.0) and incubated with
Ni-NTA resin (Qiagen, Valencia, CA) for 2 hours at 4°C. After washing, proteins
were eluted using 250 mM imidazole.
Purified GVs were treated with 6 M urea and 20 mM Tris-HCl (pH=8.0) to
remove their wild-type GvpC. The stripped GVs were isolated with two rounds of
centrifugally assisted buoyancy purification in urea. Purified polyarginine modified-
GvpC was then added according to the formula: 2 x optical density x 198 nM x
liters GVs = nmol of recombinant GvpC and dialyzed in PBS for 8 hours. 105
molar excess of Alexa Fluor 488 NHS (Thermo Fisher) was then added to the GVs
and incubated at room temperature for 4 hours under gentle rotation, before being
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quenched with 20 mM Tris-HCl (pH=8.0) and dialyzed in PBS to remove excess
dye.
Cell culture and gas vesicle labeling. Chinese hamster ovary cells (CHO-
K1; ATCC) were cultured in DMEM (Corning) with 10% FBS (Thermo Fisher)
and penicillin/streptomycin (Corning). Coverslips (18x18 mm) were sterilized with
70% ethanol, washed twice in PBS and placed in 6-well plates. Fibronectin (Sigma)
was diluted 1:20 in PBS and 200 µL were added to each well over the entire surface
of the coverslip and incubated for 1 hour at room temperature. Excess solution
was aspirated, and CHO-K1 cells were seeded on the coverslips and grown to 75%
confluency.
For GV labeling, the surface of a 6-well plate was covered with para n and
UV sterilized. Then, 300 µL of 37°C DMEM media and 300 µL of 114 pM (36.6
µg/mL or OD500=1) of R8-GVs was added to the bottom of the well and mixed.
The cells cultured on coverslips were inverted onto the DMEM and GV mixture, so
the cells were facing the bottom of the plate. The coverslips and GVs were incubated
at 37°C. Following incubation, the cells were washed three times with 200 µL of
PBS and fixed with 1 mL of formaldehyde for 30 minutes. The coverslips were
mounted using Diamond Antifade mountant (Thermo Fisher) and sealed using clear
nail polish.
Fluorescence imaging. Fluorescence images were taken on an Olympus IX-71
inverted microscope using Hg lamp illumination through a 1.4 NA oil immersion
objective and using the enhanced green fluorescent protein filter set (Chroma).
To register fluorescence images with phase images, a 1-µm tip glass pipette was
secured to the specimen and cells were imaged in the vicinity of the tip across the
two instruments.
Gas vesicle expression in Salmonella. GV expression in Salmonella ty-
phimurium (strain ELH1301) cells was performed as described previously26. Briefly,
the hybrid GV gene cluster, under the control of the luxI promoter (addgene 106475),
was transformed into S. typhimurium cells. Monoclonal cells from an individual
plated colony were cryostocked. Cells containing the GV genes were grown in 5 mL
of 2xYT media with 50 µg/mL kanamycin for 16 hours at 37°C, 250 rpm. Cultures
in 50 mL 2xYT media with 50 µg/mL kanamycin were then inoculated with 500
µL of the starter culture and grown on the shaker at 37°C until OD600=0.4 to 0.6.
These cultures were induced with 3 nM N-( -ketocaproyl)-L-homoserine lactone
(AHL) and then grown for 22 hours at 30°C, 250 rpm. Cells were then harvested by
centrifugation at 300g at 30°C for 2 hours. The buoyant cell fraction was transferred
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into clean tubes. To collapse the GVs inside cells, GV-expressing salmonella were
placed in a quartz cuvette (Hellma Analytics) connected to a N2 cylinder through a
pressure controller (Alicat Scientific) set to 1.2 MPa.
TEM sample preparation and imaging. Electron microscopy was performed
at the Beckman Institute Resource Center for Transmission Electron Microscopy
at Caltech. Purified GVs were diluted to OD500=0.2 in 10 mM HEPES bu er and
Salmonella cells were diluted to OD600 0.2 in 10 mM HEPES bu er or PBS. Samples
were then spotted on Formvar/Carbon 200 mesh grids (Ted Pella), which were
rendered hydrophilic by glow discharging (Emitek K100X). Purified GV samples
were stained with 2% uranyl acetate, while cells were imaged unstained. Image
acquisition was performed using a Tecnai T12 Lab6 120 kV transmission electron
microscope equipped with a Gatan Ultrascan 2k x 2k CCD camera.
Simulations. Holograms were simulated with MATLAB (R2017b) using a
custom hologram simulation routine. First, a two-dimensional projection image
was created using a series of Radon Transforms, modeling a typical GV-expressing
Salmonella cell as a cylinder, with a diameter of 1 µm and a length of 5 µm, with
bands of lower refractive index corresponding to areas dense in GVs as seen in TEM
images. This projection is then downsampled, via bicubic interpolation, in order to
accommodate and emulate the di raction limited resolution of the low-power DHM
instrument. Within this projection, GVs were simulated using index of refraction
values of 1.00. Other intracellular areas were simulated using an index of refraction
of 1.37. The index of refraction used to simulate the cell’s surrounding medium is
1.33.
The wavefront perturbations as a result of a collimated plane wave passing
through the simulated cell is then propagated using the angular spectrum method41.
The resulting di racted wavefront is numerically propagated and recombined with
a reference (undisturbed) plane wave in order to simulate an o -axis hologram.
Code for the simulator is provided in the Supplemental Material. The simulated
holograms were reconstructed into phase images using the commercially available
software KOALA (LynceeTec). No image noise was added to the simulation besides
quantization noise when the holograms were saved as unsigned 8-bit image files
whereas in reality there are numerous sources of noise including, but not limited to,
photon ‘shot’ noise, temporal and spatial noise due to changes in the coherence of
the illumination laser, as well as various sources of noise introduced by the digital
CCD used to record the holograms10.
Tracking. Tracking of GVs and alumina beads was performed using the
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Manual Tracking plug-in in the open source image analysis tool FIJI42.
Phase quantification of Salmonella cells. Data recorded using the DHM sys-
tem was reconstructed into phase images using the commercially available software
Koala (LynceeTec). Raw 8-bit phase images were reconstructed with quantitative
phase bounds of –⇡ to ⇡ corresponding to pixel values of 0 and 255, respectively
(described in supplementary text). After reconstruction, cell boundaries were iden-
tified with the freehand selection tool of the open source image analysis software
FIJI by team members blinded to the identity of the sample. The cell boundaries
were used to isolate the interior pixel values within the cell by creating a binary
mask about the cell boundary. These interior pixel values were converted from their
8-bit values to quantitative phase values and analyzed using MATLAB (2017b).
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6.6 Supplementary Information
Image Processing and Handling.
In the analysis of o -axis holograms, image reconstruction and post-processing steps
are necessary in order to interpret the electric field intensity recorded in a hologram
into a useful three-dimensional data set. Furthermore, post-processing methods are
used to de-noise the resulting reconstructed images.
This supplemental text outlines the methods and work flows associated with
the processing and handling of o -axis holographic images. This includes the
reconstruction process from hologram to phase images, and all de-noising steps
used to reach the final images that are presented in the main text above.
Image Reconstruction. An o -axis hologram is recorded as a single image
that contains interference patterns (or fringes) that contain the 3D information of
the sample being imaged. The spatial frequency of the fringes act as the carrier
frequency of this information. In order to reconstruct this information into a usable
form, the high spatial frequency information in the hologram must be isolated.
Supplementary Figure 6-S1a shows an example hologram, its Fourier Transform
plotted on a logarithmic scale (note the high frequency ‘lobes’ which contain the
3D information of the sample (Supplementary Figure 6-S1b), the same Fourier
transform that has been multiplied by a binary mask to isolate one of the high
frequency lobes (Supplementary Figure 6S-1c), and that isolated lobe that has been
shifted to the center of the Fourier Transform (Supplementary Figure 6-S1d).
In the formation of an o -axis hologram, two collimated beams of light are
recombined at the digital detector at an angle (o -axis of each other). This o -axis
recombination causes interference between the two beams. The spatial frequency
of these fringes is proportional to the wavelength of light used as well as the
recombination angle. If the two beams of light are named the ‘specimen’ and
‘reference’ beam where the ‘specimen’ beam interacts with the sample being imaged,
and the ‘reference’ beam remains undisturbed, then the resulting hologram can be
represented mathematically as the superposition of the two beams at the detector
(Equation 6.1).
S(x, y) = AS ⇤ ei( S(x,y) !t) (6.1a)
R(x, y) = RS ⇤ ei( R(x,y) !t) (6.1b)
 (x, y) = S(x, y) + R(x, y) (6.1c)
h =
π
  ⇤dt = (IS + IR) + SR⇤ + S⇤R (6.1d)
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where AS and AR are the amplitudes of the Specimen and Reference beam,  S and
 R are the phase di erences between the specimen and reference beams,  is the
resulting wave from the superposition of the specimen and reference beams, and h
is the hologram.
In Supplementary Figure 6-S1b there are three discrete lobes present. The
center most lobe corresponds to the summation of intensities of the specimen and
reference beams (IS+ IR) from equation 6.1d, while the two higher spatial frequency
lobes correspond to SR⇤ and S⇤R from Equation 6.1d. These two lobes are complex
conjugates of each other, but for the purposes of this work, the lobe corresponding
to SR⇤ is the chosen lobe to be isolated in Supplementary Figure 6-S1c & S1d.
With the 3D information encoded in the hologram isolated, it is then convolved
with the discrete solution to the Fresnel Di raction Integral (G) as described by
Schnars, et al.43 The reconstructed complex wavefront   is
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A(x, y, z) = | (z)| (6.2c)
 (x, y, z) = arctan(F( (z))
R( (z)) ) (6.2d)
where F is the Fourier Transform operator, the amplitude image is calculated as
the magnitude of the complex wavefront  , and the quantitative phase image  is
defined as the inverse tangent of the imaginary parts of   divided by the real parts of
 . The function G is a pure phase object that describes the propagation of an electric
field through the focal plane (z) and can be modulated to calculate the reconstructed
wavefront throughout an entire volume. For a more in-depth derivation of this
function, see Schnars, et al43.
Post-Processing. With the reconstructed amplitude A(x, y, z, t), and phase
images  (x, y, z, t), post-processing is necessary to eliminate noise from various
sources including, but not limited to, photon/shot noise, speckle noise, digitization
noise, as well as detector noise. In addition, low spatial frequency artifacts are also
common in phase reconstructions due to tilt in the sample chamber relative to the
optical axis as well as objective lens curvature.
To remove as much noise from the reconstructed images as possible, temporally
averaged images are calculated and subtracted from each phase image, as well as
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conducting spatial frequency band-pass filtering. In the subtraction of temporally
averaged phase (referred to as ‘mean subtraction’), the mean of each pixel location
is calculated through time. This mean image is then subtracted from the image used
to calculate that mean. This e ectively removes any stationary artifacts from the
image highlighting any transient particle in the image.
After this mean subtraction, band-pass filtering is done to remove any low and
high spatial frequency noise from the images. Low spatial frequency noise can
be caused by tilt in the sample chamber relative to the optical axis, as well as by
the curvature of the lenses used in the DHM instrument. Because the DHM is
an instrument that is capable of achieving di raction limited resolution, there is a
physical limit of the spatial frequencies that can be recorded. This presents a clear
upper limit to the spatial frequencies that carry useful information in the image.
Any higher frequency artifacts in the image are by definition pure noise and can be
filtered out.
Because the phase images obtained using o -axis DHM are of a quantitative
nature, this is the extent of the post-processing performed in order to preserve the
quantitative information contained in the image. Other methods are more useful in
enhancing contrast and suppressing noise but were not performed in this work.
Physical Properties
Property GV Cluster (air) Alumina Water
Density (kg/m3) 1.2 2700 1000
Viscosity (Ns/m2) - - 8.9◊10-4
Hologram Simulator
The optical theory used in the MATLAB code discussed in this document are
well reviewed by Schnars, et al.43. The main function (‘OAhologramSimulator.m’)
expects as an input, two variables. The first is called ‘waveFront’. This is a complex
matrix of the size of the final image. This matrix describes the normalized amplitude
and phase of the electric field of the sample we wish to simulate. For the purposes
of this manuscript, the variable ‘waveFront’ is provided in the file ‘waveFront.mat’.
The second input variable is ‘desiredFileName’, which is the desired file path and
name of the output. The output is the final 8-bit TIFF hologram.
The variable ‘waveFront’ is generated by creating two 3-dimensional matrices
of the electric field attenuation and the index of refraction of light that passes through
a cylindrical simulated ‘salmonella cell’ with the morphology as shown in the main
manuscript.
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With the two 3D matrices, a series of radon transforms are used to project
a collimated beam of light through the object. These projections are then used to
calculate the resultant wave front as a result of the projected electric field attenuation
and phase delay (introduced by the index of refraction matrix).
The hologram simulation code can be separated and described in eight sections.
1 DHM Parameters
This section establishes the optical performance parameters of the DHM instrument
that is to be simulated. In this implementation, the o -axis holograms that are being
simulated are of the ‘low-power’ instrument and have the appropriate performance
parameters for that instrument.
Note that the numerical aperture of the objective lenses is not necessary because
the geometric properties of the objective lens is inputted as ‘fl’ and ‘DiaLens’ (lens
focal length and lens diameter, respectively).
2 Create the undisturbed reference beam
This section creates the reference wave. The reference wave by definition is undis-
turbed and unattenuated and thus the reference wave is a simple matrix of ones.
3 Propagate target and ref to lens object focal plane
This section takes the input variable ‘waveFront’ and the newly created reference
wave front ‘U2ref’ and propagates the two waves to the focal plane of the objective
lens. The propagation of the two waves is conducted using the Angular Spectrum
Method (ASM) as described in Schnars, et al43. The propagation is done by calling
an external function ‘ang_spec_prop.m’. The output of this section are the variables
‘U3’ and ‘U3ref’, corresponding to the propagated wave front of the sample (U3)
and reference (U3ref).
4 Propagate to the lens
This section takes the output from the previous section and propagates the two wave
fronts to the objective lens. This section uses the same external function as the
previous section. The outputs are ‘U4’ and ‘U4ref’
5 Simulate the phase delay introduced by the lens
This section models an ideal objective lens that introduces a phase delay into
light as it travels through the lens. This simulates an ideal lens because it introduces
no wave front aberrations or electric field attenuation.
In addition to simulating the phase delay caused by the objective lens, it
applies this phase delay to ‘U4’ and U4ref’. The output of this section is ‘Alens’
and ‘Alensref’.
6 Propagate to focal plane
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This section takes the output of the previous section and propagates the two wave
fronts to the back focal plane of the objective lens. The outputs of this section are
the variables ‘U5’ and ‘U5ref’.
7 Combine wavefront with reference wave
This section acts as the relay lens of the ‘low-power’ instrument by recombining the
object wave front (U5) with the reference wave front (U5ref) as well as introducing
a tilt angle between them so that they create interference patterns at the ‘detector’.
The output of this section becomes a single complex wave front ‘Uccd’.
8 Generate and save the hologram
Because optical detectors such as CCD’s only image electric field intensities, the
intensity of ‘Uccd’ is calculated and saved as an 8-bit TIFF image with the file path
and location inputted at the very beginning of this routine.
3D Pseudo-Colored Rendering
The 3D rendering was generated using the commercially available software ARIVIS
Vision4D. This software allows the import of a multidimensional image that is to
be visualized in a variety of ways. The 2D images that comprise the 3D image
stack used in ARIVIS were first processed using the methods described in the Image
Processing & Handling section of this document. These processed images were
then thresholded using a user defined threshold. Next the magnitude of the image
gradient was calculated and stored as a separate stack of 2D images. The two
3D image stacks were then imported to ARIVIS Vision4D. The pixel values were
plotted using a pseudo-colored lookup table. The opacity of each pixel was plotted
as a weighted function of the magnitude of the image gradient at that pixel. This
was done to highlight areas of large changes in phase signal within the cell.
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Figure 6-S1: Representative dynamic light scattering of the hydrodynamic diameter of
pristine gas vesicles, clustered gas vesicles and alumina beads.
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Figure 6-S2: The workflow for the initial processing of holographic data. (a) A raw
hologram. (b) The Fourier Transform of the raw hologram, plotted on a logarithmic scale.
(c) The Fourier Transform of the hologram multiplied by a mask to isolate one of the high
spatial frequency lobes. (d) The isolated lobe from (c) that has been linearly shifted to the
center.
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Figure 6-S3: Representative phase DHM images of clustered GVs collapsed using 1.2 MPa
of hydrostatic pressure. Scale bars represent 25 µm.
160
C h a p t e r 7
TOWARDS ROUTINE ULTRASOUND IMAGING OF
CELLULAR FUNCTION IN VIVO
This thesis describes some of the initial progress on genetic engineering of gas
vesicles and acoustic reporter genes along with applications in magnetic resonance
imaging (MRI) and quantitative phase microscopy. Chapter 2 introduced a platform
for biomolecular engineering of the acoustic and surface properties of gas vesicles as
nanoscale ultrasound contrast agents for delivery to the body. Chapter 3 extended this
platform by characterizing the recombinant expression of gas vesicles in common-
lab strain bacteria to make the genetic engineering of gas vesicles more versatile,
and to increase access for non-specialist labs. In Chapter 4, following our success
of developing a hybrid gene cluster that allowed probiotic microbes to express
gas vesicles and be visualized with ultrasound imaging in vivo1, we designed the
first mammalian acoustic reporter genes   a genetic code that when introduced
to mammalian cells enables ultrasound imaging of the cell’s gene expression and
location deep inside the body. In Chapter 5, the air inside the gas vesicles was
used to acquire MRI contrast (based on the magnetic susceptibility mismatch of air
and water), and with simultaneous use of ultrasound to collapse the gas vesicles
in situ, background-free MRI was acquired. Chapter 6 described the ability of the
air-filled structure of gas vesicles to interact with light and produce phase contrast
for quantitative phase imaging and digital holographic microscopy.
The potential opportunities in biomedical research and medicine for the tools
and technologies described above are numerous. However, much work remains
for gas vesicles and acoustic reporter genes to be commonly used tools in many
laboratories and clinics. Several possible future directions will be discussed below.
Future directions for mammalian acoustic reporter genes.
The first generation mammalian acoustic reporter genes (mARGs) should be im-
mediately useful for a number of biological investigations. However, there are
challenges that should be addressed in future studies.
mARGs currently encode a gas vesicle variant that produces linear ultrasound
signals di cult to detect over the strong linear backscattering of mammalian cells
when using conventional ultrasound imaging schemes. To image mARGs, an ultra-
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sound scheme was developed that acquires non-linear signal from gas vesicles as
they were being collapse with a high-pressure ultrasound pulse. This resulted in
a snapshot image. For a follow-up imaging experiment, the same cells will need
to re-express gas vesicles, which can take several days, thereby limiting the time
resolution of the study. Future designs of mARGs should be detectable using non-
destructive imaging schemes. One option would be to further optimize the mARGs
to increase the number of gas vesicles expressed per mammalian cells in order to
overcome the background signal from the cells; this strategy has been used to im-
age probiotic bacteria in the gastrointestinal tract of mice with bacterial ARGs1.
To achieve this an approximate increase of two orders of magnitude in gas vesicle
expression per cell will be required. Alternatively, a broader search for gas vesicle
variants which produce non-linear ultrasound signal that can be expressed in mam-
malian cells would be desirable. Our initial study was not successful at transferring
gas vesicle gene clusters from Anabaena flos-aquae and Halobacterium salinarum
to mammalian cells. The need for non-linear signal merits further investigation into
these two gene clusters and the numerous other micro-organisms that encode gas
vesicles gene clusters in their genome2–4.
In many scenarios it would be advantageous to simultaneously image multiple
biomolecules or biological processes. Multiplexed ultrasound imaging of mARGs
will require additional variants with di erent physical properties that can be distin-
guished from each other. Using the collapse-based ultrasound imaging paradigm,
one approach could be to design or search for mARG variants that collapse at ul-
trasound pressures far apart from one another, allowing di erent populations to be
independently collapsed and imaged5. Standard signal unmixing algorithms can
be used to produce multiplexed images. The accuracy and multiplexability of this
approach will rely on gas vesicle variants that collapse over a narrow range of ultra-
sound pressures in order to reduce spectral overlaps. Alternatively, if mARG variants
can be engineered to produce non-linear ultrasound without the need to be collapsed,
using some of the strategies discussed above, the added ultrasound signature can be
used to unmix their signals. An example experiment would acquire amplitude mod-
ulation images, to detect the new mARG variant, and a collapsed-based ultrasound
image to reveal both mARG variants; spectral unmixing can produce post-processed
duplexed images.
To advance the utility of mARGs beyond cell lines, future studies should engi-
neer mARGs for viral delivery to primary cells for in vitro and in vivo investigations.
Currently, mARGs are encoded by three gene cassettes that can be packaged in a
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single adenovirus for gene delivery. However, more commonly used viral vectors
(namely adeno-associated and lenti virus) contain smaller genome size6 and require
mARGs to be divided among di erent virons. Lentivirus should be a suitable start-
ing point as it can deliver a genetic payload up to 8-10 kilo-basepairs, allowing
the three mARG cassettes to fit into two virons that transduce the same cell. The
challenge may be that the heterogeneity in viral transduction will result in a mosaic
genetic delivery that would cause variable transgene-expression in cells. To make
the system more robust, future studies should consolidate the mARG architecture
to fit inside a single lentivirus genome. This can be achieved by optimizing the
stoichiometry of gas vesicle genes to eliminate the need for duplicate booster genes.
Future directions for injectable acoustic biomolecules.
Ultrasound is one of the most widely used medical imaging modalities in clinics.
The few contrast agents available for ultrasound limits its impact on functional and
molecular imaging, which are important for many biomedical applications. The
work in this thesis describes gas vesicles as injectable nanoscale ultrasound contrast
agents. However, for gas vesicles to be widely adopted as the standard injectable
ultrasound contrast agent, several challenges will need to be addressed.
It is expected that the size of gas vesicles will a ect their behavior in complex
biological environment of the body7,8 and will a ect the intensity of the backscat-
tered ultrasound. Accordingly, the size distribution of recombinantly expressed gas
vesicles should ideally be narrow and preferably tunable. In Chapter 3, the size
distribution of recombinantly expressed gas vesicles was measured. The diameter
of these gas vesicles was tightly centered at 59 ± 9 nm but their length had a broad
distribution centered around 129 ± 70 nm. To control the length of gas vesicles in
cells the process of nucleation and elongation into fully formed gas vesicles needs
to be tuned3. One approach to expressing uniform gas vesicles is to develop genetic
circuits that initially favor the nucleation process and then switch to the elongation
phase. Alternatively, the rate of nucleation could be reduced relative to the elonga-
tion rate. This would bias the system towards the elongation of the particles if the
nucleation rate is much slower than the elongation rate. The length of gas vesicles
would be dictated by the steady-state of the two rates. Both of these approaches will
need to account for the e ects of cellular growth and division on the assembly of the
gas vesicles inside the cell. Engineering of the gas vesicle gene circuits will require
biochemical understanding of the role that di erent gas vesicles proteins play in the
nucleation and elongation processes.
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Gas vesicles as injectable contrast agents for in vivo ultrasound imaging will
benefit from optimization of their surface properties to increase their circulation time
inside the body7,8. Over two decades of investigations on various nanoscale particles
have resulted in general strategies for reducing the clearance of nanoparticles from
the body via the renal and reticuloendothelial systems (RES). Using single-photon
emission computerized tomography (SPECT imaging) we have determined that gas
vesicles are minimally cleared through the renal system9. This is expected due to
their hydrodynamic diameter being larger than the fenestrations in the renal system.
Future work should focus on reducing gas vesicles’ RES clearance rate. To do so
the surface charge (zeta potential) of gas vesicles should be slightly negative but
close to neutral (-20 to 0 mV)8. In Chapter 3, recombinantly expressed gas vesicles
were measured to have a zeta potential of -32.8 ± 10 mV. Genetic methods similar
to Chapter 2 or bioconjugate chemistries can be used to engineer gas vesicles with
more desirable zeta potential for in vivo applications. Another important parameter
to reduce RES clearance of gas vesicles is the protein corona that forms around
the nanoparticles as they circulate through the vasculature. The protein corona
are serum proteins and antibodies (opsonins) that coat the surface of gas vesicles
and assist macrophages and endothelial cells to recognize and clear them. Typical
strategies to reduce the protein corona entail decorating the nanoparticle’s surface
with biopolymers (for example polyethylene glycol)8. Future designs that enable gas
vesicles to circulate in the bloodstream for several hours will be beneficial to many
studies such as brain imaging. With further optimization to extend circulation time
to order of days will be exciting for the context of imaging diseases such as cancer.
In conclusion, gas vesicles as acoustic reporter genes and acoustic biomolecules
are exciting emerging tools for a great many biological research and medical appli-
cations. Gas vesicles’ unique physical properties and engineerability makes them
an ideal platform for creative and challenging problem solving. It is my hope that
future biomolecular engineering will address many of the outstanding challenges
discussed in this thesis   allowing gas vesicles to float to new heights.
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